data_2nab_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nab _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.427 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 7.2 m-85 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.933 -0.395 . . . . 1.25 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.51 128.88 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 1.14 111.27 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.9 t -80.48 119.04 75.16 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.629 -0.878 . . . . 0.59 108.629 168.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.19 -26.48 82.38 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.823 2.349 . . . . 0.97 113.357 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.99 -37.39 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.508 -0.314 . . . . 1.29 111.689 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 m -96.87 -19.91 18.53 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.821 -0.351 . . . . 0.92 111.757 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.43 16.27 77.38 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 111.343 -0.703 . . . . 0.3 111.343 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.57 134.59 37.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.445 . . . . 2.23 111.354 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.63 129.12 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 2.26 110.852 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.522 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 51.7 m-85 -118.57 150.42 39.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.876 . . . . 0.76 110.505 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -105.04 -19.32 13.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 3.33 110.801 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -122.82 149.12 44.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.7 110.373 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -73.19 -41.51 63.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 3.82 111.896 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.61 -45.24 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.152 0.427 . . . . 1.27 112.152 -170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.621 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -74.86 -25.79 59.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.888 0.375 . . . . 0.73 110.626 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.621 ' N ' HD21 ' A' ' 26' ' ' ASN . 76.3 t80 -66.33 -50.24 64.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.934 -0.575 . . . . 1.04 110.148 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.95 -34.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 1.07 110.267 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.91 -45.82 92.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 4.22 110.152 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.95 -35.96 82.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.5 -0.773 . . . . 0.5 110.732 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.32 -0.4 . . . . 1.19 110.89 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 49.6 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 108.903 -0.777 . . . . 1.25 108.903 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.39 120.88 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.77 0.319 . . . . 1.14 111.348 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 t -76.79 118.68 73.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 0.59 109.177 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.44 -14.27 39.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.392 2.062 . . . . 0.97 112.135 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -89.71 -27.94 19.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.883 -0.599 . . . . 1.29 111.428 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -121.69 -20.29 6.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.673 0.619 . . . . 0.92 112.673 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.77 88.88 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.695 -0.764 . . . . 0.3 111.576 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -73.66 131.63 41.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.736 0.414 . . . . 2.23 110.406 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 57.4 mt -107.05 125.94 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.392 -0.367 . . . . 2.26 111.092 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.46 150.78 37.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.76 109.541 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -104.67 -19.45 13.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.057 0.456 . . . . 3.33 110.615 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -107.77 134.29 50.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.7 109.495 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.552 ' O ' HG12 ' A' ' 28' ' ' ILE . 38.2 ttm180 -71.99 -30.49 65.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.186 -0.461 . . . . 3.82 111.157 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.1 -46.5 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.651 0.262 . . . . 1.27 111.627 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.558 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.18 -25.86 58.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.73 110.278 177.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.558 ' N ' HD21 ' A' ' 26' ' ' ASN . 74.1 t80 -64.66 -50.0 68.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.068 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 24' ' ' ARG . 46.2 mm -62.05 -33.18 57.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 116.197 -0.456 . . . . 1.07 110.031 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -60.46 -47.12 87.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.22 110.608 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -70.29 -35.09 73.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.5 111.241 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.782 0.325 . . . . 1.19 111.223 177.961 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.444 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 26.6 m-85 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.497 -0.557 . . . . 1.25 109.497 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.1 126.36 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 1.14 110.913 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 11.0 t -76.84 118.43 71.7 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.837 -0.801 . . . . 0.59 108.837 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.36 -17.74 59.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.51 2.14 . . . . 0.97 112.145 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.3 t-20 -89.83 -28.36 19.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 1.29 111.561 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 m -121.66 -20.93 6.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.084 0.772 . . . . 0.92 113.084 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.56 83.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.664 -0.779 . . . . 0.3 111.239 -172.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 22.2 tptp -67.31 137.25 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.264 0.626 . . . . 2.23 110.851 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mm -102.47 130.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.653 . . . . 2.26 111.063 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.535 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.1 m-85 -119.19 150.04 40.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.691 -1.141 . . . . 0.76 110.634 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -106.02 -13.07 15.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.393 0.616 . . . . 3.33 110.447 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 17.4 m95 -127.57 133.32 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.384 -0.599 . . . . 0.7 109.384 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 28' ' ' ILE . 62.1 mtm180 -72.46 -28.96 63.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 3.82 111.529 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.15 -49.31 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 1.27 111.644 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -75.98 -30.2 58.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.512 -0.313 . . . . 0.73 110.956 176.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.535 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.0 t80 -59.15 -51.28 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 1.04 110.835 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 24' ' ' ARG . 51.2 mm -62.32 -34.59 64.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 1.07 110.217 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -65.33 -41.14 94.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 4.22 110.279 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -66.59 -37.34 84.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 0.5 110.84 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 1.19 110.365 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.801 -0.444 . . . . 1.25 109.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.67 115.12 48.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.361 -0.381 . . . . 1.14 110.501 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.6 t -67.09 122.53 83.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.123 -0.695 . . . . 0.59 109.123 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.44 -28.6 71.11 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 123.327 2.684 . . . . 0.97 112.715 -170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -89.08 -28.03 20.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.186 -0.916 . . . . 1.29 111.925 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -113.5 -19.16 11.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.191 0.441 . . . . 0.92 112.191 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.91 15.42 81.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.764 -0.732 . . . . 0.3 112.024 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -83.46 124.69 30.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.046 -0.353 . . . . 2.23 110.046 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.86 128.9 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.188 0.518 . . . . 2.26 110.498 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.436 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 95.1 m-85 -118.15 149.37 41.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.949 -0.569 . . . . 0.76 110.009 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -99.18 -9.28 23.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.139 0.495 . . . . 3.33 110.332 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.489 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 29.9 m95 -130.16 149.47 51.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.949 -0.569 . . . . 0.7 109.83 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 50.4 mtm180 -71.91 -38.82 69.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.161 -0.472 . . . . 3.82 111.582 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.2 -49.82 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.37 0.507 . . . . 1.27 112.37 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -70.83 -29.38 65.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.691 0.282 . . . . 0.73 110.812 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.436 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 55.2 t80 -62.98 -50.28 71.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.04 110.332 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 24' ' ' ARG . 42.6 mm -63.37 -35.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 1.07 110.285 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -59.84 -44.68 93.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 4.22 110.048 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -65.79 -39.8 91.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.5 110.991 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.469 -0.332 . . . . 1.19 110.741 178.493 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.73 -0.47 . . . . 1.25 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.9 123.97 69.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 1.14 110.597 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.79 116.86 42.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.59 108.683 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 -18.28 62.44 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.466 2.111 . . . . 0.97 112.398 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -90.62 -27.53 19.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.171 -0.468 . . . . 1.29 112.027 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.4 m -114.74 -20.36 10.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.364 -0.534 . . . . 0.92 112.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.58 86.73 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.778 -0.725 . . . . 0.3 111.595 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -78.7 129.14 34.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.993 -0.373 . . . . 2.23 109.993 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.61 131.42 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.007 0.432 . . . . 2.26 110.197 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.46 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 72.1 m-85 -117.48 149.82 39.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.76 110.645 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -96.55 -25.15 15.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.472 -0.786 . . . . 3.33 110.588 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -117.5 141.49 48.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.769 -0.651 . . . . 0.7 110.072 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -73.1 -35.13 66.53 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.361 0.504 . . . . 3.82 112.361 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.43 -44.31 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.854 -0.338 . . . . 1.27 111.282 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.594 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.57 -26.2 57.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.751 0.31 . . . . 0.73 110.606 178.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.594 ' N ' HD21 ' A' ' 26' ' ' ASN . 72.4 t80 -64.44 -50.84 65.97 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.313 -0.403 . . . . 1.04 110.426 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -63.81 -34.37 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.171 0.51 . . . . 1.07 109.96 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -61.06 -40.99 95.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 4.22 110.455 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -71.48 -41.12 69.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.5 111.115 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.805 0.336 . . . . 1.19 110.916 178.198 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.346 -0.242 . . . . 1.25 110.346 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.44 120.1 60.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.873 -0.418 . . . . 1.14 109.873 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.1 t -73.86 119.22 75.06 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.968 -0.753 . . . . 0.59 108.968 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.23 -27.24 78.12 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.178 2.586 . . . . 0.97 112.91 -171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.02 -41.47 11.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.229 -0.441 . . . . 1.29 111.911 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 m -98.05 -14.84 20.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.175 0.435 . . . . 0.92 112.175 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.64 78.8 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.681 -0.771 . . . . 0.3 111.916 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -84.09 126.74 33.36 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.178 -0.304 . . . . 2.23 110.178 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 tp -106.04 120.93 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.064 0.459 . . . . 2.26 110.765 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.485 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 94.9 m-85 -115.88 149.45 38.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.026 -0.533 . . . . 0.76 109.601 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -104.13 -12.25 16.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.892 -0.595 . . . . 3.33 110.428 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.559 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 37.1 m95 -126.47 142.69 51.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.849 -0.614 . . . . 0.7 109.979 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.3 ttt180 -72.89 -34.83 66.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 3.82 112.061 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 m -61.49 -49.17 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.806 0.336 . . . . 1.27 111.878 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -74.94 -29.06 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.474 -0.33 . . . . 0.73 110.864 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.485 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 59.9 t80 -59.95 -50.22 74.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 1.04 110.614 173.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 24' ' ' ARG . 35.6 mm -63.43 -33.63 62.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.07 110.339 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 4.22 109.923 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.68 -46.31 86.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.5 110.231 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.912 -0.585 . . . . 1.19 112.196 -178.424 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 45.1 m-85 . . . . . 0 CA--C 1.518 -0.267 0 N-CA-C 109.668 -0.493 . . . . 1.25 109.668 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 20.3 t -108.25 124.27 64.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.511 0.196 . . . . 1.14 110.958 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.89 118.58 69.49 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.339 -0.615 . . . . 0.59 109.339 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.29 -19.38 63.69 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.767 2.312 . . . . 0.97 112.305 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.3 -28.15 18.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.942 -0.572 . . . . 1.29 111.854 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.67 -19.69 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.965 0.728 . . . . 0.92 112.965 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 14.22 82.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.618 -0.801 . . . . 0.3 111.325 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.5 tptp -77.44 135.64 38.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.232 -0.484 . . . . 2.23 110.246 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.46 HG23 HG23 ' A' ' 13' ' ' VAL . 41.8 pt -106.68 128.72 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.195 0.522 . . . . 2.26 111.372 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 86.4 m-85 -118.08 150.11 39.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.76 110.029 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -95.73 -22.28 17.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 3.33 110.494 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.513 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 40.3 m95 -119.11 143.59 47.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.993 -0.549 . . . . 0.7 110.035 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' HG12 ' A' ' 28' ' ' ILE . 27.9 ttm180 -72.29 -34.62 68.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.785 -0.643 . . . . 3.82 111.593 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.55 -49.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 112.033 0.382 . . . . 1.27 112.033 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.3 -30.02 64.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.673 0.273 . . . . 0.73 110.504 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.43 ' O ' HD21 ' A' ' 31' ' ' LEU . 63.2 t80 -59.36 -50.85 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 1.04 110.697 174.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 24' ' ' ARG . 48.2 mm -65.12 -35.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.362 . . . . 1.07 110.234 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -61.1 -42.89 99.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.941 -0.572 . . . . 4.22 110.208 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -69.71 -33.57 72.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.5 110.895 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 27' ' ' PHE . 3.9 mm? . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 120.75 0.309 . . . . 1.19 110.769 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.098 -0.334 . . . . 1.25 110.098 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.11 126.82 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.041 -0.527 . . . . 1.14 111.048 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.2 t -77.37 118.63 73.23 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.724 -0.843 . . . . 0.59 108.724 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.61 -19.08 48.52 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.623 2.216 . . . . 0.97 112.565 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.17 -39.15 13.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.967 -0.561 . . . . 1.29 111.757 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -99.81 -19.79 16.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.715 -0.394 . . . . 0.92 111.869 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.78 16.01 80.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.731 -0.747 . . . . 0.3 111.316 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -86.48 130.09 34.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.552 -0.324 . . . . 2.23 110.588 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.17 134.04 45.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.554 -0.535 . . . . 2.26 109.554 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -118.37 149.9 40.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.058 -0.519 . . . . 0.76 110.302 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -96.13 -25.67 15.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.808 -0.633 . . . . 3.33 111.021 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.535 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 41.0 m95 -116.38 146.55 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.7 110.202 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 28' ' ' ILE . 77.2 mtm180 -72.36 -36.84 68.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 3.82 112.114 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -60.97 -49.5 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.854 0.316 . . . . 1.27 111.854 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.22 -31.93 66.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.664 0.268 . . . . 0.73 110.477 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.52 -50.7 72.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 1.04 110.745 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.7 mm -64.83 -32.27 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.219 0.533 . . . . 1.07 110.477 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.97 -48.42 76.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.012 -0.54 . . . . 4.22 110.178 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -65.98 -34.76 78.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.5 110.805 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 116.312 -0.404 . . . . 1.19 112.025 -179.407 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.927 -0.397 . . . . 1.25 109.927 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 43.7 t -108.41 125.27 65.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.813 0.339 . . . . 1.14 111.475 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.9 t -74.71 118.12 67.71 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.354 -0.98 . . . . 0.59 108.354 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.17 -22.07 54.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.666 2.244 . . . . 0.97 113.223 -169.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -85.3 -36.98 20.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.438 -0.346 . . . . 1.29 111.428 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 m -105.77 -19.64 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.035 0.383 . . . . 0.92 112.035 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.39 16.43 79.49 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.692 -0.766 . . . . 0.3 111.836 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 41.7 tptt -83.06 130.19 35.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.682 -0.259 . . . . 2.23 110.317 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tt -106.93 128.35 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.982 0.42 . . . . 2.26 111.212 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 85.9 m-85 -118.01 150.44 39.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.149 -0.478 . . . . 0.76 109.819 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -100.57 -16.83 17.34 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.878 -0.601 . . . . 3.33 110.439 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.433 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 22.8 m95 -122.6 146.27 47.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.96 -0.564 . . . . 0.7 109.833 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.456 ' O ' HG12 ' A' ' 28' ' ' ILE . 25.7 ttt180 -72.28 -39.29 68.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.889 -0.596 . . . . 3.82 112.441 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.05 -49.8 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.062 0.393 . . . . 1.27 112.062 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.53 -29.7 63.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.779 0.323 . . . . 0.73 110.663 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.509 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 48.4 t80 -61.18 -50.92 71.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.556 . . . . 1.04 110.956 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 24' ' ' ARG . 49.9 mm -63.87 -34.25 67.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.095 0.474 . . . . 1.07 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.25 -46.21 89.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.599 -0.728 . . . . 4.22 110.223 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.51 -27.28 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.5 111.522 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 C--N 1.322 -0.63 0 O-C-N 122.154 -0.341 . . . . 1.19 111.299 178.079 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.897 0.38 . . . . 1.25 110.655 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.09 126.45 70.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 1.14 110.452 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.41 118.59 67.48 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.59 108.997 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.14 -19.76 69.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.737 2.291 . . . . 0.97 112.438 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.47 -42.62 10.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.056 -0.52 . . . . 1.29 111.728 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.0 m -98.7 -19.91 17.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.92 112.195 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.36 15.52 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.3 111.08 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -80.79 130.48 35.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.089 -0.556 . . . . 2.23 109.985 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.44 129.13 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.321 0.581 . . . . 2.26 109.936 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.542 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 62.3 m-85 -117.38 149.95 39.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.278 0.561 . . . . 0.76 110.549 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -97.1 -31.58 12.41 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.243 -0.89 . . . . 3.33 110.723 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.57 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 50.9 m95 -110.99 143.42 41.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.7 110.402 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 28' ' ' ILE . 76.5 mtm180 -72.52 -35.13 68.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.517 -0.765 . . . . 3.82 111.537 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.23 -49.61 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.812 0.301 . . . . 1.27 111.812 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -74.65 -29.93 61.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 0.73 110.887 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.542 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 68.7 t80 -61.51 -51.14 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 1.04 110.969 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 24' ' ' ARG . 50.1 mm -62.36 -33.45 59.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.044 0.449 . . . . 1.07 110.264 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -66.55 -40.55 89.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 4.22 110.138 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.82 -39.12 90.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.5 110.622 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 1.19 110.833 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 72.2 m-85 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.484 -0.561 . . . . 1.25 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 20' ' ' ILE . 16.8 t -105.62 120.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.584 0.231 . . . . 1.14 111.291 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -75.18 119.16 75.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.109 -0.7 . . . . 0.59 109.109 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.85 -14.83 45.26 Favored 'Trans proline' 0 CA--C 1.526 0.115 0 C-N-CA 122.662 2.242 . . . . 0.97 112.906 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -91.15 -33.81 15.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.477 -0.329 . . . . 1.29 111.693 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.9 m -113.97 -18.57 11.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.827 0.677 . . . . 0.92 112.827 -170.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.43 15.2 79.09 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.404 -0.903 . . . . 0.3 110.937 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -79.66 126.32 30.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.544 . . . . 2.23 109.764 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 39.5 pt -106.69 128.69 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.598 . . . . 2.26 111.645 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.417 ' O ' ' HD1' ' A' ' 12' ' ' TYR . 83.1 m-85 -117.32 150.61 38.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.76 109.242 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -98.88 -21.92 16.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.948 0.404 . . . . 3.33 110.802 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -110.34 145.21 37.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.7 110.413 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -72.61 -36.78 68.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 3.82 111.536 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.67 -49.25 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.812 0.339 . . . . 1.27 111.867 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.582 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -71.16 -25.4 62.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.972 0.415 . . . . 0.73 110.709 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.582 ' N ' HD21 ' A' ' 26' ' ' ASN . 74.6 t80 -67.01 -50.04 63.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 1.04 110.362 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.26 -32.95 56.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 1.07 110.317 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -60.17 -48.37 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 4.22 110.578 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -64.76 -37.51 87.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.603 -0.726 . . . . 0.5 110.847 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.997 -0.547 . . . . 1.19 111.568 -179.741 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.687 -0.486 . . . . 1.25 109.687 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 41.9 t -108.3 117.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.926 -0.31 . . . . 1.14 110.844 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -70.98 118.52 66.28 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.413 -0.588 . . . . 0.59 109.413 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.33 -15.98 47.0 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.508 2.138 . . . . 0.97 112.472 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.88 -25.76 23.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.998 -0.546 . . . . 1.29 111.181 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -121.16 -19.96 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.469 0.544 . . . . 0.92 112.469 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.36 15.75 80.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.3 111.227 -173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.7 tptm -83.49 135.77 34.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.518 0.327 . . . . 2.23 110.191 -176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.26 125.6 61.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 2.26 110.371 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -116.71 147.74 41.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.76 109.997 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -98.52 -28.39 13.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.805 -0.634 . . . . 3.33 110.135 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -105.51 143.44 33.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.515 -0.766 . . . . 0.7 110.911 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 28' ' ' ILE . 45.4 ttp180 -72.59 -36.19 68.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.063 -0.971 . . . . 3.82 111.419 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.14 -48.61 80.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.86 0.319 . . . . 1.27 111.86 -173.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.618 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.98 -27.0 61.55 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.994 -0.282 . . . . 0.73 110.861 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.618 ' N ' HD21 ' A' ' 26' ' ' ASN . 74.1 t80 -66.61 -50.1 64.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.787 0.327 . . . . 1.04 110.34 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.0 mm -64.19 -36.46 77.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 1.07 110.425 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -61.62 -44.77 96.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.285 0.564 . . . . 4.22 110.253 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -66.9 -35.31 79.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.067 -0.97 . . . . 0.5 111.038 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 111.91 0.337 . . . . 1.19 111.91 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 110.145 -0.317 . . . . 1.25 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' A' ' 20' ' ' ILE . 10.2 t -108.14 116.82 52.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 1.14 110.51 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 17.4 t -72.25 121.2 84.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.59 109.274 173.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.81 -13.39 24.29 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.327 2.018 . . . . 0.97 110.328 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.518 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -90.17 -28.54 18.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.744 -1.571 . . . . 1.29 111.444 -173.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' OD1' ' A' ' 16' ' ' ASN . 34.6 m -123.53 -20.49 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.638 0.607 . . . . 0.92 112.638 177.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 16.19 76.64 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.06 -0.816 . . . . 0.3 111.06 -169.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -82.29 143.97 30.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.661 0.384 . . . . 2.23 110.91 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 13' ' ' VAL . 11.5 mm -105.44 128.39 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.393 0.616 . . . . 2.26 111.124 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.0 m-85 -118.23 148.41 42.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.975 -1.011 . . . . 0.76 110.263 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -104.04 -23.31 13.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.823 -0.626 . . . . 3.33 110.673 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -113.61 152.0 30.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.471 -0.331 . . . . 0.7 110.399 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.488 ' O ' HG12 ' A' ' 28' ' ' ILE . 10.9 tpp180 -71.66 -47.63 53.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 3.82 111.659 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -48.07 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.444 0.535 . . . . 1.27 112.444 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -68.36 -26.47 65.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.296 . . . . 0.73 110.975 -178.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.628 ' N ' HD21 ' A' ' 26' ' ' ASN . 81.0 t80 -69.7 -50.18 46.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 1.04 109.799 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 24' ' ' ARG . 37.8 mm -59.16 -41.96 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 1.07 109.845 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -59.55 -42.66 92.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.557 -0.747 . . . . 4.22 110.69 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -61.75 -42.87 99.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.546 -0.752 . . . . 0.5 111.254 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.443 -0.344 . . . . 1.19 110.79 179.257 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 110.371 -0.233 . . . . 1.25 110.371 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 HG22 HG12 ' A' ' 20' ' ' ILE . 11.3 t -108.66 115.67 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.758 -0.201 . . . . 1.14 111.176 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 t -70.67 120.93 81.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.59 109.528 173.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 -16.29 48.58 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.97 112.846 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.32 -32.82 16.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.695 0.284 . . . . 1.29 111.354 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 m -113.3 -20.16 11.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.654 0.613 . . . . 0.92 112.654 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.23 80.88 Favored Glycine 0 N--CA 1.453 -0.187 0 N-CA-C 110.586 -1.005 . . . . 0.3 110.586 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -77.27 124.37 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.773 -0.714 . . . . 2.23 109.699 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 36.2 mt -106.03 130.46 57.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.99 0.424 . . . . 2.26 110.745 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -115.28 149.11 38.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.722 -0.672 . . . . 0.76 110.105 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -96.99 -16.01 20.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.455 -0.793 . . . . 3.33 110.44 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -121.62 148.61 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.008 -0.542 . . . . 0.7 110.51 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 28' ' ' ILE . 56.7 ttt180 -71.54 -38.97 70.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 3.82 111.231 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 m -65.39 -48.59 82.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.158 0.429 . . . . 1.27 112.158 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.61 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.74 -26.22 61.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.567 0.223 . . . . 0.73 111.083 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.61 ' N ' HD21 ' A' ' 26' ' ' ASN . 63.5 t80 -65.97 -49.88 66.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 1.04 110.279 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 24' ' ' ARG . 43.8 mm -60.82 -33.19 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.583 . . . . 1.07 110.052 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -62.4 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 4.22 110.682 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -67.18 -37.29 83.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.5 110.883 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.339 -0.391 . . . . 1.19 110.873 178.173 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.428 ' HH ' ' HG2' ' A' ' 24' ' ' ARG . 38.3 m-85 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.208 -0.664 . . . . 1.25 109.208 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.408 HG23 HG22 ' A' ' 20' ' ' ILE . 15.6 t -108.58 120.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.642 0.258 . . . . 1.14 111.619 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -73.03 120.24 79.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.666 -0.865 . . . . 0.59 108.666 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.83 -17.11 41.99 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.576 2.184 . . . . 0.97 112.218 -173.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -90.18 -42.69 10.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.834 -0.621 . . . . 1.29 111.389 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.31 -20.12 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.923 0.342 . . . . 0.92 111.923 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.42 15.87 78.96 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 110.995 -0.842 . . . . 0.3 110.995 -173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -81.53 135.02 35.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.034 -0.583 . . . . 2.23 109.973 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 13' ' ' VAL . 49.2 pt -106.54 130.49 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.174 0.512 . . . . 2.26 111.031 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -117.4 149.33 40.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.733 -0.667 . . . . 0.76 109.977 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -96.53 -33.24 11.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.113 -0.494 . . . . 3.33 110.651 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 62.6 m95 -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.7 110.666 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 28' ' ' ILE . 8.8 mmm180 -71.24 -36.35 71.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 3.82 111.818 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 m -63.03 -48.66 86.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 1.27 111.857 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.98 -31.9 64.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.186 -0.206 . . . . 0.73 110.984 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.451 ' O ' HD22 ' A' ' 31' ' ' LEU . 59.3 t80 -61.04 -50.83 71.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.732 0.301 . . . . 1.04 110.565 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 24' ' ' ARG . 52.0 mm -65.28 -34.18 68.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 1.07 110.043 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -60.08 -44.9 94.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.969 -0.56 . . . . 4.22 110.201 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.94 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.687 -0.688 . . . . 0.5 111.158 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.847 0.356 . . . . 1.19 111.396 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.721 -0.552 . . . . 16.78 111.721 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.43 73.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.946 0.403 . . . . 15.14 111.216 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -89.79 29.86 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 15.07 111.596 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -87.75 58.5 4.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.81 0.814 . . . . 12.38 110.672 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.53 149.71 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.775 -1.195 . . . . 11.07 107.775 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.493 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.0 tp60 -71.78 86.42 0.95 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.344 0.593 . . . . 9.58 110.214 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -149.0 135.85 19.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.519 -0.764 . . . . 7.81 110.026 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -95.06 14.84 20.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.228 0.537 . . . . 5.96 109.999 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.54 -23.6 56.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 6.87 110.808 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 53.0 pttt -89.09 99.29 12.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.362 0.601 . . . . 6.17 110.367 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.3 m -145.27 21.84 1.54 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.125 -0.489 . . . . 2.15 110.795 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.427 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 7.2 m-85 -111.6 110.82 21.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.309 -0.405 . . . . 1.25 109.933 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.51 128.88 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 1.14 111.27 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.9 t -80.48 119.04 75.16 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.629 -0.878 . . . . 0.59 108.629 168.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.19 -26.48 82.38 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.823 2.349 . . . . 0.97 113.357 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.99 -37.39 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.508 -0.314 . . . . 1.29 111.689 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 m -96.87 -19.91 18.53 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.821 -0.351 . . . . 0.92 111.757 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.43 16.27 77.38 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 111.343 -0.703 . . . . 0.3 111.343 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.57 134.59 37.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.445 . . . . 2.23 111.354 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.63 129.12 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 2.26 110.852 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.522 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 51.7 m-85 -118.57 150.42 39.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.876 . . . . 0.76 110.505 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.42 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 68.4 ttt180 -105.04 -19.32 13.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 3.33 110.801 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -122.82 149.12 44.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.7 110.373 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -73.19 -41.51 63.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 3.82 111.896 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.61 -45.24 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.152 0.427 . . . . 1.27 112.152 -170.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.621 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -74.86 -25.79 59.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.888 0.375 . . . . 0.73 110.626 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.621 ' N ' HD21 ' A' ' 26' ' ' ASN . 76.3 t80 -66.33 -50.24 64.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.934 -0.575 . . . . 1.04 110.148 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.95 -34.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 1.07 110.267 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.91 -45.82 92.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 4.22 110.152 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.95 -35.96 82.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.5 -0.773 . . . . 0.5 110.732 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? -72.64 -25.72 61.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.32 -0.4 . . . . 1.19 110.89 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -80.04 -18.23 50.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.674 0.749 . . . . 4.66 109.657 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.6 t -78.7 -0.41 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.281 -0.872 . . . . 2.12 110.583 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -66.21 -25.01 66.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.211 0.529 . . . . 4.91 110.049 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -68.25 -16.58 64.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 8.59 110.166 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -93.54 0.24 56.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 6.23 110.633 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -93.72 175.76 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.995 0.426 . . . . 8.69 110.855 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.3 ptmm? -127.19 112.03 21.53 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.728 -0.669 . . . . 10.47 109.992 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.3 -40.76 35.7 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.919 3.079 . . . . 10.47 113.148 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -153.24 -79.3 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.471 -0.566 . . . . 12.96 109.471 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.3 tttm . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.15 0.907 . . . . 15.17 111.661 -179.635 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 112.013 -0.435 . . . . 16.78 112.013 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.95 57.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 15.14 111.422 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.2 mtm -124.3 42.76 3.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.616 0.722 . . . . 15.07 110.102 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.7 52.95 0.96 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.336 -0.847 . . . . 12.38 109.52 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -77.66 -24.16 14.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 11.07 110.335 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -74.78 99.46 3.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.849 -0.797 . . . . 9.58 108.849 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.494 HG23 ' NH2' ' A' ' 22' ' ' ARG . 8.8 t -151.59 27.17 0.65 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.105 0.955 . . . . 7.81 110.104 -175.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -96.77 160.95 14.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.678 -0.692 . . . . 5.96 110.086 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 63.74 41.14 7.19 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.147 0.499 . . . . 6.87 111.132 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -103.3 53.09 0.77 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.822 -0.626 . . . . 6.17 109.615 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -78.06 98.72 5.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.575 -0.739 . . . . 2.15 111.669 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 49.6 m-85 -89.99 115.59 27.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.903 -0.777 . . . . 1.25 108.903 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.39 120.88 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.77 0.319 . . . . 1.14 111.348 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 t -76.79 118.68 73.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 0.59 109.177 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.44 -14.27 39.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.392 2.062 . . . . 0.97 112.135 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -89.71 -27.94 19.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.883 -0.599 . . . . 1.29 111.428 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -121.69 -20.29 6.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.673 0.619 . . . . 0.92 112.673 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.77 88.88 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.695 -0.764 . . . . 0.3 111.576 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -73.66 131.63 41.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.736 0.414 . . . . 2.23 110.406 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 57.4 mt -107.05 125.94 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.392 -0.367 . . . . 2.26 111.092 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.46 150.78 37.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.76 109.541 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.494 ' NH2' HG23 ' A' ' 7' ' ' THR . 68.0 ttt180 -104.67 -19.45 13.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.057 0.456 . . . . 3.33 110.615 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -107.77 134.29 50.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.7 109.495 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.552 ' O ' HG12 ' A' ' 28' ' ' ILE . 38.2 ttm180 -71.99 -30.49 65.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.186 -0.461 . . . . 3.82 111.157 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.1 -46.5 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.651 0.262 . . . . 1.27 111.627 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.558 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.18 -25.86 58.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.73 110.278 177.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.558 ' N ' HD21 ' A' ' 26' ' ' ASN . 74.1 t80 -64.66 -50.0 68.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 1.04 110.068 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 24' ' ' ARG . 46.2 mm -62.05 -33.18 57.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 116.197 -0.456 . . . . 1.07 110.031 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -60.46 -47.12 87.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 4.22 110.608 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -70.29 -35.09 73.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.5 111.241 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -77.03 -29.55 55.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.782 0.325 . . . . 1.19 111.223 177.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 64.8 ttt180 -62.7 -40.98 98.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 4.66 109.836 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -103.34 42.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.468 -0.787 . . . . 2.12 110.248 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.77 153.62 43.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 4.91 110.907 -177.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 59.16 36.73 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.424 0.63 . . . . 8.59 110.473 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -150.68 131.45 14.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.221 -0.9 . . . . 6.23 109.748 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -92.03 -28.75 16.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.864 -0.607 . . . . 8.69 110.497 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -121.86 99.48 44.28 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.145 -0.48 . . . . 10.47 110.383 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.47 116.02 2.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.839 2.359 . . . . 10.47 111.993 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -81.31 -29.31 34.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.004 -0.543 . . . . 12.96 110.304 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.7 pttp . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.853 -0.612 . . . . 15.17 110.27 179.42 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.52 -0.632 . . . . 16.78 111.52 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.98 -62.63 1.55 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.383 . . . . 15.14 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.6 mtt -114.26 -8.75 12.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 15.07 111.039 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.29 70.08 6.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.262 0.553 . . . . 12.38 111.372 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -89.49 146.55 6.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.475 -0.784 . . . . 11.07 109.14 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.414 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 7.1 tp60 -68.27 100.07 1.0 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.927 0.394 . . . . 9.58 110.748 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -166.7 158.62 13.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.838 -0.619 . . . . 7.81 109.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 t -100.84 1.52 40.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.151 0.5 . . . . 5.96 109.787 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -99.29 47.5 0.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 6.87 110.124 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -144.5 25.0 1.53 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 6.17 110.39 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.3 m -96.96 34.08 1.78 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.667 -0.697 . . . . 2.15 111.181 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.444 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 26.6 m-85 -103.86 110.17 22.19 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.497 -0.557 . . . . 1.25 109.497 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.1 126.36 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 1.14 110.913 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 11.0 t -76.84 118.43 71.7 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.837 -0.801 . . . . 0.59 108.837 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.36 -17.74 59.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.51 2.14 . . . . 0.97 112.145 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.434 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.3 t-20 -89.83 -28.36 19.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 1.29 111.561 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 m -121.66 -20.93 6.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.084 0.772 . . . . 0.92 113.084 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.56 83.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.664 -0.779 . . . . 0.3 111.239 -172.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.41 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 22.2 tptp -67.31 137.25 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.264 0.626 . . . . 2.23 110.851 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mm -102.47 130.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.653 . . . . 2.26 111.063 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.535 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.1 m-85 -119.19 150.04 40.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.691 -1.141 . . . . 0.76 110.634 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -106.02 -13.07 15.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.393 0.616 . . . . 3.33 110.447 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 17.4 m95 -127.57 133.32 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.384 -0.599 . . . . 0.7 109.384 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.508 ' O ' HG12 ' A' ' 28' ' ' ILE . 62.1 mtm180 -72.46 -28.96 63.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 3.82 111.529 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.15 -49.31 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 1.27 111.644 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -75.98 -30.2 58.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.512 -0.313 . . . . 0.73 110.956 176.404 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.535 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.0 t80 -59.15 -51.28 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 1.04 110.835 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 24' ' ' ARG . 51.2 mm -62.32 -34.59 64.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 1.07 110.217 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -65.33 -41.14 94.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 4.22 110.279 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -66.59 -37.34 84.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 0.5 110.84 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD22 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? -73.42 -27.8 61.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 1.19 110.365 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -74.77 -16.39 60.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 4.66 109.955 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 t -94.82 22.61 6.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.811 . . . . 2.12 110.614 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -83.51 -25.44 31.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 4.91 110.395 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -70.91 -22.77 62.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.852 -0.613 . . . . 8.59 110.071 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -88.44 36.02 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 6.23 110.42 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -126.21 166.59 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 8.69 110.298 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -105.73 121.39 46.08 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.061 -0.518 . . . . 10.47 110.462 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.91 -60.28 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.836 2.357 . . . . 10.47 112.537 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -154.17 -49.28 0.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.481 -0.327 . . . . 12.96 110.458 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.107 -0.949 . . . . 15.17 110.253 -177.082 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 112.109 -0.397 . . . . 16.78 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 -66.78 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 15.14 110.435 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.0 ttp -99.29 -81.71 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 15.07 110.097 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 64.59 -64.53 0.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.947 0.779 . . . . 12.38 111.481 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.46 137.32 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.769 -0.456 . . . . 11.07 109.769 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -69.55 107.88 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.167 0.508 . . . . 9.58 110.396 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -113.5 111.63 22.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.916 -0.583 . . . . 7.81 111.357 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.6 t 55.35 44.21 27.66 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.744 -0.662 . . . . 5.96 110.255 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -121.25 156.18 33.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.751 -0.659 . . . . 6.87 109.595 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -102.35 74.14 1.38 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.475 0.655 . . . . 6.17 110.487 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -110.19 92.49 4.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.31 -0.859 . . . . 2.15 109.34 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -86.19 110.68 19.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.155 -0.475 . . . . 1.25 109.801 -177.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.67 115.12 48.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.361 -0.381 . . . . 1.14 110.501 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.6 t -67.09 122.53 83.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.123 -0.695 . . . . 0.59 109.123 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.44 -28.6 71.11 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 123.327 2.684 . . . . 0.97 112.715 -170.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -89.08 -28.03 20.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.186 -0.916 . . . . 1.29 111.925 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -113.5 -19.16 11.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.191 0.441 . . . . 0.92 112.191 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.91 15.42 81.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.764 -0.732 . . . . 0.3 112.024 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -83.46 124.69 30.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.046 -0.353 . . . . 2.23 110.046 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.86 128.9 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.188 0.518 . . . . 2.26 110.498 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.436 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 95.1 m-85 -118.15 149.37 41.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.949 -0.569 . . . . 0.76 110.009 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -99.18 -9.28 23.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.139 0.495 . . . . 3.33 110.332 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.489 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 29.9 m95 -130.16 149.47 51.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.949 -0.569 . . . . 0.7 109.83 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 50.4 mtm180 -71.91 -38.82 69.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.161 -0.472 . . . . 3.82 111.582 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.2 -49.82 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.37 0.507 . . . . 1.27 112.37 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.489 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -70.83 -29.38 65.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.691 0.282 . . . . 0.73 110.812 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.436 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 55.2 t80 -62.98 -50.28 71.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 1.04 110.332 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 24' ' ' ARG . 42.6 mm -63.37 -35.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 1.07 110.285 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -59.84 -44.68 93.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 4.22 110.048 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -65.79 -39.8 91.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.5 110.991 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.58 -35.14 76.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.469 -0.332 . . . . 1.19 110.741 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -73.51 -13.42 61.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.451 . . . . 4.66 110.429 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -98.04 30.22 3.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.571 . . . . 2.12 110.284 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -68.44 94.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.073 0.464 . . . . 4.91 110.365 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.498 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 1.7 mmp_? -101.3 60.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.988 -0.551 . . . . 8.59 109.804 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -82.58 65.78 7.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.253 0.549 . . . . 6.23 110.803 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.33 -62.46 1.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 8.69 110.159 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.81 147.31 33.8 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.624 -0.717 . . . . 10.47 109.909 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.27 40.07 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.949 2.433 . . . . 10.47 112.905 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 35.1 t60 69.95 -61.32 0.46 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.475 0.71 . . . . 12.96 111.778 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.4 tptp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.674 -0.679 . . . . 15.17 110.043 -178.101 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.719 -0.553 . . . . 16.78 111.719 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.5 -15.29 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 15.14 110.7 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtt -101.55 63.48 0.96 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 15.07 109.882 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -83.64 35.44 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 12.38 111.686 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -74.21 136.08 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.861 -0.609 . . . . 11.07 109.509 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.8 tp60 -72.76 106.26 4.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 9.58 110.461 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -162.25 136.24 6.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 7.81 109.756 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -83.4 -5.5 59.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 5.96 110.51 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.55 -33.6 75.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 6.87 110.957 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 60.2 pttt -76.11 77.84 2.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.77 0.795 . . . . 6.17 110.928 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -130.26 24.14 5.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.75 -0.659 . . . . 2.15 110.668 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -104.81 108.34 19.77 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.73 -0.47 . . . . 1.25 109.73 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.9 123.97 69.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 1.14 110.597 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.79 116.86 42.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.59 108.683 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 -18.28 62.44 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.466 2.111 . . . . 0.97 112.398 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -90.62 -27.53 19.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.171 -0.468 . . . . 1.29 112.027 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.4 m -114.74 -20.36 10.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.364 -0.534 . . . . 0.92 112.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.58 86.73 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.778 -0.725 . . . . 0.3 111.595 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -78.7 129.14 34.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.993 -0.373 . . . . 2.23 109.993 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.61 131.42 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.007 0.432 . . . . 2.26 110.197 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.46 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 72.1 m-85 -117.48 149.82 39.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.76 110.645 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -96.55 -25.15 15.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.472 -0.786 . . . . 3.33 110.588 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -117.5 141.49 48.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.769 -0.651 . . . . 0.7 110.072 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -73.1 -35.13 66.53 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.361 0.504 . . . . 3.82 112.361 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.43 -44.31 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.854 -0.338 . . . . 1.27 111.282 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.594 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.57 -26.2 57.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.751 0.31 . . . . 0.73 110.606 178.084 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.594 ' N ' HD21 ' A' ' 26' ' ' ASN . 72.4 t80 -64.44 -50.84 65.97 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.313 -0.403 . . . . 1.04 110.426 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -63.81 -34.37 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.171 0.51 . . . . 1.07 109.96 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -61.06 -40.99 95.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 4.22 110.455 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -71.48 -41.12 69.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.5 111.115 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.51 -37.52 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.805 0.336 . . . . 1.19 110.916 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -68.47 -23.49 64.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.168 0.509 . . . . 4.66 110.436 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -80.14 10.85 3.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.947 -0.569 . . . . 2.12 111.023 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -74.97 -9.18 58.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.463 0.649 . . . . 4.91 109.785 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.18 -22.99 66.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.996 -1.002 . . . . 8.59 111.252 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -112.89 27.71 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.376 -0.374 . . . . 6.23 111.526 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.57 170.28 8.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.916 0.389 . . . . 8.69 111.089 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -137.09 102.34 9.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.95 -0.568 . . . . 10.47 109.83 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.2 -43.89 24.93 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.569 2.846 . . . . 10.47 113.06 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -157.39 -65.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.579 -0.282 . . . . 12.96 110.32 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 15.17 110.712 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.819 -0.512 . . . . 16.78 111.819 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.33 123.53 11.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.773 0.287 . . . . 15.14 110.601 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -163.35 177.07 9.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.47 -0.332 . . . . 15.07 110.586 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 53.4 mm-40 -73.3 -177.45 2.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.486 -0.325 . . . . 12.38 111.139 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t 73.94 -61.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.755 -0.657 . . . . 11.07 111.19 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -90.04 7.25 38.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 9.58 111.104 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.447 ' OG1' ' HA ' ' A' ' 4' ' ' GLU . 3.7 m -60.09 -23.92 64.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 7.81 111.651 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m 65.27 26.74 12.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.527 -0.761 . . . . 5.96 110.782 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -75.84 -59.47 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 6.87 109.951 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -162.35 64.97 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.8 0.81 . . . . 6.17 110.872 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -95.0 100.35 12.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 2.15 109.612 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -96.31 110.97 23.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.559 -0.291 . . . . 1.25 110.346 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.44 120.1 60.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.873 -0.418 . . . . 1.14 109.873 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.1 t -73.86 119.22 75.06 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.968 -0.753 . . . . 0.59 108.968 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.23 -27.24 78.12 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.178 2.586 . . . . 0.97 112.91 -171.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' HH21 ' A' ' 35' ' ' ARG . 26.6 t-20 -90.02 -41.47 11.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.229 -0.441 . . . . 1.29 111.911 -175.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 m -98.05 -14.84 20.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.175 0.435 . . . . 0.92 112.175 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.64 78.8 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.681 -0.771 . . . . 0.3 111.916 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -84.09 126.74 33.36 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.178 -0.304 . . . . 2.23 110.178 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 tp -106.04 120.93 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.064 0.459 . . . . 2.26 110.765 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.485 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 94.9 m-85 -115.88 149.45 38.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.026 -0.533 . . . . 0.76 109.601 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -104.13 -12.25 16.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.892 -0.595 . . . . 3.33 110.428 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.559 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 37.1 m95 -126.47 142.69 51.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.849 -0.614 . . . . 0.7 109.979 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.3 ttt180 -72.89 -34.83 66.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 3.82 112.061 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 m -61.49 -49.17 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.806 0.336 . . . . 1.27 111.878 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -74.94 -29.06 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.474 -0.33 . . . . 0.73 110.864 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.485 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 59.9 t80 -59.95 -50.22 74.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 1.04 110.614 173.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.64 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 35.6 mm -63.43 -33.63 62.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 1.07 110.339 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 4.22 109.923 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.68 -46.31 86.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.5 110.231 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.5 -24.02 67.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.912 -0.585 . . . . 1.19 112.196 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.64 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 5.1 mmp_? -58.37 -38.58 77.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 4.66 110.463 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 29.9 t -96.86 -22.62 16.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.042 0.448 . . . . 2.12 109.991 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 33' ' ' SER . 81.1 mtm180 70.86 -81.69 0.03 OUTLIER 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.171 -0.922 . . . . 4.91 111.325 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.431 HH21 ' ND2' ' A' ' 16' ' ' ASN . 40.6 ttm180 -101.61 130.21 47.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.647 -0.706 . . . . 8.59 110.636 -171.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -86.01 -42.09 14.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.538 . . . . 6.23 110.874 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -117.82 139.7 50.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.338 0.59 . . . . 8.69 110.511 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 25.3 ttmm -96.85 -43.29 0.25 Allowed Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.31 -0.859 . . . . 10.47 110.84 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.458 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 15.7 Cg_exo -70.26 147.73 60.31 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.683 1.589 . . . . 10.47 111.492 172.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -80.46 59.94 3.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 12.96 110.668 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.545 -0.741 . . . . 15.17 110.11 -178.26 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 112.222 -0.351 . . . . 16.78 112.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.69 66.48 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.072 0.463 . . . . 15.14 111.443 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.1 ttm -82.51 98.11 8.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.893 -0.594 . . . . 15.07 109.922 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -80.28 155.69 27.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 12.38 110.923 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.72 150.14 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.68 -0.691 . . . . 11.07 111.201 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.97 112.72 22.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.83 -0.623 . . . . 9.58 110.258 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -119.47 4.57 11.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 7.81 110.965 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -96.5 134.68 39.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.689 . . . . 5.96 109.609 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -74.86 -55.96 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 6.87 112.032 -170.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -135.94 33.53 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.316 0.579 . . . . 6.17 110.914 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 p -131.68 86.09 2.31 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.454 -0.794 . . . . 2.15 109.618 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 45.1 m-85 -96.56 122.34 39.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.522 -0.763 . . . . 1.25 109.668 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 20.3 t -108.25 124.27 64.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.511 0.196 . . . . 1.14 110.958 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.89 118.58 69.49 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.339 -0.615 . . . . 0.59 109.339 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.29 -19.38 63.69 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.767 2.312 . . . . 0.97 112.305 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.3 -28.15 18.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.942 -0.572 . . . . 1.29 111.854 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.67 -19.69 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.965 0.728 . . . . 0.92 112.965 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 14.22 82.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.618 -0.801 . . . . 0.3 111.325 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.5 tptp -77.44 135.64 38.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.232 -0.484 . . . . 2.23 110.246 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.46 HG23 HG23 ' A' ' 13' ' ' VAL . 41.8 pt -106.68 128.72 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.195 0.522 . . . . 2.26 111.372 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 86.4 m-85 -118.08 150.11 39.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.76 110.029 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -95.73 -22.28 17.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 3.33 110.494 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 40.3 m95 -119.11 143.59 47.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.993 -0.549 . . . . 0.7 110.035 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.409 ' O ' HG12 ' A' ' 28' ' ' ILE . 27.9 ttm180 -72.29 -34.62 68.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.785 -0.643 . . . . 3.82 111.593 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.55 -49.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 112.033 0.382 . . . . 1.27 112.033 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.513 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.3 -30.02 64.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.673 0.273 . . . . 0.73 110.504 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.43 ' O ' HD21 ' A' ' 31' ' ' LEU . 63.2 t80 -59.36 -50.85 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 1.04 110.697 174.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.409 HG12 ' O ' ' A' ' 24' ' ' ARG . 48.2 mm -65.12 -35.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.362 . . . . 1.07 110.234 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -61.1 -42.89 99.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.941 -0.572 . . . . 4.22 110.208 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -69.71 -33.57 72.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.5 110.895 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.43 HD21 ' O ' ' A' ' 27' ' ' PHE . 3.9 mm? -71.42 -31.14 66.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.75 0.309 . . . . 1.19 110.769 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -72.27 -12.65 61.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 4.66 111.352 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -62.21 -33.51 74.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.931 0.396 . . . . 2.12 110.112 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' GLU . 9.7 ptm180 -104.75 87.48 2.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.45 0.643 . . . . 4.91 110.863 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -82.78 38.96 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.139 0.971 . . . . 8.59 109.113 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.457 ' H ' ' C ' ' A' ' 34' ' ' ARG . 19.1 mm-40 -77.09 -17.74 58.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.984 -1.007 . . . . 6.23 109.487 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -65.62 153.76 40.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 8.69 110.145 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -81.62 134.97 49.95 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 109.209 -0.663 . . . . 10.47 109.209 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.29 61.09 5.82 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.643 2.229 . . . . 10.47 112.951 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -73.43 -16.7 61.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.359 0.6 . . . . 12.96 109.398 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.285 -0.864 . . . . 15.17 109.42 175.77 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.972 -0.451 . . . . 16.78 111.972 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.09 26.81 3.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.175 0.512 . . . . 15.14 110.703 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -92.67 64.14 4.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 15.07 109.783 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.18 20.45 5.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 12.38 111.289 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.36 128.93 36.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 11.07 109.678 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.462 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.7 tp60 -72.34 101.96 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.072 0.463 . . . . 9.58 110.616 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -165.64 146.31 6.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.867 -0.606 . . . . 7.81 110.054 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -100.72 6.77 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 5.96 110.186 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.17 -28.34 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.066 -0.515 . . . . 6.87 110.428 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -76.13 61.59 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.844 0.831 . . . . 6.17 111.078 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -118.15 27.29 9.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.654 -0.703 . . . . 2.15 110.821 -175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.09 107.6 17.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.453 -0.499 . . . . 1.25 110.098 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.11 126.82 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.041 -0.527 . . . . 1.14 111.048 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.2 t -77.37 118.63 73.23 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.724 -0.843 . . . . 0.59 108.724 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.61 -19.08 48.52 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.623 2.216 . . . . 0.97 112.565 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.17 -39.15 13.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.967 -0.561 . . . . 1.29 111.757 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -99.81 -19.79 16.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.715 -0.394 . . . . 0.92 111.869 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.78 16.01 80.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.731 -0.747 . . . . 0.3 111.316 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -86.48 130.09 34.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.552 -0.324 . . . . 2.23 110.588 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.17 134.04 45.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.554 -0.535 . . . . 2.26 109.554 176.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -118.37 149.9 40.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.058 -0.519 . . . . 0.76 110.302 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -96.13 -25.67 15.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.808 -0.633 . . . . 3.33 111.021 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.535 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 41.0 m95 -116.38 146.55 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.7 110.202 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' O ' HG12 ' A' ' 28' ' ' ILE . 77.2 mtm180 -72.36 -36.84 68.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 3.82 112.114 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -60.97 -49.5 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.854 0.316 . . . . 1.27 111.854 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.535 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.22 -31.93 66.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.664 0.268 . . . . 0.73 110.477 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.52 -50.7 72.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 1.04 110.745 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.7 mm -64.83 -32.27 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.219 0.533 . . . . 1.07 110.477 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.97 -48.42 76.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.012 -0.54 . . . . 4.22 110.178 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -65.98 -34.76 78.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.5 110.805 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.83 -24.54 61.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.312 -0.404 . . . . 1.19 112.025 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -70.23 -17.19 63.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.218 0.532 . . . . 4.66 110.163 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -79.34 13.96 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.907 -0.588 . . . . 2.12 110.839 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -70.73 -13.52 62.09 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.86 0.362 . . . . 4.91 111.335 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -76.6 -14.24 60.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.33 0.586 . . . . 8.59 110.018 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -104.26 22.95 13.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.733 -0.667 . . . . 6.23 110.906 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -91.53 167.62 12.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.139 -0.482 . . . . 8.69 110.279 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 13.8 ptmm? -139.71 108.56 7.14 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.953 0.406 . . . . 10.47 110.557 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' A' ' 38' ' ' LYS . 10.5 Cg_endo -55.39 -39.9 88.5 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.96 2.44 . . . . 10.47 112.411 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -159.51 -57.96 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.154 -0.475 . . . . 12.96 110.145 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.123 -0.942 . . . . 15.17 110.643 -178.935 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.979 -0.448 . . . . 16.78 111.979 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.08 86.69 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.009 0.433 . . . . 15.14 110.888 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -124.99 105.58 9.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.109 -0.496 . . . . 15.07 110.039 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -160.78 97.1 1.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.827 -0.624 . . . . 12.38 109.505 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -73.73 107.53 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.055 0.455 . . . . 11.07 110.156 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.425 ' H ' ' CD ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -80.33 85.63 5.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.502 -0.772 . . . . 9.58 111.525 -174.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 10' ' ' LYS . 14.5 t -168.48 159.1 10.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 7.81 110.112 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -114.34 -27.23 7.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.115 -0.493 . . . . 5.96 111.277 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -130.95 -16.44 3.25 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.217 0.451 . . . . 6.87 112.217 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.467 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 4.1 mptp? -84.49 68.78 10.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.396 0.617 . . . . 6.17 110.695 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -129.0 78.69 1.87 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.467 -0.788 . . . . 2.15 109.64 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.49 114.03 20.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.573 -0.739 . . . . 1.25 109.927 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 43.7 t -108.41 125.27 65.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.813 0.339 . . . . 1.14 111.475 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.9 t -74.71 118.12 67.71 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.354 -0.98 . . . . 0.59 108.354 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.17 -22.07 54.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.666 2.244 . . . . 0.97 113.223 -169.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -85.3 -36.98 20.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.438 -0.346 . . . . 1.29 111.428 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 m -105.77 -19.64 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.035 0.383 . . . . 0.92 112.035 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.39 16.43 79.49 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.692 -0.766 . . . . 0.3 111.836 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 41.7 tptt -83.06 130.19 35.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.682 -0.259 . . . . 2.23 110.317 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tt -106.93 128.35 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.982 0.42 . . . . 2.26 111.212 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.509 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 85.9 m-85 -118.01 150.44 39.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.149 -0.478 . . . . 0.76 109.819 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -100.57 -16.83 17.34 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.878 -0.601 . . . . 3.33 110.439 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.433 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 22.8 m95 -122.6 146.27 47.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.96 -0.564 . . . . 0.7 109.833 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' O ' HG12 ' A' ' 28' ' ' ILE . 25.7 ttt180 -72.28 -39.29 68.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.889 -0.596 . . . . 3.82 112.441 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.05 -49.8 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.062 0.393 . . . . 1.27 112.062 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.433 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.53 -29.7 63.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.779 0.323 . . . . 0.73 110.663 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.509 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 48.4 t80 -61.18 -50.92 71.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.556 . . . . 1.04 110.956 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 24' ' ' ARG . 49.9 mm -63.87 -34.25 67.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.095 0.474 . . . . 1.07 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.25 -46.21 89.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.599 -0.728 . . . . 4.22 110.223 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.51 -27.28 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.5 111.522 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.7 -23.22 67.03 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.154 -0.341 . . . . 1.19 111.299 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -60.42 -25.77 66.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 4.66 109.43 169.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.7 m -97.31 74.73 2.51 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.265 1.031 . . . . 2.12 110.432 172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -118.57 -53.56 2.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.845 -1.525 . . . . 4.91 107.733 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -159.6 60.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.749 -1.114 . . . . 8.59 109.757 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.487 ' HG2' ' N ' ' A' ' 37' ' ' GLN . 1.4 pm0 -85.48 -46.46 10.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.772 -0.371 . . . . 6.23 110.114 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.487 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 14.5 mm100 -146.11 -70.36 0.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.585 . . . . 8.69 109.765 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.16 125.46 26.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.7 -0.682 . . . . 10.47 109.876 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.99 116.25 2.66 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.141 2.561 . . . . 10.47 112.771 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -93.55 64.76 3.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 12.96 110.658 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.462 -0.78 . . . . 15.17 109.689 177.865 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.818 -0.513 . . . . 16.78 111.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.61 -1.65 22.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 15.14 111.315 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.5 mtt -88.32 -12.67 42.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.369 . . . . 15.07 111.164 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -78.83 57.34 2.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.113 0.483 . . . . 12.38 111.231 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.38 126.6 41.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.782 -0.645 . . . . 11.07 109.499 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.8 tp60 -72.06 89.17 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.115 0.484 . . . . 9.58 110.756 -177.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -166.91 148.85 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.961 -0.563 . . . . 7.81 110.075 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 t -91.28 76.65 5.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.952 -0.759 . . . . 5.96 108.952 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -146.51 -41.39 0.2 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 6.87 111.483 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.415 ' HB2' HD11 ' A' ' 20' ' ' ILE . 47.7 pttt -75.32 70.73 2.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.771 0.796 . . . . 6.17 111.172 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -115.53 12.78 16.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.596 -0.729 . . . . 2.15 110.795 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -97.39 108.42 21.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.897 0.38 . . . . 1.25 110.655 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.09 126.45 70.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 1.14 110.452 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.41 118.59 67.48 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.59 108.997 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.14 -19.76 69.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.737 2.291 . . . . 0.97 112.438 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.47 -42.62 10.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.056 -0.52 . . . . 1.29 111.728 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.0 m -98.7 -19.91 17.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.92 112.195 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.36 15.52 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.3 111.08 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -80.79 130.48 35.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.089 -0.556 . . . . 2.23 109.985 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.415 HD11 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -106.44 129.13 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.321 0.581 . . . . 2.26 109.936 -178.411 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 62.3 m-85 -117.38 149.95 39.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.278 0.561 . . . . 0.76 110.549 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -97.1 -31.58 12.41 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.243 -0.89 . . . . 3.33 110.723 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.57 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 50.9 m95 -110.99 143.42 41.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.7 110.402 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.517 ' O ' HG12 ' A' ' 28' ' ' ILE . 76.5 mtm180 -72.52 -35.13 68.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.517 -0.765 . . . . 3.82 111.537 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.23 -49.61 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.812 0.301 . . . . 1.27 111.812 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -74.65 -29.93 61.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 0.73 110.887 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.542 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 68.7 t80 -61.51 -51.14 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 1.04 110.969 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.517 HG12 ' O ' ' A' ' 24' ' ' ARG . 50.1 mm -62.36 -33.45 59.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.044 0.449 . . . . 1.07 110.264 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -66.55 -40.55 89.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 4.22 110.138 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.82 -39.12 90.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.5 110.622 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? -69.01 -25.16 64.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 1.19 110.833 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -68.17 -26.16 65.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.336 0.588 . . . . 4.66 110.028 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -76.1 2.34 13.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.649 -0.705 . . . . 2.12 111.2 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -69.72 -21.07 63.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.338 0.59 . . . . 4.91 109.892 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -83.05 -7.37 59.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.438 -0.801 . . . . 8.59 109.953 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.28 16.27 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 6.23 109.961 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.94 164.77 12.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 8.69 110.622 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -99.16 130.9 26.27 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.795 -0.639 . . . . 10.47 110.213 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.81 -63.38 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.365 2.71 . . . . 10.47 113.205 -173.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -159.62 -58.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.311 -0.404 . . . . 12.96 110.342 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.2 tttm . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.972 -1.013 . . . . 15.17 109.975 -174.396 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.179 -0.369 . . . . 16.78 112.179 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.73 118.05 25.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.427 -0.212 . . . . 15.14 110.427 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.0 mtm 72.69 -44.42 0.59 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 15.07 111.406 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.33 141.05 51.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.705 -0.48 . . . . 12.38 109.705 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.65 159.95 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.255 -0.429 . . . . 11.07 110.611 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -89.38 43.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.33 0.586 . . . . 9.58 110.755 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.57 145.9 13.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.415 -0.811 . . . . 7.81 109.67 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -74.5 -60.5 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.142 -0.481 . . . . 5.96 111.01 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.436 ' HG3' ' HG2' ' A' ' 10' ' ' LYS . 3.0 pt20 -170.62 -45.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.191 -0.459 . . . . 6.87 110.921 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.436 ' HG2' ' HG3' ' A' ' 9' ' ' GLN . 51.8 pttt -153.71 128.96 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 6.17 110.85 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -101.53 141.31 34.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.002 -0.545 . . . . 2.15 109.716 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 72.2 m-85 -100.06 117.36 34.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.906 -0.588 . . . . 1.25 109.484 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 20' ' ' ILE . 16.8 t -105.62 120.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.584 0.231 . . . . 1.14 111.291 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -75.18 119.16 75.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.109 -0.7 . . . . 0.59 109.109 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.85 -14.83 45.26 Favored 'Trans proline' 0 CA--C 1.526 0.115 0 C-N-CA 122.662 2.242 . . . . 0.97 112.906 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -91.15 -33.81 15.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.477 -0.329 . . . . 1.29 111.693 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.9 m -113.97 -18.57 11.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.827 0.677 . . . . 0.92 112.827 -170.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.43 15.2 79.09 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.404 -0.903 . . . . 0.3 110.937 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -79.66 126.32 30.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.544 . . . . 2.23 109.764 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 39.5 pt -106.69 128.69 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.598 . . . . 2.26 111.645 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.417 ' O ' ' HD1' ' A' ' 12' ' ' TYR . 83.1 m-85 -117.32 150.61 38.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.76 109.242 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -98.88 -21.92 16.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.948 0.404 . . . . 3.33 110.802 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -110.34 145.21 37.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.7 110.413 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -72.61 -36.78 68.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 3.82 111.536 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.67 -49.25 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.812 0.339 . . . . 1.27 111.867 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.582 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -71.16 -25.4 62.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.972 0.415 . . . . 0.73 110.709 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.582 ' N ' HD21 ' A' ' 26' ' ' ASN . 74.6 t80 -67.01 -50.04 63.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 1.04 110.362 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.26 -32.95 56.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 1.07 110.317 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -60.17 -48.37 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 4.22 110.578 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -64.76 -37.51 87.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.603 -0.726 . . . . 0.5 110.847 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.35 -24.62 50.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.997 -0.547 . . . . 1.19 111.568 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -64.03 -35.86 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 4.66 110.137 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.512 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 21.3 m -86.21 42.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 2.12 110.053 175.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -56.98 146.88 25.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.574 -0.739 . . . . 4.91 111.01 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 70.54 48.67 0.44 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.34 1.067 . . . . 8.59 108.257 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.512 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.2 mp0 -60.78 -48.13 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.839 -1.528 . . . . 6.23 110.152 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 67.84 165.3 0.23 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.404 -0.816 . . . . 8.69 111.192 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 23.7 tptm -94.89 -53.33 0.23 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.584 -0.734 . . . . 10.47 110.758 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 93.4 Cg_endo -78.38 92.34 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.941 1.761 . . . . 10.47 112.161 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -105.47 25.47 10.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.254 -0.43 . . . . 12.96 111.341 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.716 -0.659 . . . . 15.17 109.804 177.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.023 -0.431 . . . . 16.78 112.023 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.73 101.39 9.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.765 0.317 . . . . 15.14 110.522 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.4 ttt -59.44 -51.08 71.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.76 -0.655 . . . . 15.07 110.802 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -110.85 113.0 25.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.864 -0.607 . . . . 12.38 109.691 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.8 t -61.75 119.33 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 11.07 111.14 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 56.65 63.98 1.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.109 -0.95 . . . . 9.58 110.898 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -83.03 60.23 5.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.813 0.816 . . . . 7.81 109.467 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.589 ' OG ' ' HD3' ' A' ' 22' ' ' ARG . 66.1 m 65.06 -80.67 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.583 -1.19 . . . . 5.96 111.175 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -175.11 -48.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.214 0.531 . . . . 6.87 109.929 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.773 ' HZ3' ' HH ' ' A' ' 12' ' ' TYR . 21.8 pttp -93.63 150.69 20.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.597 -0.729 . . . . 6.17 109.985 -178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.0 p -150.04 125.13 10.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.143 0.497 . . . . 2.15 110.841 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.773 ' HH ' ' HZ3' ' A' ' 10' ' ' LYS . 14.0 m-85 -100.99 120.65 40.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.734 -0.667 . . . . 1.25 109.687 -178.079 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 41.9 t -108.3 117.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.926 -0.31 . . . . 1.14 110.844 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -70.98 118.52 66.28 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.413 -0.588 . . . . 0.59 109.413 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.33 -15.98 47.0 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.508 2.138 . . . . 0.97 112.472 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.88 -25.76 23.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.998 -0.546 . . . . 1.29 111.181 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -121.16 -19.96 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.469 0.544 . . . . 0.92 112.469 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.36 15.75 80.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.3 111.227 -173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.7 tptm -83.49 135.77 34.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.518 0.327 . . . . 2.23 110.191 -176.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.26 125.6 61.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 2.26 110.371 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -116.71 147.74 41.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.76 109.997 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.589 ' HD3' ' OG ' ' A' ' 8' ' ' SER . 13.1 ttm180 -98.52 -28.39 13.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.805 -0.634 . . . . 3.33 110.135 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -105.51 143.44 33.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.515 -0.766 . . . . 0.7 110.911 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.439 ' O ' HG12 ' A' ' 28' ' ' ILE . 45.4 ttp180 -72.59 -36.19 68.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.063 -0.971 . . . . 3.82 111.419 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.14 -48.61 80.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.86 0.319 . . . . 1.27 111.86 -173.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.618 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.98 -27.0 61.55 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.994 -0.282 . . . . 0.73 110.861 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.618 ' N ' HD21 ' A' ' 26' ' ' ASN . 74.1 t80 -66.61 -50.1 64.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.787 0.327 . . . . 1.04 110.34 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.0 mm -64.19 -36.46 77.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 1.07 110.425 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -61.62 -44.77 96.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.285 0.564 . . . . 4.22 110.253 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -66.9 -35.31 79.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.067 -0.97 . . . . 0.5 111.038 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 3.9 mm? -78.08 -34.47 50.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.91 0.337 . . . . 1.19 111.91 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.34 -42.31 99.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.83 0.347 . . . . 4.66 110.935 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -75.76 -33.85 60.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.409 . . . . 2.12 110.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 11.2 mtp180 67.49 -63.46 0.3 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.402 0.681 . . . . 4.91 112.521 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.481 ' NH2' ' HA ' ' A' ' 39' ' ' PRO . 23.3 tpt180 -156.21 -70.17 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.169 -0.308 . . . . 8.59 110.169 -176.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 55.77 42.32 29.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.432 0.457 . . . . 6.23 111.779 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.81 138.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.741 -0.837 . . . . 8.69 108.741 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -54.22 113.22 4.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 10.47 111.633 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.481 ' HA ' ' NH2' ' A' ' 35' ' ' ARG . 64.4 Cg_endo -76.95 -24.88 9.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.789 2.326 . . . . 10.47 111.993 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -179.86 -29.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.123 -0.944 . . . . 12.96 108.895 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.405 ' HE3' ' HB2' ' A' ' 41' ' ' LYS . 39.2 ttmt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 115.323 -0.853 . . . . 15.17 109.339 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.08 -0.408 . . . . 16.78 112.08 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.2 -48.95 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.352 . . . . 15.14 110.916 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -86.67 109.55 19.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.43 . . . . 15.07 110.155 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -171.22 101.43 0.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.881 -0.6 . . . . 12.38 109.793 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t 56.35 66.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.632 0.729 . . . . 11.07 110.473 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 3.4 pt20 -108.72 32.48 4.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.533 -0.758 . . . . 9.58 110.36 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -59.46 -74.87 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.335 -0.848 . . . . 7.81 111.268 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t -142.26 9.92 1.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.77 0.319 . . . . 5.96 110.637 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.45 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 17.8 pt20 -115.17 1.09 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.713 0.292 . . . . 6.87 111.498 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 64.9 tttm -154.14 148.47 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 6.17 109.505 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' OG ' ' HB2' ' A' ' 6' ' ' GLN . 21.4 p 47.24 72.63 0.24 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.891 0.744 . . . . 2.15 110.362 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -77.42 124.78 28.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.227 -0.897 . . . . 1.25 110.145 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' A' ' 20' ' ' ILE . 10.2 t -108.14 116.82 52.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 1.14 110.51 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.518 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 17.4 t -72.25 121.2 84.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.59 109.274 173.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.81 -13.39 24.29 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.327 2.018 . . . . 0.97 110.328 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.518 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -90.17 -28.54 18.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.744 -1.571 . . . . 1.29 111.444 -173.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.6 m -123.53 -20.49 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.638 0.607 . . . . 0.92 112.638 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 16.19 76.64 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.06 -0.816 . . . . 0.3 111.06 -169.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -82.29 143.97 30.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.661 0.384 . . . . 2.23 110.91 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' CD1' HG23 ' A' ' 13' ' ' VAL . 11.5 mm -105.44 128.39 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.393 0.616 . . . . 2.26 111.124 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.466 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.0 m-85 -118.23 148.41 42.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.975 -1.011 . . . . 0.76 110.263 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -104.04 -23.31 13.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.823 -0.626 . . . . 3.33 110.673 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -113.61 152.0 30.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.471 -0.331 . . . . 0.7 110.399 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.488 ' O ' HG12 ' A' ' 28' ' ' ILE . 10.9 tpp180 -71.66 -47.63 53.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 3.82 111.659 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -48.07 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.444 0.535 . . . . 1.27 112.444 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.628 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -68.36 -26.47 65.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.296 . . . . 0.73 110.975 -178.557 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.628 ' N ' HD21 ' A' ' 26' ' ' ASN . 81.0 t80 -69.7 -50.18 46.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 1.04 109.799 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.563 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 37.8 mm -59.16 -41.96 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 1.07 109.845 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -59.55 -42.66 92.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.557 -0.747 . . . . 4.22 110.69 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -61.75 -42.87 99.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.546 -0.752 . . . . 0.5 111.254 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.1 -36.69 64.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.443 -0.344 . . . . 1.19 110.79 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.563 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 26.2 mmm180 -66.27 -40.57 90.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.589 -0.278 . . . . 4.66 110.729 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -60.36 -41.48 93.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.522 . . . . 2.12 110.577 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -65.59 -45.6 82.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 4.91 110.678 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 55.32 78.8 0.17 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.344 0.593 . . . . 8.59 110.106 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 63.8 3.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.492 -0.777 . . . . 6.23 111.565 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -122.33 168.61 11.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.685 -0.689 . . . . 8.69 109.801 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.12 101.14 53.03 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.47 110.119 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.64 -34.98 96.97 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 123.088 2.525 . . . . 10.47 112.727 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -151.5 -46.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.557 -0.292 . . . . 12.96 111.342 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.219 -0.896 . . . . 15.17 111.634 -176.148 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 112.148 -0.381 . . . . 16.78 112.148 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.19 -165.93 0.18 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.81 0.444 . . . . 15.14 111.191 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.4 mtp 67.6 28.53 7.43 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.061 0.458 . . . . 15.07 110.928 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -86.86 70.09 10.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.975 -0.557 . . . . 12.38 110.362 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 t 58.43 55.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.742 0.782 . . . . 11.07 109.839 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.42 76.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 9.58 108.913 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -87.36 54.3 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.72 -0.673 . . . . 7.81 109.896 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 57.33 80.94 0.15 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.31 -0.859 . . . . 5.96 109.594 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -68.28 94.75 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.7 . . . . 6.87 111.182 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 47.7 mmtm 55.76 48.93 17.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.812 -0.631 . . . . 6.17 111.219 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -132.78 77.08 1.72 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.555 -0.748 . . . . 2.15 109.781 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 52.5 m-85 -91.57 117.19 29.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.711 -0.677 . . . . 1.25 110.371 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.412 HG22 HG12 ' A' ' 20' ' ' ILE . 11.3 t -108.66 115.67 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.758 -0.201 . . . . 1.14 111.176 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 t -70.67 120.93 81.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.59 109.528 173.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 -16.29 48.58 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.97 112.846 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.32 -32.82 16.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.695 0.284 . . . . 1.29 111.354 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 m -113.3 -20.16 11.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.654 0.613 . . . . 0.92 112.654 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.23 80.88 Favored Glycine 0 N--CA 1.453 -0.187 0 N-CA-C 110.586 -1.005 . . . . 0.3 110.586 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -77.27 124.37 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.773 -0.714 . . . . 2.23 109.699 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.535 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 36.2 mt -106.03 130.46 57.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.99 0.424 . . . . 2.26 110.745 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -115.28 149.11 38.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.722 -0.672 . . . . 0.76 110.105 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 12.3 ttm180 -96.99 -16.01 20.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.455 -0.793 . . . . 3.33 110.44 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -121.62 148.61 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.008 -0.542 . . . . 0.7 110.51 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.513 ' O ' HG12 ' A' ' 28' ' ' ILE . 56.7 ttt180 -71.54 -38.97 70.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 3.82 111.231 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 m -65.39 -48.59 82.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.158 0.429 . . . . 1.27 112.158 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.61 HD21 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.74 -26.22 61.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.567 0.223 . . . . 0.73 111.083 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.61 ' N ' HD21 ' A' ' 26' ' ' ASN . 63.5 t80 -65.97 -49.88 66.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 1.04 110.279 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 24' ' ' ARG . 43.8 mm -60.82 -33.19 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.583 . . . . 1.07 110.052 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -62.4 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 4.22 110.682 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -67.18 -37.29 83.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.5 110.883 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.09 -29.64 49.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.339 -0.391 . . . . 1.19 110.873 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -66.66 -37.93 85.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.569 -0.53 . . . . 4.66 109.569 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -79.27 55.59 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.563 -0.744 . . . . 2.12 109.604 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -80.61 60.05 3.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.887 0.851 . . . . 4.91 110.27 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -112.43 25.16 11.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.583 -1.189 . . . . 8.59 109.085 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -82.63 -25.48 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.791 -1.095 . . . . 6.23 109.883 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -131.61 -63.33 0.84 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.367 -0.833 . . . . 8.69 110.103 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.49 92.11 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.329 0 O-C-N 123.812 0.695 . . . . 10.47 111.488 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.09 141.62 26.59 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.762 2.308 . . . . 10.47 111.249 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -79.86 -20.85 44.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.599 -0.519 . . . . 12.96 109.599 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.368 -0.825 . . . . 15.17 110.132 176.669 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.826 -0.11 . . . . 16.78 112.826 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.79 -51.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.936 0.398 . . . . 15.14 110.428 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.69 77.78 1.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.115 0.483 . . . . 15.07 111.031 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -98.58 125.33 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.694 -0.685 . . . . 12.38 110.117 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -92.71 -40.44 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.878 0.371 . . . . 11.07 110.505 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -80.75 69.68 7.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.27 0.557 . . . . 9.58 110.643 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -160.36 175.36 12.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.664 -0.698 . . . . 7.81 109.468 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m 69.7 130.19 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.936 0.773 . . . . 5.96 111.09 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -68.08 -30.22 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 6.87 109.851 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.55 123.68 10.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 6.17 109.775 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 p -145.33 124.85 13.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 2.15 110.945 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.428 ' HH ' ' HG2' ' A' ' 24' ' ' ARG . 38.3 m-85 -111.54 129.04 56.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.42 -0.809 . . . . 1.25 109.208 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.408 HG23 HG22 ' A' ' 20' ' ' ILE . 15.6 t -108.58 120.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.642 0.258 . . . . 1.14 111.619 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -73.03 120.24 79.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.666 -0.865 . . . . 0.59 108.666 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.83 -17.11 41.99 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.576 2.184 . . . . 0.97 112.218 -173.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -90.18 -42.69 10.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.834 -0.621 . . . . 1.29 111.389 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.31 -20.12 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.923 0.342 . . . . 0.92 111.923 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.42 15.87 78.96 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 110.995 -0.842 . . . . 0.3 110.995 -173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -81.53 135.02 35.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.034 -0.583 . . . . 2.23 109.973 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 13' ' ' VAL . 49.2 pt -106.54 130.49 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.174 0.512 . . . . 2.26 111.031 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -117.4 149.33 40.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.733 -0.667 . . . . 0.76 109.977 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -96.53 -33.24 11.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.113 -0.494 . . . . 3.33 110.651 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.617 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 62.6 m95 -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.7 110.666 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' O ' HG12 ' A' ' 28' ' ' ILE . 8.8 mmm180 -71.24 -36.35 71.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 3.82 111.818 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 m -63.03 -48.66 86.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 1.27 111.857 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.98 -31.9 64.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.186 -0.206 . . . . 0.73 110.984 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.451 ' O ' HD22 ' A' ' 31' ' ' LEU . 59.3 t80 -61.04 -50.83 71.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.732 0.301 . . . . 1.04 110.565 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 24' ' ' ARG . 52.0 mm -65.28 -34.18 68.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 1.07 110.043 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -60.08 -44.9 94.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.969 -0.56 . . . . 4.22 110.201 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.94 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.687 -0.688 . . . . 0.5 111.158 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? -77.21 -31.9 55.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.847 0.356 . . . . 1.19 111.396 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -72.57 -25.45 61.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.046 0.451 . . . . 4.66 110.703 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -85.11 10.05 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 2.12 111.281 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -74.56 -66.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.113 -0.329 . . . . 4.91 110.113 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 56.79 44.62 23.1 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.736 0.779 . . . . 8.59 109.505 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 29.95 7.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.833 -1.076 . . . . 6.23 110.048 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -68.62 -24.24 64.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.773 -0.649 . . . . 8.69 110.215 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.463 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 28.7 ttpp -134.21 -46.47 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.622 -0.717 . . . . 10.47 110.782 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 3.2 Cg_exo -82.43 86.29 1.53 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.275 1.984 . . . . 10.47 111.816 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -94.5 44.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 12.96 110.854 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.647 -0.706 . . . . 15.17 111.128 -178.052 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.427 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 7.2 m-85 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.933 -0.395 . . . . 0.78000000000000003 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.51 128.88 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.42999999999999999 111.27 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.9 t -80.48 119.04 75.16 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.629 -0.878 . . . . 0.58999999999999997 108.629 168.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.19 -26.48 82.38 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.823 2.349 . . . . 0.60999999999999999 113.357 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.99 -37.39 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.508 -0.314 . . . . 1.24 111.689 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 m -96.87 -19.91 18.53 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.821 -0.351 . . . . 0.78000000000000003 111.757 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.43 16.27 77.38 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 111.343 -0.703 . . . . 0.29999999999999999 111.343 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.57 134.59 37.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.445 . . . . 1.6100000000000001 111.354 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.63 129.12 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 1.77 110.852 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 51.7 m-85 -118.57 150.42 39.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.876 . . . . 0.5 110.505 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -105.04 -19.32 13.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 2.8500000000000001 110.801 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.4 ' HD1' HD22 ' A' ' 26' ' ' ASN . 55.8 m95 -122.82 149.12 44.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.58999999999999997 110.373 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -73.19 -41.51 63.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 3.3399999999999999 111.896 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.61 -45.24 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.152 0.427 . . . . 0.57999999999999996 112.152 -170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.4 HD22 ' HD1' ' A' ' 23' ' ' TRP . 18.1 p30 -74.86 -25.79 59.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.888 0.375 . . . . 0.72999999999999998 110.626 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.523 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.3 t80 -66.33 -50.24 64.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.934 -0.575 . . . . 0.59999999999999998 110.148 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.95 -34.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.22 110.267 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.91 -45.82 92.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 3.6099999999999999 110.152 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -64.95 -35.96 82.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.5 -0.773 . . . . 0.42999999999999999 110.732 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.32 -0.4 . . . . 0.48999999999999999 110.89 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 49.6 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 108.903 -0.777 . . . . 0.78000000000000003 108.903 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.39 120.88 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.77 0.319 . . . . 0.42999999999999999 111.348 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 t -76.79 118.68 73.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 0.58999999999999997 109.177 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.44 -14.27 39.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.392 2.062 . . . . 0.60999999999999999 112.135 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -89.71 -27.94 19.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.883 -0.599 . . . . 1.24 111.428 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -121.69 -20.29 6.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.673 0.619 . . . . 0.78000000000000003 112.673 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.77 88.88 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.695 -0.764 . . . . 0.29999999999999999 111.576 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -73.66 131.63 41.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.736 0.414 . . . . 1.6100000000000001 110.406 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 57.4 mt -107.05 125.94 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.392 -0.367 . . . . 1.77 111.092 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.46 150.78 37.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.5 109.541 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -104.67 -19.45 13.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.057 0.456 . . . . 2.8500000000000001 110.615 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.509 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 58.5 m95 -107.77 134.29 50.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 109.495 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' O ' HG12 ' A' ' 28' ' ' ILE . 38.2 ttm180 -71.99 -30.49 65.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.186 -0.461 . . . . 3.3399999999999999 111.157 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.1 -46.5 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 111.627 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 25.2 p30 -75.18 -25.86 58.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.72999999999999998 110.278 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -64.66 -50.0 68.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.59999999999999998 110.068 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 24' ' ' ARG . 46.2 mm -62.05 -33.18 57.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.031 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -60.46 -47.12 87.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 3.6099999999999999 110.608 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -70.29 -35.09 73.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.42999999999999999 111.241 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.782 0.325 . . . . 0.48999999999999999 111.223 177.961 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 26.6 m-85 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.497 -0.557 . . . . 0.78000000000000003 109.497 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.1 126.36 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.42999999999999999 110.913 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 11.0 t -76.84 118.43 71.7 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.837 -0.801 . . . . 0.58999999999999997 108.837 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.36 -17.74 59.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.51 2.14 . . . . 0.60999999999999999 112.145 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.445 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 6.2 t30 -89.83 -28.36 19.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 1.24 111.561 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 m -121.66 -20.93 6.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.084 0.772 . . . . 0.78000000000000003 113.084 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.56 83.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.664 -0.779 . . . . 0.29999999999999999 111.239 -172.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 22.2 tptp -67.31 137.25 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.264 0.626 . . . . 1.6100000000000001 110.851 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mm -102.47 130.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.653 . . . . 1.77 111.063 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.539 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.1 m-85 -119.19 150.04 40.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.691 -1.141 . . . . 0.5 110.634 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -106.02 -13.07 15.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.393 0.616 . . . . 2.8500000000000001 110.447 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 17.4 m95 -127.57 133.32 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.384 -0.599 . . . . 0.58999999999999997 109.384 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 28' ' ' ILE . 62.1 mtm180 -72.46 -28.96 63.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 3.3399999999999999 111.529 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.15 -49.31 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.57999999999999996 111.644 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -75.98 -30.2 58.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.512 -0.313 . . . . 0.72999999999999998 110.956 176.404 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.0 t80 -59.15 -51.28 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.59999999999999998 110.835 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 24' ' ' ARG . 51.2 mm -62.32 -34.59 64.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.22 110.217 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -65.33 -41.14 94.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 3.6099999999999999 110.279 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -66.59 -37.34 84.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 0.42999999999999999 110.84 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.48999999999999999 110.365 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 39.1 m-85 . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.801 -0.444 . . . . 0.78000000000000003 109.801 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.67 115.12 48.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 110.501 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.6 t -67.09 122.53 83.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.123 -0.695 . . . . 0.58999999999999997 109.123 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.44 -28.6 71.11 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 123.327 2.684 . . . . 0.60999999999999999 112.715 -170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -89.08 -28.03 20.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.186 -0.916 . . . . 1.24 111.925 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -113.5 -19.16 11.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.191 0.441 . . . . 0.78000000000000003 112.191 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.91 15.42 81.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.764 -0.732 . . . . 0.29999999999999999 112.024 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -83.46 124.69 30.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.046 -0.353 . . . . 1.6100000000000001 110.046 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -102.86 128.9 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.188 0.518 . . . . 1.77 110.498 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 95.1 m-85 -118.15 149.37 41.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.949 -0.569 . . . . 0.5 110.009 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -99.18 -9.28 23.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.139 0.495 . . . . 2.8500000000000001 110.332 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 29.9 m95 -130.16 149.47 51.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.949 -0.569 . . . . 0.58999999999999997 109.83 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 28' ' ' ILE . 50.4 mtm180 -71.91 -38.82 69.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.161 -0.472 . . . . 3.3399999999999999 111.582 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.2 -49.82 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.37 0.507 . . . . 0.57999999999999996 112.37 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -70.83 -29.38 65.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.691 0.282 . . . . 0.72999999999999998 110.812 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.442 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 55.2 t80 -62.98 -50.28 71.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.59999999999999998 110.332 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 24' ' ' ARG . 42.6 mm -63.37 -35.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.22 110.285 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -59.84 -44.68 93.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 3.6099999999999999 110.048 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -65.79 -39.8 91.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.42999999999999999 110.991 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.469 -0.332 . . . . 0.48999999999999999 110.741 178.493 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.73 -0.47 . . . . 0.78000000000000003 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.9 123.97 69.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.42999999999999999 110.597 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.79 116.86 42.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.58999999999999997 108.683 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 -18.28 62.44 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.466 2.111 . . . . 0.60999999999999999 112.398 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -90.62 -27.53 19.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.171 -0.468 . . . . 1.24 112.027 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.4 m -114.74 -20.36 10.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.364 -0.534 . . . . 0.78000000000000003 112.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.58 86.73 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.778 -0.725 . . . . 0.29999999999999999 111.595 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -78.7 129.14 34.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.993 -0.373 . . . . 1.6100000000000001 109.993 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.61 131.42 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.007 0.432 . . . . 1.77 110.197 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 72.1 m-85 -117.48 149.82 39.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.5 110.645 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -96.55 -25.15 15.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.472 -0.786 . . . . 2.8500000000000001 110.588 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 56.5 m95 -117.5 141.49 48.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.769 -0.651 . . . . 0.58999999999999997 110.072 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -73.1 -35.13 66.53 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.361 0.504 . . . . 3.3399999999999999 112.361 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.43 -44.31 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.854 -0.338 . . . . 0.57999999999999996 111.282 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 26.7 p30 -75.57 -26.2 57.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.751 0.31 . . . . 0.72999999999999998 110.606 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 72.4 t80 -64.44 -50.84 65.97 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.313 -0.403 . . . . 0.59999999999999998 110.426 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -63.81 -34.37 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.171 0.51 . . . . 0.22 109.96 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -61.06 -40.99 95.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 3.6099999999999999 110.455 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -71.48 -41.12 69.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.42999999999999999 111.115 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.805 0.336 . . . . 0.48999999999999999 110.916 178.198 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.346 -0.242 . . . . 0.78000000000000003 110.346 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.44 120.1 60.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.873 -0.418 . . . . 0.42999999999999999 109.873 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.1 t -73.86 119.22 75.06 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.968 -0.753 . . . . 0.58999999999999997 108.968 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.23 -27.24 78.12 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.178 2.586 . . . . 0.60999999999999999 112.91 -171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.02 -41.47 11.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.229 -0.441 . . . . 1.24 111.911 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 m -98.05 -14.84 20.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.175 0.435 . . . . 0.78000000000000003 112.175 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.64 78.8 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.681 -0.771 . . . . 0.29999999999999999 111.916 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -84.09 126.74 33.36 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.178 -0.304 . . . . 1.6100000000000001 110.178 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 tp -106.04 120.93 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.064 0.459 . . . . 1.77 110.765 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 94.9 m-85 -115.88 149.45 38.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.026 -0.533 . . . . 0.5 109.601 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -104.13 -12.25 16.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.892 -0.595 . . . . 2.8500000000000001 110.428 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.57 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 37.1 m95 -126.47 142.69 51.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.849 -0.614 . . . . 0.58999999999999997 109.979 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.3 ttt180 -72.89 -34.83 66.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 3.3399999999999999 112.061 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 m -61.49 -49.17 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.806 0.336 . . . . 0.57999999999999996 111.878 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -74.94 -29.06 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.474 -0.33 . . . . 0.72999999999999998 110.864 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.49 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 59.9 t80 -59.95 -50.22 74.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.59999999999999998 110.614 173.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 24' ' ' ARG . 35.6 mm -63.43 -33.63 62.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.22 110.339 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 3.6099999999999999 109.923 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.68 -46.31 86.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 110.231 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.912 -0.585 . . . . 0.48999999999999999 112.196 -178.424 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 45.1 m-85 . . . . . 0 CA--C 1.518 -0.267 0 N-CA-C 109.668 -0.493 . . . . 0.78000000000000003 109.668 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 20' ' ' ILE . 20.3 t -108.25 124.27 64.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.511 0.196 . . . . 0.42999999999999999 110.958 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.89 118.58 69.49 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.339 -0.615 . . . . 0.58999999999999997 109.339 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.29 -19.38 63.69 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.767 2.312 . . . . 0.60999999999999999 112.305 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -90.3 -28.15 18.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.942 -0.572 . . . . 1.24 111.854 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.67 -19.69 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.965 0.728 . . . . 0.78000000000000003 112.965 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 14.22 82.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.618 -0.801 . . . . 0.29999999999999999 111.325 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.5 tptp -77.44 135.64 38.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.232 -0.484 . . . . 1.6100000000000001 110.246 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 13' ' ' VAL . 41.8 pt -106.68 128.72 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.195 0.522 . . . . 1.77 111.372 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 86.4 m-85 -118.08 150.11 39.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.5 110.029 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -95.73 -22.28 17.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 2.8500000000000001 110.494 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 40.3 m95 -119.11 143.59 47.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.993 -0.549 . . . . 0.58999999999999997 110.035 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 28' ' ' ILE . 27.9 ttm180 -72.29 -34.62 68.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.785 -0.643 . . . . 3.3399999999999999 111.593 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.55 -49.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 112.033 0.382 . . . . 0.57999999999999996 112.033 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.3 -30.02 64.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.673 0.273 . . . . 0.72999999999999998 110.504 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HD23 ' A' ' 31' ' ' LEU . 63.2 t80 -59.36 -50.85 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.59999999999999998 110.697 174.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 24' ' ' ARG . 48.2 mm -65.12 -35.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.362 . . . . 0.22 110.234 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -61.1 -42.89 99.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.941 -0.572 . . . . 3.6099999999999999 110.208 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -69.71 -33.57 72.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.42999999999999999 110.895 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 27' ' ' PHE . 3.9 mm? . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 120.75 0.309 . . . . 0.48999999999999999 110.769 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.098 -0.334 . . . . 0.78000000000000003 110.098 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.11 126.82 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.041 -0.527 . . . . 0.42999999999999999 111.048 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.2 t -77.37 118.63 73.23 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.724 -0.843 . . . . 0.58999999999999997 108.724 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.61 -19.08 48.52 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.565 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.17 -39.15 13.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.967 -0.561 . . . . 1.24 111.757 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -99.81 -19.79 16.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 111.869 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.78 16.01 80.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.731 -0.747 . . . . 0.29999999999999999 111.316 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -86.48 130.09 34.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.552 -0.324 . . . . 1.6100000000000001 110.588 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -103.17 134.04 45.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.554 -0.535 . . . . 1.77 109.554 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' N ' HD13 ' A' ' 20' ' ' ILE . 58.4 m-85 -118.37 149.9 40.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.058 -0.519 . . . . 0.5 110.302 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -96.13 -25.67 15.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.808 -0.633 . . . . 2.8500000000000001 111.021 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.544 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 41.0 m95 -116.38 146.55 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 110.202 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' ILE . 77.2 mtm180 -72.36 -36.84 68.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 3.3399999999999999 112.114 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -60.97 -49.5 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.854 0.316 . . . . 0.57999999999999996 111.854 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.22 -31.93 66.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.664 0.268 . . . . 0.72999999999999998 110.477 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.52 -50.7 72.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.59999999999999998 110.745 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.7 mm -64.83 -32.27 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.219 0.533 . . . . 0.22 110.477 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.97 -48.42 76.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.012 -0.54 . . . . 3.6099999999999999 110.178 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -65.98 -34.76 78.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.42999999999999999 110.805 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 116.312 -0.404 . . . . 0.48999999999999999 112.025 -179.407 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.927 -0.397 . . . . 0.78000000000000003 109.927 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 43.7 t -108.41 125.27 65.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.813 0.339 . . . . 0.42999999999999999 111.475 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.9 t -74.71 118.12 67.71 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.354 -0.98 . . . . 0.58999999999999997 108.354 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.17 -22.07 54.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.666 2.244 . . . . 0.60999999999999999 113.223 -169.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -85.3 -36.98 20.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.438 -0.346 . . . . 1.24 111.428 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 m -105.77 -19.64 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.035 0.383 . . . . 0.78000000000000003 112.035 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.39 16.43 79.49 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.692 -0.766 . . . . 0.29999999999999999 111.836 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 41.7 tptt -83.06 130.19 35.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.682 -0.259 . . . . 1.6100000000000001 110.317 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tt -106.93 128.35 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.982 0.42 . . . . 1.77 111.212 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 85.9 m-85 -118.01 150.44 39.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.149 -0.478 . . . . 0.5 109.819 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -100.57 -16.83 17.34 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.878 -0.601 . . . . 2.8500000000000001 110.439 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 22.8 m95 -122.6 146.27 47.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.96 -0.564 . . . . 0.58999999999999997 109.833 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 25.7 ttt180 -72.28 -39.29 68.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.889 -0.596 . . . . 3.3399999999999999 112.441 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.05 -49.8 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.062 0.393 . . . . 0.57999999999999996 112.062 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.53 -29.7 63.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.779 0.323 . . . . 0.72999999999999998 110.663 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.513 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 48.4 t80 -61.18 -50.92 71.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.556 . . . . 0.59999999999999998 110.956 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 24' ' ' ARG . 49.9 mm -63.87 -34.25 67.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.095 0.474 . . . . 0.22 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.25 -46.21 89.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.599 -0.728 . . . . 3.6099999999999999 110.223 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 23.7 t-80 -72.51 -27.28 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.42999999999999999 111.522 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 C--N 1.322 -0.63 0 O-C-N 122.154 -0.341 . . . . 0.48999999999999999 111.299 178.079 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.78000000000000003 110.655 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.09 126.45 70.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.42999999999999999 110.452 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.41 118.59 67.48 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.58999999999999997 108.997 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.14 -19.76 69.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.737 2.291 . . . . 0.60999999999999999 112.438 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -90.47 -42.62 10.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.056 -0.52 . . . . 1.24 111.728 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.0 m -98.7 -19.91 17.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.78000000000000003 112.195 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.36 15.52 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.29999999999999999 111.08 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -80.79 130.48 35.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.089 -0.556 . . . . 1.6100000000000001 109.985 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.44 129.13 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.321 0.581 . . . . 1.77 109.936 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 62.3 m-85 -117.38 149.95 39.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.278 0.561 . . . . 0.5 110.549 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -97.1 -31.58 12.41 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.243 -0.89 . . . . 2.8500000000000001 110.723 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.581 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 50.9 m95 -110.99 143.42 41.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.402 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 76.5 mtm180 -72.52 -35.13 68.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.517 -0.765 . . . . 3.3399999999999999 111.537 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.23 -49.61 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.812 0.301 . . . . 0.57999999999999996 111.812 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -74.65 -29.93 61.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.887 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 68.7 t80 -61.51 -51.14 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.59999999999999998 110.969 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 24' ' ' ARG . 50.1 mm -62.36 -33.45 59.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.044 0.449 . . . . 0.22 110.264 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -66.55 -40.55 89.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 3.6099999999999999 110.138 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.8 t-80 -65.82 -39.12 90.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.42999999999999999 110.622 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.48999999999999999 110.833 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 72.2 m-85 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.484 -0.561 . . . . 0.78000000000000003 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 20' ' ' ILE . 16.8 t -105.62 120.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.584 0.231 . . . . 0.42999999999999999 111.291 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -75.18 119.16 75.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.109 -0.7 . . . . 0.58999999999999997 109.109 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.85 -14.83 45.26 Favored 'Trans proline' 0 CA--C 1.526 0.115 0 C-N-CA 122.662 2.242 . . . . 0.60999999999999999 112.906 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -91.15 -33.81 15.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.477 -0.329 . . . . 1.24 111.693 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.9 m -113.97 -18.57 11.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.827 0.677 . . . . 0.78000000000000003 112.827 -170.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.43 15.2 79.09 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.404 -0.903 . . . . 0.29999999999999999 110.937 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -79.66 126.32 30.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.544 . . . . 1.6100000000000001 109.764 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 39.5 pt -106.69 128.69 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.598 . . . . 1.77 111.645 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HD1' ' A' ' 12' ' ' TYR . 83.1 m-85 -117.32 150.61 38.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.5 109.242 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -98.88 -21.92 16.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.948 0.404 . . . . 2.8500000000000001 110.802 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 63.7 m95 -110.34 145.21 37.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.58999999999999997 110.413 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -72.61 -36.78 68.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 3.3399999999999999 111.536 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.67 -49.25 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.812 0.339 . . . . 0.57999999999999996 111.867 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 22.3 p30 -71.16 -25.4 62.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.972 0.415 . . . . 0.72999999999999998 110.709 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.01 -50.04 63.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.59999999999999998 110.362 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.26 -32.95 56.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.22 110.317 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -60.17 -48.37 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 3.6099999999999999 110.578 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -64.76 -37.51 87.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.603 -0.726 . . . . 0.42999999999999999 110.847 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.997 -0.547 . . . . 0.48999999999999999 111.568 -179.741 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.687 -0.486 . . . . 0.78000000000000003 109.687 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 41.9 t -108.3 117.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.926 -0.31 . . . . 0.42999999999999999 110.844 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -70.98 118.52 66.28 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.413 -0.588 . . . . 0.58999999999999997 109.413 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.33 -15.98 47.0 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.508 2.138 . . . . 0.60999999999999999 112.472 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -87.88 -25.76 23.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.998 -0.546 . . . . 1.24 111.181 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -121.16 -19.96 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.469 0.544 . . . . 0.78000000000000003 112.469 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.36 15.75 80.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.29999999999999999 111.227 -173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.7 tptm -83.49 135.77 34.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.518 0.327 . . . . 1.6100000000000001 110.191 -176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.26 125.6 61.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 1.77 110.371 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 87.5 m-85 -116.71 147.74 41.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.5 109.997 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -98.52 -28.39 13.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.805 -0.634 . . . . 2.8500000000000001 110.135 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -105.51 143.44 33.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.515 -0.766 . . . . 0.58999999999999997 110.911 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 28' ' ' ILE . 45.4 ttp180 -72.59 -36.19 68.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.063 -0.971 . . . . 3.3399999999999999 111.419 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.14 -48.61 80.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.86 0.319 . . . . 0.57999999999999996 111.86 -173.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -72.98 -27.0 61.55 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.994 -0.282 . . . . 0.72999999999999998 110.861 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 74.1 t80 -66.61 -50.1 64.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.787 0.327 . . . . 0.59999999999999998 110.34 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.0 mm -64.19 -36.46 77.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.22 110.425 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -61.62 -44.77 96.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.285 0.564 . . . . 3.6099999999999999 110.253 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -66.9 -35.31 79.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.067 -0.97 . . . . 0.42999999999999999 111.038 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 111.91 0.337 . . . . 0.48999999999999999 111.91 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 110.145 -0.317 . . . . 0.78000000000000003 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 20' ' ' ILE . 10.2 t -108.14 116.82 52.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.42999999999999999 110.51 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 17.4 t -72.25 121.2 84.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.58999999999999997 109.274 173.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.81 -13.39 24.29 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.327 2.018 . . . . 0.60999999999999999 110.328 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -90.17 -28.54 18.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.744 -1.571 . . . . 1.24 111.444 -173.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.6 m -123.53 -20.49 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.638 0.607 . . . . 0.78000000000000003 112.638 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 16.19 76.64 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.06 -0.816 . . . . 0.29999999999999999 111.06 -169.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -82.29 143.97 30.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.661 0.384 . . . . 1.6100000000000001 110.91 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 13' ' ' VAL . 11.5 mm -105.44 128.39 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.393 0.616 . . . . 1.77 111.124 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.0 m-85 -118.23 148.41 42.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.975 -1.011 . . . . 0.5 110.263 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -104.04 -23.31 13.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.823 -0.626 . . . . 2.8500000000000001 110.673 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.523 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 63.5 m95 -113.61 152.0 30.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.471 -0.331 . . . . 0.58999999999999997 110.399 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 28' ' ' ILE . 10.9 tpp180 -71.66 -47.63 53.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 3.3399999999999999 111.659 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -48.07 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.444 0.535 . . . . 0.57999999999999996 112.444 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 19.8 p30 -68.36 -26.47 65.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.296 . . . . 0.72999999999999998 110.975 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 81.0 t80 -69.7 -50.18 46.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.59999999999999998 109.799 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 24' ' ' ARG . 37.8 mm -59.16 -41.96 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.22 109.845 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -59.55 -42.66 92.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.557 -0.747 . . . . 3.6099999999999999 110.69 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -61.75 -42.87 99.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.546 -0.752 . . . . 0.42999999999999999 111.254 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.443 -0.344 . . . . 0.48999999999999999 110.79 179.257 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 110.371 -0.233 . . . . 0.78000000000000003 110.371 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 20' ' ' ILE . 11.3 t -108.66 115.67 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.758 -0.201 . . . . 0.42999999999999999 111.176 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 t -70.67 120.93 81.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 173.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 -16.29 48.58 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.60999999999999999 112.846 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.32 -32.82 16.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.695 0.284 . . . . 1.24 111.354 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 m -113.3 -20.16 11.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.654 0.613 . . . . 0.78000000000000003 112.654 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.23 80.88 Favored Glycine 0 N--CA 1.453 -0.187 0 N-CA-C 110.586 -1.005 . . . . 0.29999999999999999 110.586 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -77.27 124.37 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.773 -0.714 . . . . 1.6100000000000001 109.699 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 36.2 mt -106.03 130.46 57.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.99 0.424 . . . . 1.77 110.745 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -115.28 149.11 38.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.722 -0.672 . . . . 0.5 110.105 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -96.99 -16.01 20.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.455 -0.793 . . . . 2.8500000000000001 110.44 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -121.62 148.61 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.51 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 28' ' ' ILE . 56.7 ttt180 -71.54 -38.97 70.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 3.3399999999999999 111.231 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 m -65.39 -48.59 82.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.158 0.429 . . . . 0.57999999999999996 112.158 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -72.74 -26.22 61.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.567 0.223 . . . . 0.72999999999999998 111.083 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -65.97 -49.88 66.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.59999999999999998 110.279 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 24' ' ' ARG . 43.8 mm -60.82 -33.19 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.583 . . . . 0.22 110.052 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -62.4 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 3.6099999999999999 110.682 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-80 -67.18 -37.29 83.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.42999999999999999 110.883 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.339 -0.391 . . . . 0.48999999999999999 110.873 178.173 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 38.3 m-85 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.208 -0.664 . . . . 0.78000000000000003 109.208 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 20' ' ' ILE . 15.6 t -108.58 120.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.642 0.258 . . . . 0.42999999999999999 111.619 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -73.03 120.24 79.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.666 -0.865 . . . . 0.58999999999999997 108.666 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.83 -17.11 41.99 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.576 2.184 . . . . 0.60999999999999999 112.218 -173.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -90.18 -42.69 10.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.834 -0.621 . . . . 1.24 111.389 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.31 -20.12 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.923 0.342 . . . . 0.78000000000000003 111.923 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.42 15.87 78.96 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 110.995 -0.842 . . . . 0.29999999999999999 110.995 -173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -81.53 135.02 35.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.034 -0.583 . . . . 1.6100000000000001 109.973 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 13' ' ' VAL . 49.2 pt -106.54 130.49 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.174 0.512 . . . . 1.77 111.031 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -117.4 149.33 40.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.733 -0.667 . . . . 0.5 109.977 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -96.53 -33.24 11.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.113 -0.494 . . . . 2.8500000000000001 110.651 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 62.6 m95 -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.58999999999999997 110.666 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 28' ' ' ILE . 8.8 mmm180 -71.24 -36.35 71.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 3.3399999999999999 111.818 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 m -63.03 -48.66 86.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 0.57999999999999996 111.857 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.626 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.98 -31.9 64.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.186 -0.206 . . . . 0.72999999999999998 110.984 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 31' ' ' LEU . 59.3 t80 -61.04 -50.83 71.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.732 0.301 . . . . 0.59999999999999998 110.565 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 24' ' ' ARG . 52.0 mm -65.28 -34.18 68.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.22 110.043 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -60.08 -44.9 94.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.969 -0.56 . . . . 3.6099999999999999 110.201 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -64.94 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.687 -0.688 . . . . 0.42999999999999999 111.158 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.847 0.356 . . . . 0.48999999999999999 111.396 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.721 -0.552 . . . . 16.57 111.721 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.43 73.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.946 0.403 . . . . 15.0 111.216 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -89.79 29.86 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 14.85 111.596 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -87.75 58.5 4.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.81 0.814 . . . . 12.380000000000001 110.672 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.53 149.71 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.775 -1.195 . . . . 10.720000000000001 107.775 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.515 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.0 tp60 -71.78 86.42 0.95 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.344 0.593 . . . . 9.1199999999999992 110.214 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -149.0 135.85 19.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.519 -0.764 . . . . 7.5300000000000002 110.026 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -95.06 14.84 20.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.228 0.537 . . . . 5.79 109.999 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.54 -23.6 56.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 6.1799999999999997 110.808 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 53.0 pttt -89.09 99.29 12.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.362 0.601 . . . . 5.7800000000000002 110.367 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.3 m -145.27 21.84 1.54 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.125 -0.489 . . . . 1.8899999999999999 110.795 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.427 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 7.2 m-85 -111.6 110.82 21.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.309 -0.405 . . . . 0.78000000000000003 109.933 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.51 128.88 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.42999999999999999 111.27 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.9 t -80.48 119.04 75.16 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.629 -0.878 . . . . 0.58999999999999997 108.629 168.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.19 -26.48 82.38 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.823 2.349 . . . . 0.60999999999999999 113.357 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.99 -37.39 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.508 -0.314 . . . . 1.24 111.689 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 m -96.87 -19.91 18.53 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.821 -0.351 . . . . 0.78000000000000003 111.757 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.43 16.27 77.38 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 111.343 -0.703 . . . . 0.29999999999999999 111.343 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.57 134.59 37.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.445 . . . . 1.6100000000000001 111.354 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.63 129.12 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 1.77 110.852 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 51.7 m-85 -118.57 150.42 39.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.876 . . . . 0.5 110.505 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 68.4 ttt180 -105.04 -19.32 13.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 2.8500000000000001 110.801 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.4 ' HD1' HD22 ' A' ' 26' ' ' ASN . 55.8 m95 -122.82 149.12 44.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.58999999999999997 110.373 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -73.19 -41.51 63.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 3.3399999999999999 111.896 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.61 -45.24 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.152 0.427 . . . . 0.57999999999999996 112.152 -170.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.4 HD22 ' HD1' ' A' ' 23' ' ' TRP . 18.1 p30 -74.86 -25.79 59.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.888 0.375 . . . . 0.72999999999999998 110.626 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.523 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.3 t80 -66.33 -50.24 64.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.934 -0.575 . . . . 0.59999999999999998 110.148 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.95 -34.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.22 110.267 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.91 -45.82 92.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 3.6099999999999999 110.152 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.95 -35.96 82.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.5 -0.773 . . . . 0.42999999999999999 110.732 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? -72.64 -25.72 61.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.32 -0.4 . . . . 0.48999999999999999 110.89 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -80.04 -18.23 50.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.674 0.749 . . . . 4.0 109.657 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.6 t -78.7 -0.41 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.281 -0.872 . . . . 1.6699999999999999 110.583 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -66.21 -25.01 66.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.211 0.529 . . . . 4.29 110.049 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -68.25 -16.58 64.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 7.8200000000000003 110.166 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -93.54 0.24 56.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 6.2300000000000004 110.633 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -93.72 175.76 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.995 0.426 . . . . 8.0999999999999996 110.855 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 11.3 ptmm? -127.19 112.03 21.53 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.728 -0.669 . . . . 10.19 109.992 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.3 -40.76 35.7 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.919 3.079 . . . . 10.4 113.148 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -153.24 -79.3 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.471 -0.566 . . . . 12.77 109.471 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 38' ' ' LYS . 62.3 tttm . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.15 0.907 . . . . 14.94 111.661 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 112.013 -0.435 . . . . 16.57 112.013 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.95 57.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 15.0 111.422 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.2 mtm -124.3 42.76 3.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.616 0.722 . . . . 14.85 110.102 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.7 52.95 0.96 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.336 -0.847 . . . . 12.380000000000001 109.52 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -77.66 -24.16 14.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 10.720000000000001 110.335 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 59.9 tp60 -74.78 99.46 3.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.849 -0.797 . . . . 9.1199999999999992 108.849 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' NH2' ' A' ' 22' ' ' ARG . 8.8 t -151.59 27.17 0.65 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.105 0.955 . . . . 7.5300000000000002 110.104 -175.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -96.77 160.95 14.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.678 -0.692 . . . . 5.79 110.086 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 63.74 41.14 7.19 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.147 0.499 . . . . 6.1799999999999997 111.132 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -103.3 53.09 0.77 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.822 -0.626 . . . . 5.7800000000000002 109.615 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -78.06 98.72 5.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.575 -0.739 . . . . 1.8899999999999999 111.669 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 49.6 m-85 -89.99 115.59 27.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.903 -0.777 . . . . 0.78000000000000003 108.903 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.39 120.88 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.77 0.319 . . . . 0.42999999999999999 111.348 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 t -76.79 118.68 73.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 0.58999999999999997 109.177 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.44 -14.27 39.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.392 2.062 . . . . 0.60999999999999999 112.135 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -89.71 -27.94 19.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.883 -0.599 . . . . 1.24 111.428 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -121.69 -20.29 6.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.673 0.619 . . . . 0.78000000000000003 112.673 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.77 88.88 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.695 -0.764 . . . . 0.29999999999999999 111.576 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -73.66 131.63 41.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.736 0.414 . . . . 1.6100000000000001 110.406 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 57.4 mt -107.05 125.94 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.392 -0.367 . . . . 1.77 111.092 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.46 150.78 37.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.5 109.541 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' NH2' HG23 ' A' ' 7' ' ' THR . 68.0 ttt180 -104.67 -19.45 13.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.057 0.456 . . . . 2.8500000000000001 110.615 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 58.5 m95 -107.77 134.29 50.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 109.495 177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' O ' HG12 ' A' ' 28' ' ' ILE . 38.2 ttm180 -71.99 -30.49 65.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.186 -0.461 . . . . 3.3399999999999999 111.157 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.1 -46.5 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 111.627 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 25.2 p30 -75.18 -25.86 58.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.72999999999999998 110.278 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -64.66 -50.0 68.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.59999999999999998 110.068 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 24' ' ' ARG . 46.2 mm -62.05 -33.18 57.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.031 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -60.46 -47.12 87.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 3.6099999999999999 110.608 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -70.29 -35.09 73.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.42999999999999999 111.241 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' O ' ' HD2' ' A' ' 34' ' ' ARG . 3.9 mm? -77.03 -29.55 55.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.782 0.325 . . . . 0.48999999999999999 111.223 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 64.8 ttt180 -62.7 -40.98 98.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 4.0 109.836 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -103.34 42.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.468 -0.787 . . . . 1.6699999999999999 110.248 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.77 153.62 43.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 4.29 110.907 -177.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 59.16 36.73 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.424 0.63 . . . . 7.8200000000000003 110.473 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -150.68 131.45 14.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.221 -0.9 . . . . 6.2300000000000004 109.748 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -92.03 -28.75 16.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.864 -0.607 . . . . 8.0999999999999996 110.497 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -121.86 99.48 44.28 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.145 -0.48 . . . . 10.19 110.383 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.47 116.02 2.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.839 2.359 . . . . 10.4 111.993 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -81.31 -29.31 34.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.004 -0.543 . . . . 12.77 110.304 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.7 pttp . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.853 -0.612 . . . . 14.94 110.27 179.42 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.52 -0.632 . . . . 16.57 111.52 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.98 -62.63 1.55 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.383 . . . . 15.0 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.6 mtt -114.26 -8.75 12.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 14.85 111.039 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.29 70.08 6.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.262 0.553 . . . . 12.380000000000001 111.372 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -89.49 146.55 6.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.475 -0.784 . . . . 10.720000000000001 109.14 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 7.1 tp60 -68.27 100.07 1.0 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.927 0.394 . . . . 9.1199999999999992 110.748 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -166.7 158.62 13.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.838 -0.619 . . . . 7.5300000000000002 109.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 t -100.84 1.52 40.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.151 0.5 . . . . 5.79 109.787 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -99.29 47.5 0.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 6.1799999999999997 110.124 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -144.5 25.0 1.53 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 5.7800000000000002 110.39 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.3 m -96.96 34.08 1.78 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.667 -0.697 . . . . 1.8899999999999999 111.181 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 26.6 m-85 -103.86 110.17 22.19 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.497 -0.557 . . . . 0.78000000000000003 109.497 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.1 126.36 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.42999999999999999 110.913 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 11.0 t -76.84 118.43 71.7 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.837 -0.801 . . . . 0.58999999999999997 108.837 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.36 -17.74 59.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.51 2.14 . . . . 0.60999999999999999 112.145 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.445 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.3 t-20 -89.83 -28.36 19.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 1.24 111.561 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 m -121.66 -20.93 6.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.084 0.772 . . . . 0.78000000000000003 113.084 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.56 83.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.664 -0.779 . . . . 0.29999999999999999 111.239 -172.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 22.2 tptp -67.31 137.25 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.264 0.626 . . . . 1.6100000000000001 110.851 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mm -102.47 130.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.653 . . . . 1.77 111.063 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.539 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.1 m-85 -119.19 150.04 40.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.691 -1.141 . . . . 0.5 110.634 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -106.02 -13.07 15.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.393 0.616 . . . . 2.8500000000000001 110.447 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 17.4 m95 -127.57 133.32 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.384 -0.599 . . . . 0.58999999999999997 109.384 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 28' ' ' ILE . 62.1 mtm180 -72.46 -28.96 63.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 3.3399999999999999 111.529 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.15 -49.31 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.57999999999999996 111.644 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -75.98 -30.2 58.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.512 -0.313 . . . . 0.72999999999999998 110.956 176.404 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.0 t80 -59.15 -51.28 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.59999999999999998 110.835 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 24' ' ' ARG . 51.2 mm -62.32 -34.59 64.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.22 110.217 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -65.33 -41.14 94.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 3.6099999999999999 110.279 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -66.59 -37.34 84.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 0.42999999999999999 110.84 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? -73.42 -27.8 61.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.48999999999999999 110.365 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 32' ' ' ARG . 39.5 ttm180 -74.77 -16.39 60.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 4.0 109.955 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 t -94.82 22.61 6.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.811 . . . . 1.6699999999999999 110.614 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -83.51 -25.44 31.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 4.29 110.395 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -70.91 -22.77 62.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.852 -0.613 . . . . 7.8200000000000003 110.071 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -88.44 36.02 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 6.2300000000000004 110.42 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -126.21 166.59 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 8.0999999999999996 110.298 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -105.73 121.39 46.08 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.061 -0.518 . . . . 10.19 110.462 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.91 -60.28 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.836 2.357 . . . . 10.4 112.537 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -154.17 -49.28 0.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.481 -0.327 . . . . 12.77 110.458 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.107 -0.949 . . . . 14.94 110.253 -177.082 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 112.109 -0.397 . . . . 16.57 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 -66.78 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 15.0 110.435 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.0 ttp -99.29 -81.71 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 14.85 110.097 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 64.59 -64.53 0.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.947 0.779 . . . . 12.380000000000001 111.481 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.46 137.32 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.769 -0.456 . . . . 10.720000000000001 109.769 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -69.55 107.88 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.167 0.508 . . . . 9.1199999999999992 110.396 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -113.5 111.63 22.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.916 -0.583 . . . . 7.5300000000000002 111.357 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.6 t 55.35 44.21 27.66 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.744 -0.662 . . . . 5.79 110.255 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -121.25 156.18 33.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.751 -0.659 . . . . 6.1799999999999997 109.595 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -102.35 74.14 1.38 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.475 0.655 . . . . 5.7800000000000002 110.487 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -110.19 92.49 4.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.31 -0.859 . . . . 1.8899999999999999 109.34 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 39.1 m-85 -86.19 110.68 19.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.155 -0.475 . . . . 0.78000000000000003 109.801 -177.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.67 115.12 48.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 110.501 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.6 t -67.09 122.53 83.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.123 -0.695 . . . . 0.58999999999999997 109.123 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.44 -28.6 71.11 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 123.327 2.684 . . . . 0.60999999999999999 112.715 -170.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -89.08 -28.03 20.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.186 -0.916 . . . . 1.24 111.925 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -113.5 -19.16 11.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.191 0.441 . . . . 0.78000000000000003 112.191 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.91 15.42 81.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.764 -0.732 . . . . 0.29999999999999999 112.024 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -83.46 124.69 30.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.046 -0.353 . . . . 1.6100000000000001 110.046 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -102.86 128.9 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.188 0.518 . . . . 1.77 110.498 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 95.1 m-85 -118.15 149.37 41.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.949 -0.569 . . . . 0.5 110.009 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -99.18 -9.28 23.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.139 0.495 . . . . 2.8500000000000001 110.332 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 29.9 m95 -130.16 149.47 51.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.949 -0.569 . . . . 0.58999999999999997 109.83 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 28' ' ' ILE . 50.4 mtm180 -71.91 -38.82 69.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.161 -0.472 . . . . 3.3399999999999999 111.582 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.2 -49.82 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.37 0.507 . . . . 0.57999999999999996 112.37 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -70.83 -29.38 65.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.691 0.282 . . . . 0.72999999999999998 110.812 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 55.2 t80 -62.98 -50.28 71.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.59999999999999998 110.332 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 24' ' ' ARG . 42.6 mm -63.37 -35.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.22 110.285 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -59.84 -44.68 93.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 3.6099999999999999 110.048 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -65.79 -39.8 91.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.42999999999999999 110.991 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.58 -35.14 76.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.469 -0.332 . . . . 0.48999999999999999 110.741 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -73.51 -13.42 61.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.451 . . . . 4.0 110.429 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -98.04 30.22 3.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.571 . . . . 1.6699999999999999 110.284 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -68.44 94.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.073 0.464 . . . . 4.29 110.365 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.517 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 1.7 mmp_? -101.3 60.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.988 -0.551 . . . . 7.8200000000000003 109.804 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -82.58 65.78 7.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.253 0.549 . . . . 6.2300000000000004 110.803 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.33 -62.46 1.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 8.0999999999999996 110.159 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.81 147.31 33.8 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.624 -0.717 . . . . 10.19 109.909 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.27 40.07 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.949 2.433 . . . . 10.4 112.905 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 35.1 t60 69.95 -61.32 0.46 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.475 0.71 . . . . 12.77 111.778 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.4 tptp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.674 -0.679 . . . . 14.94 110.043 -178.101 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.719 -0.553 . . . . 16.57 111.719 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.5 -15.29 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 15.0 110.7 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtt -101.55 63.48 0.96 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 14.85 109.882 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -83.64 35.44 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 12.380000000000001 111.686 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -74.21 136.08 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.861 -0.609 . . . . 10.720000000000001 109.509 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.8 tp60 -72.76 106.26 4.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 9.1199999999999992 110.461 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -162.25 136.24 6.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 7.5300000000000002 109.756 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -83.4 -5.5 59.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 5.79 110.51 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.55 -33.6 75.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 6.1799999999999997 110.957 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 60.2 pttt -76.11 77.84 2.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.77 0.795 . . . . 5.7800000000000002 110.928 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -130.26 24.14 5.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.75 -0.659 . . . . 1.8899999999999999 110.668 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -104.81 108.34 19.77 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.73 -0.47 . . . . 0.78000000000000003 109.73 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.9 123.97 69.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.42999999999999999 110.597 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.79 116.86 42.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.58999999999999997 108.683 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 -18.28 62.44 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.466 2.111 . . . . 0.60999999999999999 112.398 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -90.62 -27.53 19.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.171 -0.468 . . . . 1.24 112.027 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.4 m -114.74 -20.36 10.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.364 -0.534 . . . . 0.78000000000000003 112.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.58 86.73 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.778 -0.725 . . . . 0.29999999999999999 111.595 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -78.7 129.14 34.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.993 -0.373 . . . . 1.6100000000000001 109.993 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.61 131.42 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.007 0.432 . . . . 1.77 110.197 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 72.1 m-85 -117.48 149.82 39.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.5 110.645 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -96.55 -25.15 15.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.472 -0.786 . . . . 2.8500000000000001 110.588 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.436 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 56.5 m95 -117.5 141.49 48.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.769 -0.651 . . . . 0.58999999999999997 110.072 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -73.1 -35.13 66.53 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.361 0.504 . . . . 3.3399999999999999 112.361 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.43 -44.31 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.854 -0.338 . . . . 0.57999999999999996 111.282 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 26.7 p30 -75.57 -26.2 57.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.751 0.31 . . . . 0.72999999999999998 110.606 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 72.4 t80 -64.44 -50.84 65.97 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.313 -0.403 . . . . 0.59999999999999998 110.426 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -63.81 -34.37 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.171 0.51 . . . . 0.22 109.96 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -61.06 -40.99 95.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 3.6099999999999999 110.455 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -71.48 -41.12 69.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.42999999999999999 111.115 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.51 -37.52 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.805 0.336 . . . . 0.48999999999999999 110.916 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -68.47 -23.49 64.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.168 0.509 . . . . 4.0 110.436 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -80.14 10.85 3.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.947 -0.569 . . . . 1.6699999999999999 111.023 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -74.97 -9.18 58.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.463 0.649 . . . . 4.29 109.785 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.18 -22.99 66.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.996 -1.002 . . . . 7.8200000000000003 111.252 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -112.89 27.71 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.376 -0.374 . . . . 6.2300000000000004 111.526 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 98.1 mt-30 -98.57 170.28 8.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.916 0.389 . . . . 8.0999999999999996 111.089 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -137.09 102.34 9.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.95 -0.568 . . . . 10.19 109.83 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.2 -43.89 24.93 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.569 2.846 . . . . 10.4 113.06 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -157.39 -65.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.579 -0.282 . . . . 12.77 110.32 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 14.94 110.712 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.819 -0.512 . . . . 16.57 111.819 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.33 123.53 11.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.773 0.287 . . . . 15.0 110.601 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -163.35 177.07 9.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.47 -0.332 . . . . 14.85 110.586 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 53.4 mm-40 -73.3 -177.45 2.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.486 -0.325 . . . . 12.380000000000001 111.139 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t 73.94 -61.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.755 -0.657 . . . . 10.720000000000001 111.19 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -90.04 7.25 38.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 9.1199999999999992 111.104 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 4' ' ' GLU . 3.7 m -60.09 -23.92 64.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 7.5300000000000002 111.651 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m 65.27 26.74 12.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.527 -0.761 . . . . 5.79 110.782 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -75.84 -59.47 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 6.1799999999999997 109.951 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -162.35 64.97 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.8 0.81 . . . . 5.7800000000000002 110.872 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -95.0 100.35 12.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 1.8899999999999999 109.612 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -96.31 110.97 23.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.559 -0.291 . . . . 0.78000000000000003 110.346 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.44 120.1 60.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.873 -0.418 . . . . 0.42999999999999999 109.873 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.1 t -73.86 119.22 75.06 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.968 -0.753 . . . . 0.58999999999999997 108.968 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.23 -27.24 78.12 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.178 2.586 . . . . 0.60999999999999999 112.91 -171.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.445 ' ND2' HH21 ' A' ' 35' ' ' ARG . 26.6 t-20 -90.02 -41.47 11.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.229 -0.441 . . . . 1.24 111.911 -175.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 m -98.05 -14.84 20.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.175 0.435 . . . . 0.78000000000000003 112.175 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.64 78.8 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.681 -0.771 . . . . 0.29999999999999999 111.916 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -84.09 126.74 33.36 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.178 -0.304 . . . . 1.6100000000000001 110.178 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 tp -106.04 120.93 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.064 0.459 . . . . 1.77 110.765 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 94.9 m-85 -115.88 149.45 38.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.026 -0.533 . . . . 0.5 109.601 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -104.13 -12.25 16.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.892 -0.595 . . . . 2.8500000000000001 110.428 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.57 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 37.1 m95 -126.47 142.69 51.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.849 -0.614 . . . . 0.58999999999999997 109.979 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.3 ttt180 -72.89 -34.83 66.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 3.3399999999999999 112.061 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 m -61.49 -49.17 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.806 0.336 . . . . 0.57999999999999996 111.878 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -74.94 -29.06 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.474 -0.33 . . . . 0.72999999999999998 110.864 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.49 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 59.9 t80 -59.95 -50.22 74.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.59999999999999998 110.614 173.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 35.6 mm -63.43 -33.63 62.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.22 110.339 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 3.6099999999999999 109.923 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.68 -46.31 86.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 110.231 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.5 -24.02 67.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.912 -0.585 . . . . 0.48999999999999999 112.196 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 5.1 mmp_? -58.37 -38.58 77.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 4.0 110.463 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 29.9 t -96.86 -22.62 16.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.042 0.448 . . . . 1.6699999999999999 109.991 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' SER . 81.1 mtm180 70.86 -81.69 0.03 OUTLIER 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.171 -0.922 . . . . 4.29 111.325 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.445 HH21 ' ND2' ' A' ' 16' ' ' ASN . 40.6 ttm180 -101.61 130.21 47.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.647 -0.706 . . . . 7.8200000000000003 110.636 -171.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -86.01 -42.09 14.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.538 . . . . 6.2300000000000004 110.874 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -117.82 139.7 50.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.338 0.59 . . . . 8.0999999999999996 110.511 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 25.3 ttmm -96.85 -43.29 0.25 Allowed Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.31 -0.859 . . . . 10.19 110.84 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 15.7 Cg_exo -70.26 147.73 60.31 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.683 1.589 . . . . 10.4 111.492 172.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -80.46 59.94 3.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 12.77 110.668 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.545 -0.741 . . . . 14.94 110.11 -178.26 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 112.222 -0.351 . . . . 16.57 112.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.69 66.48 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.072 0.463 . . . . 15.0 111.443 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.1 ttm -82.51 98.11 8.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.893 -0.594 . . . . 14.85 109.922 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -80.28 155.69 27.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 12.380000000000001 110.923 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.72 150.14 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.68 -0.691 . . . . 10.720000000000001 111.201 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.97 112.72 22.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.83 -0.623 . . . . 9.1199999999999992 110.258 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -119.47 4.57 11.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 7.5300000000000002 110.965 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -96.5 134.68 39.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.689 . . . . 5.79 109.609 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 10' ' ' LYS . 34.9 tt0 -74.86 -55.96 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 6.1799999999999997 112.032 -170.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG3' ' HG2' ' A' ' 9' ' ' GLN . 65.1 mttm -135.94 33.53 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.316 0.579 . . . . 5.7800000000000002 110.914 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 p -131.68 86.09 2.31 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.454 -0.794 . . . . 1.8899999999999999 109.618 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 45.1 m-85 -96.56 122.34 39.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.522 -0.763 . . . . 0.78000000000000003 109.668 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 20' ' ' ILE . 20.3 t -108.25 124.27 64.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.511 0.196 . . . . 0.42999999999999999 110.958 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.89 118.58 69.49 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.339 -0.615 . . . . 0.58999999999999997 109.339 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.29 -19.38 63.69 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.767 2.312 . . . . 0.60999999999999999 112.305 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.3 -28.15 18.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.942 -0.572 . . . . 1.24 111.854 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.67 -19.69 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.965 0.728 . . . . 0.78000000000000003 112.965 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 14.22 82.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.618 -0.801 . . . . 0.29999999999999999 111.325 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.5 tptp -77.44 135.64 38.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.232 -0.484 . . . . 1.6100000000000001 110.246 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 13' ' ' VAL . 41.8 pt -106.68 128.72 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.195 0.522 . . . . 1.77 111.372 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 86.4 m-85 -118.08 150.11 39.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.5 110.029 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -95.73 -22.28 17.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 2.8500000000000001 110.494 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 40.3 m95 -119.11 143.59 47.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.993 -0.549 . . . . 0.58999999999999997 110.035 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 28' ' ' ILE . 27.9 ttm180 -72.29 -34.62 68.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.785 -0.643 . . . . 3.3399999999999999 111.593 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.55 -49.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 112.033 0.382 . . . . 0.57999999999999996 112.033 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.3 -30.02 64.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.673 0.273 . . . . 0.72999999999999998 110.504 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HD23 ' A' ' 31' ' ' LEU . 63.2 t80 -59.36 -50.85 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.59999999999999998 110.697 174.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 24' ' ' ARG . 48.2 mm -65.12 -35.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.362 . . . . 0.22 110.234 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -61.1 -42.89 99.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.941 -0.572 . . . . 3.6099999999999999 110.208 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -69.71 -33.57 72.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.42999999999999999 110.895 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 27' ' ' PHE . 3.9 mm? -71.42 -31.14 66.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.75 0.309 . . . . 0.48999999999999999 110.769 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -72.27 -12.65 61.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 4.0 111.352 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -62.21 -33.51 74.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.931 0.396 . . . . 1.6699999999999999 110.112 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' A' ' 36' ' ' GLU . 9.7 ptm180 -104.75 87.48 2.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.45 0.643 . . . . 4.29 110.863 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -82.78 38.96 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.139 0.971 . . . . 7.8200000000000003 109.113 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 34' ' ' ARG . 19.1 mm-40 -77.09 -17.74 58.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.984 -1.007 . . . . 6.2300000000000004 109.487 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -65.62 153.76 40.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 8.0999999999999996 110.145 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -81.62 134.97 49.95 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 109.209 -0.663 . . . . 10.19 109.209 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.29 61.09 5.82 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.643 2.229 . . . . 10.4 112.951 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -73.43 -16.7 61.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.359 0.6 . . . . 12.77 109.398 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.285 -0.864 . . . . 14.94 109.42 175.77 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.972 -0.451 . . . . 16.57 111.972 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.09 26.81 3.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.175 0.512 . . . . 15.0 110.703 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -92.67 64.14 4.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 14.85 109.783 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.18 20.45 5.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 12.380000000000001 111.289 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.36 128.93 36.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.720000000000001 109.678 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.7 tp60 -72.34 101.96 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.072 0.463 . . . . 9.1199999999999992 110.616 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -165.64 146.31 6.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.867 -0.606 . . . . 7.5300000000000002 110.054 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -100.72 6.77 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 5.79 110.186 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.17 -28.34 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.066 -0.515 . . . . 6.1799999999999997 110.428 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -76.13 61.59 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.844 0.831 . . . . 5.7800000000000002 111.078 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -118.15 27.29 9.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.654 -0.703 . . . . 1.8899999999999999 110.821 -175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.09 107.6 17.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.453 -0.499 . . . . 0.78000000000000003 110.098 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.11 126.82 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.041 -0.527 . . . . 0.42999999999999999 111.048 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.2 t -77.37 118.63 73.23 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.724 -0.843 . . . . 0.58999999999999997 108.724 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.61 -19.08 48.52 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.565 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.17 -39.15 13.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.967 -0.561 . . . . 1.24 111.757 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -99.81 -19.79 16.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 111.869 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.78 16.01 80.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.731 -0.747 . . . . 0.29999999999999999 111.316 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -86.48 130.09 34.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.552 -0.324 . . . . 1.6100000000000001 110.588 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -103.17 134.04 45.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.554 -0.535 . . . . 1.77 109.554 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' N ' HD13 ' A' ' 20' ' ' ILE . 58.4 m-85 -118.37 149.9 40.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.058 -0.519 . . . . 0.5 110.302 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -96.13 -25.67 15.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.808 -0.633 . . . . 2.8500000000000001 111.021 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.544 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 41.0 m95 -116.38 146.55 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 110.202 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' ILE . 77.2 mtm180 -72.36 -36.84 68.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 3.3399999999999999 112.114 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -60.97 -49.5 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.854 0.316 . . . . 0.57999999999999996 111.854 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.22 -31.93 66.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.664 0.268 . . . . 0.72999999999999998 110.477 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.52 -50.7 72.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.59999999999999998 110.745 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.7 mm -64.83 -32.27 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.219 0.533 . . . . 0.22 110.477 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.97 -48.42 76.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.012 -0.54 . . . . 3.6099999999999999 110.178 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -65.98 -34.76 78.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.42999999999999999 110.805 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.83 -24.54 61.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.312 -0.404 . . . . 0.48999999999999999 112.025 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -70.23 -17.19 63.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.218 0.532 . . . . 4.0 110.163 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -79.34 13.96 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.907 -0.588 . . . . 1.6699999999999999 110.839 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -70.73 -13.52 62.09 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.86 0.362 . . . . 4.29 111.335 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -76.6 -14.24 60.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.33 0.586 . . . . 7.8200000000000003 110.018 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -104.26 22.95 13.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.733 -0.667 . . . . 6.2300000000000004 110.906 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -91.53 167.62 12.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.139 -0.482 . . . . 8.0999999999999996 110.279 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 13.8 ptmm? -139.71 108.56 7.14 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.953 0.406 . . . . 10.19 110.557 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 38' ' ' LYS . 10.5 Cg_endo -55.39 -39.9 88.5 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.96 2.44 . . . . 10.4 112.411 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -159.51 -57.96 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.154 -0.475 . . . . 12.77 110.145 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.123 -0.942 . . . . 14.94 110.643 -178.935 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.979 -0.448 . . . . 16.57 111.979 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.08 86.69 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.009 0.433 . . . . 15.0 110.888 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -124.99 105.58 9.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.109 -0.496 . . . . 14.85 110.039 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -160.78 97.1 1.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.827 -0.624 . . . . 12.380000000000001 109.505 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -73.73 107.53 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.055 0.455 . . . . 10.720000000000001 110.156 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.51 ' CD ' ' H ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -80.33 85.63 5.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.502 -0.772 . . . . 9.1199999999999992 111.525 -174.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 10' ' ' LYS . 14.5 t -168.48 159.1 10.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 7.5300000000000002 110.112 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -114.34 -27.23 7.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.115 -0.493 . . . . 5.79 111.277 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -130.95 -16.44 3.25 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.217 0.451 . . . . 6.1799999999999997 112.217 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 4.1 mptp? -84.49 68.78 10.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.396 0.617 . . . . 5.7800000000000002 110.695 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -129.0 78.69 1.87 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.467 -0.788 . . . . 1.8899999999999999 109.64 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.49 114.03 20.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.573 -0.739 . . . . 0.78000000000000003 109.927 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 43.7 t -108.41 125.27 65.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.813 0.339 . . . . 0.42999999999999999 111.475 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.9 t -74.71 118.12 67.71 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.354 -0.98 . . . . 0.58999999999999997 108.354 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.17 -22.07 54.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.666 2.244 . . . . 0.60999999999999999 113.223 -169.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -85.3 -36.98 20.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.438 -0.346 . . . . 1.24 111.428 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 m -105.77 -19.64 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.035 0.383 . . . . 0.78000000000000003 112.035 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.39 16.43 79.49 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.692 -0.766 . . . . 0.29999999999999999 111.836 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 41.7 tptt -83.06 130.19 35.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.682 -0.259 . . . . 1.6100000000000001 110.317 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tt -106.93 128.35 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.982 0.42 . . . . 1.77 111.212 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 85.9 m-85 -118.01 150.44 39.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.149 -0.478 . . . . 0.5 109.819 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -100.57 -16.83 17.34 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.878 -0.601 . . . . 2.8500000000000001 110.439 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 22.8 m95 -122.6 146.27 47.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.96 -0.564 . . . . 0.58999999999999997 109.833 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 25.7 ttt180 -72.28 -39.29 68.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.889 -0.596 . . . . 3.3399999999999999 112.441 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.05 -49.8 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.062 0.393 . . . . 0.57999999999999996 112.062 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.53 -29.7 63.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.779 0.323 . . . . 0.72999999999999998 110.663 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 48.4 t80 -61.18 -50.92 71.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.556 . . . . 0.59999999999999998 110.956 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 24' ' ' ARG . 49.9 mm -63.87 -34.25 67.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.095 0.474 . . . . 0.22 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.25 -46.21 89.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.599 -0.728 . . . . 3.6099999999999999 110.223 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.51 -27.28 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.42999999999999999 111.522 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.7 -23.22 67.03 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.154 -0.341 . . . . 0.48999999999999999 111.299 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -60.42 -25.77 66.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 4.0 109.43 169.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.402 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 58.7 m -97.31 74.73 2.51 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.265 1.031 . . . . 1.6699999999999999 110.432 172.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -118.57 -53.56 2.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.845 -1.525 . . . . 4.29 107.733 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -159.6 60.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.749 -1.114 . . . . 7.8200000000000003 109.757 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HG2' ' N ' ' A' ' 37' ' ' GLN . 1.4 pm0 -85.48 -46.46 10.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.772 -0.371 . . . . 6.2300000000000004 110.114 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 84.1 mm-40 -146.11 -70.36 0.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.585 . . . . 8.0999999999999996 109.765 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.16 125.46 26.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.7 -0.682 . . . . 10.19 109.876 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.99 116.25 2.66 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.141 2.561 . . . . 10.4 112.771 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -93.55 64.76 3.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 12.77 110.658 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.462 -0.78 . . . . 14.94 109.689 177.865 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.818 -0.513 . . . . 16.57 111.818 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.61 -1.65 22.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 15.0 111.315 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.5 mtt -88.32 -12.67 42.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.369 . . . . 14.85 111.164 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -78.83 57.34 2.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.113 0.483 . . . . 12.380000000000001 111.231 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.38 126.6 41.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.782 -0.645 . . . . 10.720000000000001 109.499 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.8 tp60 -72.06 89.17 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.115 0.484 . . . . 9.1199999999999992 110.756 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -166.91 148.85 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.961 -0.563 . . . . 7.5300000000000002 110.075 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 t -91.28 76.65 5.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.952 -0.759 . . . . 5.79 108.952 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -146.51 -41.39 0.2 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 6.1799999999999997 111.483 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 20' ' ' ILE . 47.7 pttt -75.32 70.73 2.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.771 0.796 . . . . 5.7800000000000002 111.172 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -115.53 12.78 16.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.596 -0.729 . . . . 1.8899999999999999 110.795 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -97.39 108.42 21.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.897 0.38 . . . . 0.78000000000000003 110.655 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.09 126.45 70.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.42999999999999999 110.452 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.41 118.59 67.48 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.58999999999999997 108.997 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.14 -19.76 69.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.737 2.291 . . . . 0.60999999999999999 112.438 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.47 -42.62 10.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.056 -0.52 . . . . 1.24 111.728 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.0 m -98.7 -19.91 17.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.78000000000000003 112.195 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.36 15.52 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.29999999999999999 111.08 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -80.79 130.48 35.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.089 -0.556 . . . . 1.6100000000000001 109.985 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -106.44 129.13 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.321 0.581 . . . . 1.77 109.936 -178.411 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 62.3 m-85 -117.38 149.95 39.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.278 0.561 . . . . 0.5 110.549 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -97.1 -31.58 12.41 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.243 -0.89 . . . . 2.8500000000000001 110.723 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.581 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 50.9 m95 -110.99 143.42 41.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.402 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 76.5 mtm180 -72.52 -35.13 68.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.517 -0.765 . . . . 3.3399999999999999 111.537 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.23 -49.61 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.812 0.301 . . . . 0.57999999999999996 111.812 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -74.65 -29.93 61.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.887 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 68.7 t80 -61.51 -51.14 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.59999999999999998 110.969 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 24' ' ' ARG . 50.1 mm -62.36 -33.45 59.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.044 0.449 . . . . 0.22 110.264 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -66.55 -40.55 89.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 3.6099999999999999 110.138 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.82 -39.12 90.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.42999999999999999 110.622 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? -69.01 -25.16 64.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.48999999999999999 110.833 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -68.17 -26.16 65.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.336 0.588 . . . . 4.0 110.028 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -76.1 2.34 13.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.649 -0.705 . . . . 1.6699999999999999 111.2 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -69.72 -21.07 63.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.338 0.59 . . . . 4.29 109.892 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -83.05 -7.37 59.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.438 -0.801 . . . . 7.8200000000000003 109.953 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.28 16.27 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 6.2300000000000004 109.961 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -109.94 164.77 12.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 8.0999999999999996 110.622 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -99.16 130.9 26.27 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.795 -0.639 . . . . 10.19 110.213 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.81 -63.38 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.365 2.71 . . . . 10.4 113.205 -173.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -159.62 -58.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.311 -0.404 . . . . 12.77 110.342 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.2 tttm . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.972 -1.013 . . . . 14.94 109.975 -174.396 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.179 -0.369 . . . . 16.57 112.179 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.73 118.05 25.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.427 -0.212 . . . . 15.0 110.427 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.0 mtm 72.69 -44.42 0.59 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 14.85 111.406 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.33 141.05 51.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.705 -0.48 . . . . 12.380000000000001 109.705 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.65 159.95 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.255 -0.429 . . . . 10.720000000000001 110.611 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -89.38 43.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.33 0.586 . . . . 9.1199999999999992 110.755 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.57 145.9 13.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.415 -0.811 . . . . 7.5300000000000002 109.67 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -74.5 -60.5 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.142 -0.481 . . . . 5.79 111.01 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.454 ' HG3' ' HG2' ' A' ' 10' ' ' LYS . 17.3 pt20 -170.62 -45.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.191 -0.459 . . . . 6.1799999999999997 110.921 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 9' ' ' GLN . 51.8 pttt -153.71 128.96 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 5.7800000000000002 110.85 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -101.53 141.31 34.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.002 -0.545 . . . . 1.8899999999999999 109.716 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 72.2 m-85 -100.06 117.36 34.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.906 -0.588 . . . . 0.78000000000000003 109.484 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 20' ' ' ILE . 16.8 t -105.62 120.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.584 0.231 . . . . 0.42999999999999999 111.291 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -75.18 119.16 75.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.109 -0.7 . . . . 0.58999999999999997 109.109 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.85 -14.83 45.26 Favored 'Trans proline' 0 CA--C 1.526 0.115 0 C-N-CA 122.662 2.242 . . . . 0.60999999999999999 112.906 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -91.15 -33.81 15.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.477 -0.329 . . . . 1.24 111.693 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.9 m -113.97 -18.57 11.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.827 0.677 . . . . 0.78000000000000003 112.827 -170.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.43 15.2 79.09 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.404 -0.903 . . . . 0.29999999999999999 110.937 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -79.66 126.32 30.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.544 . . . . 1.6100000000000001 109.764 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 39.5 pt -106.69 128.69 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.598 . . . . 1.77 111.645 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HD1' ' A' ' 12' ' ' TYR . 83.1 m-85 -117.32 150.61 38.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.5 109.242 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -98.88 -21.92 16.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.948 0.404 . . . . 2.8500000000000001 110.802 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 63.7 m95 -110.34 145.21 37.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.58999999999999997 110.413 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -72.61 -36.78 68.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 3.3399999999999999 111.536 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.67 -49.25 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.812 0.339 . . . . 0.57999999999999996 111.867 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 22.3 p30 -71.16 -25.4 62.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.972 0.415 . . . . 0.72999999999999998 110.709 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -67.01 -50.04 63.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.59999999999999998 110.362 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.26 -32.95 56.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.22 110.317 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -60.17 -48.37 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 3.6099999999999999 110.578 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -64.76 -37.51 87.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.603 -0.726 . . . . 0.42999999999999999 110.847 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.35 -24.62 50.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.997 -0.547 . . . . 0.48999999999999999 111.568 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -64.03 -35.86 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 4.0 110.137 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 21.3 m -86.21 42.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 1.6699999999999999 110.053 175.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -56.98 146.88 25.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.574 -0.739 . . . . 4.29 111.01 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 70.54 48.67 0.44 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.34 1.067 . . . . 7.8200000000000003 108.257 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.2 mp0 -60.78 -48.13 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.839 -1.528 . . . . 6.2300000000000004 110.152 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 67.84 165.3 0.23 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.404 -0.816 . . . . 8.0999999999999996 111.192 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 23.7 tptm -94.89 -53.33 0.23 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.584 -0.734 . . . . 10.19 110.758 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 93.4 Cg_endo -78.38 92.34 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.941 1.761 . . . . 10.4 112.161 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -105.47 25.47 10.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.254 -0.43 . . . . 12.77 111.341 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.716 -0.659 . . . . 14.94 109.804 177.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.023 -0.431 . . . . 16.57 112.023 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.73 101.39 9.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.765 0.317 . . . . 15.0 110.522 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.4 ttt -59.44 -51.08 71.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.76 -0.655 . . . . 14.85 110.802 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -110.85 113.0 25.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.864 -0.607 . . . . 12.380000000000001 109.691 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.8 t -61.75 119.33 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 10.720000000000001 111.14 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 56.65 63.98 1.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.109 -0.95 . . . . 9.1199999999999992 110.898 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -83.03 60.23 5.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.813 0.816 . . . . 7.5300000000000002 109.467 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.601 ' OG ' ' HD3' ' A' ' 22' ' ' ARG . 66.1 m 65.06 -80.67 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.583 -1.19 . . . . 5.79 111.175 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -175.11 -48.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.214 0.531 . . . . 6.1799999999999997 109.929 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.63 150.69 20.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.597 -0.729 . . . . 5.7800000000000002 109.985 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.0 p -150.04 125.13 10.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.143 0.497 . . . . 1.8899999999999999 110.841 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -100.99 120.65 40.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.734 -0.667 . . . . 0.78000000000000003 109.687 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 41.9 t -108.3 117.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.926 -0.31 . . . . 0.42999999999999999 110.844 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -70.98 118.52 66.28 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.413 -0.588 . . . . 0.58999999999999997 109.413 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.33 -15.98 47.0 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.508 2.138 . . . . 0.60999999999999999 112.472 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.88 -25.76 23.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.998 -0.546 . . . . 1.24 111.181 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -121.16 -19.96 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.469 0.544 . . . . 0.78000000000000003 112.469 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.36 15.75 80.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.29999999999999999 111.227 -173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.7 tptm -83.49 135.77 34.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.518 0.327 . . . . 1.6100000000000001 110.191 -176.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.26 125.6 61.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 1.77 110.371 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 87.5 m-85 -116.71 147.74 41.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.5 109.997 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.601 ' HD3' ' OG ' ' A' ' 8' ' ' SER . 13.1 ttm180 -98.52 -28.39 13.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.805 -0.634 . . . . 2.8500000000000001 110.135 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -105.51 143.44 33.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.515 -0.766 . . . . 0.58999999999999997 110.911 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 28' ' ' ILE . 45.4 ttp180 -72.59 -36.19 68.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.063 -0.971 . . . . 3.3399999999999999 111.419 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.14 -48.61 80.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.86 0.319 . . . . 0.57999999999999996 111.86 -173.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 19.6 p30 -72.98 -27.0 61.55 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.994 -0.282 . . . . 0.72999999999999998 110.861 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 74.1 t80 -66.61 -50.1 64.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.787 0.327 . . . . 0.59999999999999998 110.34 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.0 mm -64.19 -36.46 77.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.22 110.425 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -61.62 -44.77 96.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.285 0.564 . . . . 3.6099999999999999 110.253 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -66.9 -35.31 79.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.067 -0.97 . . . . 0.42999999999999999 111.038 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 3.9 mm? -78.08 -34.47 50.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.91 0.337 . . . . 0.48999999999999999 111.91 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.34 -42.31 99.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.83 0.347 . . . . 4.0 110.935 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -75.76 -33.85 60.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.409 . . . . 1.6699999999999999 110.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 11.2 mtp180 67.49 -63.46 0.3 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.402 0.681 . . . . 4.29 112.521 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' NH2' ' HA ' ' A' ' 39' ' ' PRO . 23.3 tpt180 -156.21 -70.17 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.169 -0.308 . . . . 7.8200000000000003 110.169 -176.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 55.77 42.32 29.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.432 0.457 . . . . 6.2300000000000004 111.779 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -174.81 138.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.741 -0.837 . . . . 8.0999999999999996 108.741 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -54.22 113.22 4.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 10.19 111.633 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HA ' ' NH2' ' A' ' 35' ' ' ARG . 64.4 Cg_endo -76.95 -24.88 9.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.789 2.326 . . . . 10.4 111.993 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -179.86 -29.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.123 -0.944 . . . . 12.77 108.895 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 41' ' ' LYS . 39.2 ttmt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 115.323 -0.853 . . . . 14.94 109.339 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.08 -0.408 . . . . 16.57 112.08 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.2 -48.95 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.352 . . . . 15.0 110.916 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -86.67 109.55 19.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.43 . . . . 14.85 110.155 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -171.22 101.43 0.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.881 -0.6 . . . . 12.380000000000001 109.793 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t 56.35 66.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.632 0.729 . . . . 10.720000000000001 110.473 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 3.4 pt20 -108.72 32.48 4.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.533 -0.758 . . . . 9.1199999999999992 110.36 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -59.46 -74.87 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.335 -0.848 . . . . 7.5300000000000002 111.268 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t -142.26 9.92 1.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.77 0.319 . . . . 5.79 110.637 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.453 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 17.8 pt20 -115.17 1.09 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.713 0.292 . . . . 6.1799999999999997 111.498 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 64.9 tttm -154.14 148.47 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 5.7800000000000002 109.505 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 6' ' ' GLN . 21.4 p 47.24 72.63 0.24 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.891 0.744 . . . . 1.8899999999999999 110.362 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -77.42 124.78 28.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.227 -0.897 . . . . 0.78000000000000003 110.145 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 20' ' ' ILE . 10.2 t -108.14 116.82 52.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.42999999999999999 110.51 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 17.4 t -72.25 121.2 84.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.58999999999999997 109.274 173.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.81 -13.39 24.29 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.327 2.018 . . . . 0.60999999999999999 110.328 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -90.17 -28.54 18.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.744 -1.571 . . . . 1.24 111.444 -173.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.6 m -123.53 -20.49 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.638 0.607 . . . . 0.78000000000000003 112.638 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 16.19 76.64 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.06 -0.816 . . . . 0.29999999999999999 111.06 -169.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -82.29 143.97 30.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.661 0.384 . . . . 1.6100000000000001 110.91 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 13' ' ' VAL . 11.5 mm -105.44 128.39 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.393 0.616 . . . . 1.77 111.124 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.0 m-85 -118.23 148.41 42.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.975 -1.011 . . . . 0.5 110.263 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -104.04 -23.31 13.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.823 -0.626 . . . . 2.8500000000000001 110.673 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.523 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 63.5 m95 -113.61 152.0 30.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.471 -0.331 . . . . 0.58999999999999997 110.399 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 28' ' ' ILE . 10.9 tpp180 -71.66 -47.63 53.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 3.3399999999999999 111.659 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -48.07 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.444 0.535 . . . . 0.57999999999999996 112.444 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 23' ' ' TRP . 19.8 p30 -68.36 -26.47 65.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.296 . . . . 0.72999999999999998 110.975 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.469 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 81.0 t80 -69.7 -50.18 46.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.59999999999999998 109.799 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 37.8 mm -59.16 -41.96 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.22 109.845 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -59.55 -42.66 92.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.557 -0.747 . . . . 3.6099999999999999 110.69 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -61.75 -42.87 99.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.546 -0.752 . . . . 0.42999999999999999 111.254 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.1 -36.69 64.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.443 -0.344 . . . . 0.48999999999999999 110.79 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 26.2 mmm180 -66.27 -40.57 90.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.589 -0.278 . . . . 4.0 110.729 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -60.36 -41.48 93.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.522 . . . . 1.6699999999999999 110.577 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -65.59 -45.6 82.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 4.29 110.678 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 55.32 78.8 0.17 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.344 0.593 . . . . 7.8200000000000003 110.106 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 63.8 3.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.492 -0.777 . . . . 6.2300000000000004 111.565 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -122.33 168.61 11.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.685 -0.689 . . . . 8.0999999999999996 109.801 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.12 101.14 53.03 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.19 110.119 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.64 -34.98 96.97 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 123.088 2.525 . . . . 10.4 112.727 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -151.5 -46.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.557 -0.292 . . . . 12.77 111.342 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.219 -0.896 . . . . 14.94 111.634 -176.148 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 112.148 -0.381 . . . . 16.57 112.148 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.19 -165.93 0.18 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.81 0.444 . . . . 15.0 111.191 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.4 mtp 67.6 28.53 7.43 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.061 0.458 . . . . 14.85 110.928 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -86.86 70.09 10.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.975 -0.557 . . . . 12.380000000000001 110.362 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 t 58.43 55.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.742 0.782 . . . . 10.720000000000001 109.839 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.42 76.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 9.1199999999999992 108.913 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -87.36 54.3 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.72 -0.673 . . . . 7.5300000000000002 109.896 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 57.33 80.94 0.15 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.31 -0.859 . . . . 5.79 109.594 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -68.28 94.75 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.7 . . . . 6.1799999999999997 111.182 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 47.7 mmtm 55.76 48.93 17.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.812 -0.631 . . . . 5.7800000000000002 111.219 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -132.78 77.08 1.72 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.555 -0.748 . . . . 1.8899999999999999 109.781 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 52.5 m-85 -91.57 117.19 29.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.711 -0.677 . . . . 0.78000000000000003 110.371 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 20' ' ' ILE . 11.3 t -108.66 115.67 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.758 -0.201 . . . . 0.42999999999999999 111.176 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 t -70.67 120.93 81.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 173.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 -16.29 48.58 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.60999999999999999 112.846 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.32 -32.82 16.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.695 0.284 . . . . 1.24 111.354 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 m -113.3 -20.16 11.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.654 0.613 . . . . 0.78000000000000003 112.654 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.23 80.88 Favored Glycine 0 N--CA 1.453 -0.187 0 N-CA-C 110.586 -1.005 . . . . 0.29999999999999999 110.586 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -77.27 124.37 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.773 -0.714 . . . . 1.6100000000000001 109.699 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 36.2 mt -106.03 130.46 57.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.99 0.424 . . . . 1.77 110.745 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -115.28 149.11 38.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.722 -0.672 . . . . 0.5 110.105 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 12.3 ttm180 -96.99 -16.01 20.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.455 -0.793 . . . . 2.8500000000000001 110.44 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -121.62 148.61 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.51 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 28' ' ' ILE . 56.7 ttt180 -71.54 -38.97 70.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 3.3399999999999999 111.231 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 m -65.39 -48.59 82.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.158 0.429 . . . . 0.57999999999999996 112.158 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -72.74 -26.22 61.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.567 0.223 . . . . 0.72999999999999998 111.083 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -65.97 -49.88 66.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.59999999999999998 110.279 177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 24' ' ' ARG . 43.8 mm -60.82 -33.19 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.583 . . . . 0.22 110.052 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -62.4 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 3.6099999999999999 110.682 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -67.18 -37.29 83.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.42999999999999999 110.883 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.09 -29.64 49.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.339 -0.391 . . . . 0.48999999999999999 110.873 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -66.66 -37.93 85.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.569 -0.53 . . . . 4.0 109.569 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -79.27 55.59 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.563 -0.744 . . . . 1.6699999999999999 109.604 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -80.61 60.05 3.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.887 0.851 . . . . 4.29 110.27 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -112.43 25.16 11.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.583 -1.189 . . . . 7.8200000000000003 109.085 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -82.63 -25.48 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.791 -1.095 . . . . 6.2300000000000004 109.883 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -131.61 -63.33 0.84 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.367 -0.833 . . . . 8.0999999999999996 110.103 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.49 92.11 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.329 0 O-C-N 123.812 0.695 . . . . 10.19 111.488 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.09 141.62 26.59 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.762 2.308 . . . . 10.4 111.249 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -79.86 -20.85 44.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.599 -0.519 . . . . 12.77 109.599 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.368 -0.825 . . . . 14.94 110.132 176.669 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.826 -0.11 . . . . 16.57 112.826 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.79 -51.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.936 0.398 . . . . 15.0 110.428 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.69 77.78 1.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.115 0.483 . . . . 14.85 111.031 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -98.58 125.33 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.694 -0.685 . . . . 12.380000000000001 110.117 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -92.71 -40.44 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.878 0.371 . . . . 10.720000000000001 110.505 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -80.75 69.68 7.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.27 0.557 . . . . 9.1199999999999992 110.643 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -160.36 175.36 12.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.664 -0.698 . . . . 7.5300000000000002 109.468 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m 69.7 130.19 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.936 0.773 . . . . 5.79 111.09 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -68.08 -30.22 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 6.1799999999999997 109.851 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.55 123.68 10.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 5.7800000000000002 109.775 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 p -145.33 124.85 13.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 1.8899999999999999 110.945 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 38.3 m-85 -111.54 129.04 56.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.42 -0.809 . . . . 0.78000000000000003 109.208 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 20' ' ' ILE . 15.6 t -108.58 120.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.642 0.258 . . . . 0.42999999999999999 111.619 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -73.03 120.24 79.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.666 -0.865 . . . . 0.58999999999999997 108.666 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.83 -17.11 41.99 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.576 2.184 . . . . 0.60999999999999999 112.218 -173.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -90.18 -42.69 10.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.834 -0.621 . . . . 1.24 111.389 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.31 -20.12 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.923 0.342 . . . . 0.78000000000000003 111.923 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.42 15.87 78.96 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 110.995 -0.842 . . . . 0.29999999999999999 110.995 -173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -81.53 135.02 35.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.034 -0.583 . . . . 1.6100000000000001 109.973 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 13' ' ' VAL . 49.2 pt -106.54 130.49 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.174 0.512 . . . . 1.77 111.031 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -117.4 149.33 40.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.733 -0.667 . . . . 0.5 109.977 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -96.53 -33.24 11.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.113 -0.494 . . . . 2.8500000000000001 110.651 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 62.6 m95 -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.58999999999999997 110.666 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 28' ' ' ILE . 8.8 mmm180 -71.24 -36.35 71.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 3.3399999999999999 111.818 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 m -63.03 -48.66 86.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 0.57999999999999996 111.857 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.626 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.98 -31.9 64.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.186 -0.206 . . . . 0.72999999999999998 110.984 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 31' ' ' LEU . 59.3 t80 -61.04 -50.83 71.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.732 0.301 . . . . 0.59999999999999998 110.565 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 24' ' ' ARG . 52.0 mm -65.28 -34.18 68.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.22 110.043 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -60.08 -44.9 94.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.969 -0.56 . . . . 3.6099999999999999 110.201 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.94 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.687 -0.688 . . . . 0.42999999999999999 111.158 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? -77.21 -31.9 55.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.847 0.356 . . . . 0.48999999999999999 111.396 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -72.57 -25.45 61.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.046 0.451 . . . . 4.0 110.703 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -85.11 10.05 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 1.6699999999999999 111.281 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -74.56 -66.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.113 -0.329 . . . . 4.29 110.113 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 56.79 44.62 23.1 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.736 0.779 . . . . 7.8200000000000003 109.505 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 29.95 7.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.833 -1.076 . . . . 6.2300000000000004 110.048 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -68.62 -24.24 64.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.773 -0.649 . . . . 8.0999999999999996 110.215 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 28.7 ttpp -134.21 -46.47 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.622 -0.717 . . . . 10.19 110.782 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' CD ' ' H ' ' A' ' 38' ' ' LYS . 3.2 Cg_exo -82.43 86.29 1.53 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.275 1.984 . . . . 10.4 111.816 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -94.5 44.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 12.77 110.854 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.647 -0.706 . . . . 14.94 111.128 -178.052 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.427 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 7.2 m-85 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 109.933 -0.395 . . . . 0.78000000000000003 109.933 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.51 128.88 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.42999999999999999 111.27 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.9 t -80.48 119.04 75.16 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.629 -0.878 . . . . 0.58999999999999997 108.629 168.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.19 -26.48 82.38 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.823 2.349 . . . . 0.60999999999999999 113.357 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.99 -37.39 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.508 -0.314 . . . . 1.24 111.689 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 m -96.87 -19.91 18.53 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.821 -0.351 . . . . 0.78000000000000003 111.757 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.43 16.27 77.38 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 111.343 -0.703 . . . . 0.29999999999999999 111.343 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.57 134.59 37.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.445 . . . . 1.6100000000000001 111.354 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.63 129.12 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 1.77 110.852 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 51.7 m-85 -118.57 150.42 39.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.876 . . . . 0.5 110.505 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -105.04 -19.32 13.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 2.8500000000000001 110.801 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -122.82 149.12 44.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.58999999999999997 110.373 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -73.19 -41.51 63.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 3.3399999999999999 111.896 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.61 -45.24 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.152 0.427 . . . . 0.57999999999999996 112.152 -170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.671 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -74.86 -25.79 59.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.888 0.375 . . . . 0.72999999999999998 110.626 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.671 ' N ' HD22 ' A' ' 26' ' ' ASN . 76.3 t80 -66.33 -50.24 64.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.934 -0.575 . . . . 0.59999999999999998 110.148 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.95 -34.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.22 110.267 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.91 -45.82 92.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 3.6099999999999999 110.152 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.95 -35.96 82.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.5 -0.773 . . . . 0.42999999999999999 110.732 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? . . . . . 0 C--N 1.326 -0.431 0 CA-C-N 116.32 -0.4 . . . . 0.48999999999999999 110.89 177.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 49.6 m-85 . . . . . 0 CA--C 1.517 -0.302 0 N-CA-C 108.903 -0.777 . . . . 0.78000000000000003 108.903 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.39 120.88 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.77 0.319 . . . . 0.42999999999999999 111.348 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 t -76.79 118.68 73.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 0.58999999999999997 109.177 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.44 -14.27 39.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.392 2.062 . . . . 0.60999999999999999 112.135 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -89.71 -27.94 19.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.883 -0.599 . . . . 1.24 111.428 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -121.69 -20.29 6.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.673 0.619 . . . . 0.78000000000000003 112.673 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.77 88.88 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.695 -0.764 . . . . 0.29999999999999999 111.576 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -73.66 131.63 41.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.736 0.414 . . . . 1.6100000000000001 110.406 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 57.4 mt -107.05 125.94 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.392 -0.367 . . . . 1.77 111.092 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.46 150.78 37.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.5 109.541 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -104.67 -19.45 13.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.057 0.456 . . . . 2.8500000000000001 110.615 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -107.77 134.29 50.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 109.495 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' O ' HG12 ' A' ' 28' ' ' ILE . 38.2 ttm180 -71.99 -30.49 65.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.186 -0.461 . . . . 3.3399999999999999 111.157 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.1 -46.5 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 111.627 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.613 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.18 -25.86 58.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.72999999999999998 110.278 177.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.613 ' N ' HD22 ' A' ' 26' ' ' ASN . 74.1 t80 -64.66 -50.0 68.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.59999999999999998 110.068 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 24' ' ' ARG . 46.2 mm -62.05 -33.18 57.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.031 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -60.46 -47.12 87.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 3.6099999999999999 110.608 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -70.29 -35.09 73.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.42999999999999999 111.241 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.327 -0.397 0 CA-C-O 120.782 0.325 . . . . 0.48999999999999999 111.223 177.961 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 26.6 m-85 . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.497 -0.557 . . . . 0.78000000000000003 109.497 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.1 126.36 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.42999999999999999 110.913 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 11.0 t -76.84 118.43 71.7 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.837 -0.801 . . . . 0.58999999999999997 108.837 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.36 -17.74 59.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.51 2.14 . . . . 0.60999999999999999 112.145 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.445 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.3 t-20 -89.83 -28.36 19.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 1.24 111.561 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 m -121.66 -20.93 6.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.084 0.772 . . . . 0.78000000000000003 113.084 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.56 83.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.664 -0.779 . . . . 0.29999999999999999 111.239 -172.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 22.2 tptp -67.31 137.25 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.264 0.626 . . . . 1.6100000000000001 110.851 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mm -102.47 130.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.653 . . . . 1.77 111.063 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.539 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.1 m-85 -119.19 150.04 40.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.691 -1.141 . . . . 0.5 110.634 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -106.02 -13.07 15.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.393 0.616 . . . . 2.8500000000000001 110.447 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 17.4 m95 -127.57 133.32 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.384 -0.599 . . . . 0.58999999999999997 109.384 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 28' ' ' ILE . 62.1 mtm180 -72.46 -28.96 63.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 3.3399999999999999 111.529 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.15 -49.31 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.57999999999999996 111.644 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -75.98 -30.2 58.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.512 -0.313 . . . . 0.72999999999999998 110.956 176.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.0 t80 -59.15 -51.28 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.59999999999999998 110.835 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 24' ' ' ARG . 51.2 mm -62.32 -34.59 64.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.22 110.217 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -65.33 -41.14 94.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 3.6099999999999999 110.279 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -66.59 -37.34 84.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 0.42999999999999999 110.84 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.48999999999999999 110.365 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 39.1 m-85 . . . . . 0 N--CA 1.451 -0.375 0 N-CA-C 109.801 -0.444 . . . . 0.78000000000000003 109.801 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.67 115.12 48.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 110.501 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.6 t -67.09 122.53 83.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.123 -0.695 . . . . 0.58999999999999997 109.123 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.44 -28.6 71.11 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 123.327 2.684 . . . . 0.60999999999999999 112.715 -170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -89.08 -28.03 20.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.186 -0.916 . . . . 1.24 111.925 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -113.5 -19.16 11.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.191 0.441 . . . . 0.78000000000000003 112.191 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.91 15.42 81.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.764 -0.732 . . . . 0.29999999999999999 112.024 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -83.46 124.69 30.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.046 -0.353 . . . . 1.6100000000000001 110.046 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -102.86 128.9 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.188 0.518 . . . . 1.77 110.498 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 95.1 m-85 -118.15 149.37 41.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.949 -0.569 . . . . 0.5 110.009 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -99.18 -9.28 23.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.139 0.495 . . . . 2.8500000000000001 110.332 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 29.9 m95 -130.16 149.47 51.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.949 -0.569 . . . . 0.58999999999999997 109.83 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 28' ' ' ILE . 50.4 mtm180 -71.91 -38.82 69.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.161 -0.472 . . . . 3.3399999999999999 111.582 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.2 -49.82 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.37 0.507 . . . . 0.57999999999999996 112.37 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -70.83 -29.38 65.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.691 0.282 . . . . 0.72999999999999998 110.812 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.442 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 55.2 t80 -62.98 -50.28 71.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.59999999999999998 110.332 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 24' ' ' ARG . 42.6 mm -63.37 -35.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.22 110.285 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -59.84 -44.68 93.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 3.6099999999999999 110.048 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -65.79 -39.8 91.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.42999999999999999 110.991 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.324 -0.514 0 CA-C-N 116.469 -0.332 . . . . 0.48999999999999999 110.741 178.493 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.73 -0.47 . . . . 0.78000000000000003 109.73 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.9 123.97 69.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.42999999999999999 110.597 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.79 116.86 42.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.58999999999999997 108.683 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 -18.28 62.44 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.466 2.111 . . . . 0.60999999999999999 112.398 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -90.62 -27.53 19.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.171 -0.468 . . . . 1.24 112.027 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.4 m -114.74 -20.36 10.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.364 -0.534 . . . . 0.78000000000000003 112.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.58 86.73 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.778 -0.725 . . . . 0.29999999999999999 111.595 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -78.7 129.14 34.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.993 -0.373 . . . . 1.6100000000000001 109.993 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.61 131.42 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.007 0.432 . . . . 1.77 110.197 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 72.1 m-85 -117.48 149.82 39.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.5 110.645 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -96.55 -25.15 15.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.472 -0.786 . . . . 2.8500000000000001 110.588 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -117.5 141.49 48.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.769 -0.651 . . . . 0.58999999999999997 110.072 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -73.1 -35.13 66.53 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.361 0.504 . . . . 3.3399999999999999 112.361 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.43 -44.31 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.854 -0.338 . . . . 0.57999999999999996 111.282 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.648 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.57 -26.2 57.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.751 0.31 . . . . 0.72999999999999998 110.606 178.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.648 ' N ' HD22 ' A' ' 26' ' ' ASN . 72.4 t80 -64.44 -50.84 65.97 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.313 -0.403 . . . . 0.59999999999999998 110.426 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -63.81 -34.37 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.171 0.51 . . . . 0.22 109.96 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -61.06 -40.99 95.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 3.6099999999999999 110.455 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -71.48 -41.12 69.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.42999999999999999 111.115 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.326 -0.424 0 CA-C-O 120.805 0.336 . . . . 0.48999999999999999 110.916 178.198 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 . . . . . 0 CA--C 1.518 -0.265 0 N-CA-C 110.346 -0.242 . . . . 0.78000000000000003 110.346 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.44 120.1 60.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.873 -0.418 . . . . 0.42999999999999999 109.873 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.1 t -73.86 119.22 75.06 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.968 -0.753 . . . . 0.58999999999999997 108.968 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.23 -27.24 78.12 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.178 2.586 . . . . 0.60999999999999999 112.91 -171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -90.02 -41.47 11.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.229 -0.441 . . . . 1.24 111.911 -175.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 m -98.05 -14.84 20.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.175 0.435 . . . . 0.78000000000000003 112.175 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.64 78.8 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.681 -0.771 . . . . 0.29999999999999999 111.916 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -84.09 126.74 33.36 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.178 -0.304 . . . . 1.6100000000000001 110.178 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 tp -106.04 120.93 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.064 0.459 . . . . 1.77 110.765 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 94.9 m-85 -115.88 149.45 38.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.026 -0.533 . . . . 0.5 109.601 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -104.13 -12.25 16.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.892 -0.595 . . . . 2.8500000000000001 110.428 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.57 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 37.1 m95 -126.47 142.69 51.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.849 -0.614 . . . . 0.58999999999999997 109.979 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.3 ttt180 -72.89 -34.83 66.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 3.3399999999999999 112.061 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 m -61.49 -49.17 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.806 0.336 . . . . 0.57999999999999996 111.878 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -74.94 -29.06 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.474 -0.33 . . . . 0.72999999999999998 110.864 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.49 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 59.9 t80 -59.95 -50.22 74.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.59999999999999998 110.614 173.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 24' ' ' ARG . 35.6 mm -63.43 -33.63 62.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.22 110.339 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 3.6099999999999999 109.923 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.68 -46.31 86.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 110.231 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.324 -0.52 0 CA-C-N 115.912 -0.585 . . . . 0.48999999999999999 112.196 -178.424 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 45.1 m-85 . . . . . 0 CA--C 1.518 -0.267 0 N-CA-C 109.668 -0.493 . . . . 0.78000000000000003 109.668 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 20' ' ' ILE . 20.3 t -108.25 124.27 64.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.511 0.196 . . . . 0.42999999999999999 110.958 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.89 118.58 69.49 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.339 -0.615 . . . . 0.58999999999999997 109.339 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.29 -19.38 63.69 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.767 2.312 . . . . 0.60999999999999999 112.305 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.3 -28.15 18.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.942 -0.572 . . . . 1.24 111.854 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.67 -19.69 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.965 0.728 . . . . 0.78000000000000003 112.965 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 14.22 82.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.618 -0.801 . . . . 0.29999999999999999 111.325 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.5 tptp -77.44 135.64 38.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.232 -0.484 . . . . 1.6100000000000001 110.246 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 13' ' ' VAL . 41.8 pt -106.68 128.72 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.195 0.522 . . . . 1.77 111.372 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 86.4 m-85 -118.08 150.11 39.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.5 110.029 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -95.73 -22.28 17.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 2.8500000000000001 110.494 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 40.3 m95 -119.11 143.59 47.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.993 -0.549 . . . . 0.58999999999999997 110.035 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 28' ' ' ILE . 27.9 ttm180 -72.29 -34.62 68.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.785 -0.643 . . . . 3.3399999999999999 111.593 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.55 -49.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 112.033 0.382 . . . . 0.57999999999999996 112.033 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.3 -30.02 64.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.673 0.273 . . . . 0.72999999999999998 110.504 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HD23 ' A' ' 31' ' ' LEU . 63.2 t80 -59.36 -50.85 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.59999999999999998 110.697 174.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 24' ' ' ARG . 48.2 mm -65.12 -35.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.362 . . . . 0.22 110.234 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -61.1 -42.89 99.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.941 -0.572 . . . . 3.6099999999999999 110.208 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -69.71 -33.57 72.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.42999999999999999 110.895 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 27' ' ' PHE . 3.9 mm? . . . . . 0 C--N 1.323 -0.563 0 CA-C-O 120.75 0.309 . . . . 0.48999999999999999 110.769 176.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.098 -0.334 . . . . 0.78000000000000003 110.098 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.11 126.82 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.041 -0.527 . . . . 0.42999999999999999 111.048 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.2 t -77.37 118.63 73.23 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.724 -0.843 . . . . 0.58999999999999997 108.724 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.61 -19.08 48.52 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.565 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.17 -39.15 13.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.967 -0.561 . . . . 1.24 111.757 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -99.81 -19.79 16.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 111.869 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.78 16.01 80.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.731 -0.747 . . . . 0.29999999999999999 111.316 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -86.48 130.09 34.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.552 -0.324 . . . . 1.6100000000000001 110.588 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -103.17 134.04 45.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.554 -0.535 . . . . 1.77 109.554 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.401 ' N ' HD13 ' A' ' 20' ' ' ILE . 58.4 m-85 -118.37 149.9 40.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.058 -0.519 . . . . 0.5 110.302 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -96.13 -25.67 15.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.808 -0.633 . . . . 2.8500000000000001 111.021 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.544 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 41.0 m95 -116.38 146.55 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 110.202 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' ILE . 77.2 mtm180 -72.36 -36.84 68.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 3.3399999999999999 112.114 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -60.97 -49.5 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.854 0.316 . . . . 0.57999999999999996 111.854 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.22 -31.93 66.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.664 0.268 . . . . 0.72999999999999998 110.477 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.52 -50.7 72.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.59999999999999998 110.745 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.7 mm -64.83 -32.27 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.219 0.533 . . . . 0.22 110.477 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.97 -48.42 76.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.012 -0.54 . . . . 3.6099999999999999 110.178 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -65.98 -34.76 78.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.42999999999999999 110.805 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? . . . . . 0 C--N 1.325 -0.5 0 CA-C-N 116.312 -0.404 . . . . 0.48999999999999999 112.025 -179.407 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 . . . . . 0 N--CA 1.453 -0.279 0 N-CA-C 109.927 -0.397 . . . . 0.78000000000000003 109.927 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 43.7 t -108.41 125.27 65.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.813 0.339 . . . . 0.42999999999999999 111.475 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.9 t -74.71 118.12 67.71 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.354 -0.98 . . . . 0.58999999999999997 108.354 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.17 -22.07 54.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.666 2.244 . . . . 0.60999999999999999 113.223 -169.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -85.3 -36.98 20.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.438 -0.346 . . . . 1.24 111.428 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 m -105.77 -19.64 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.035 0.383 . . . . 0.78000000000000003 112.035 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.39 16.43 79.49 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.692 -0.766 . . . . 0.29999999999999999 111.836 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 41.7 tptt -83.06 130.19 35.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.682 -0.259 . . . . 1.6100000000000001 110.317 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tt -106.93 128.35 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.982 0.42 . . . . 1.77 111.212 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 85.9 m-85 -118.01 150.44 39.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.149 -0.478 . . . . 0.5 109.819 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -100.57 -16.83 17.34 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.878 -0.601 . . . . 2.8500000000000001 110.439 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 22.8 m95 -122.6 146.27 47.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.96 -0.564 . . . . 0.58999999999999997 109.833 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 25.7 ttt180 -72.28 -39.29 68.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.889 -0.596 . . . . 3.3399999999999999 112.441 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.05 -49.8 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.062 0.393 . . . . 0.57999999999999996 112.062 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.53 -29.7 63.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.779 0.323 . . . . 0.72999999999999998 110.663 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.513 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 48.4 t80 -61.18 -50.92 71.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.556 . . . . 0.59999999999999998 110.956 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 24' ' ' ARG . 49.9 mm -63.87 -34.25 67.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.095 0.474 . . . . 0.22 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.25 -46.21 89.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.599 -0.728 . . . . 3.6099999999999999 110.223 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.51 -27.28 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.42999999999999999 111.522 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 C--N 1.322 -0.63 0 O-C-N 122.154 -0.341 . . . . 0.48999999999999999 111.299 178.079 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 . . . . . 0 CA--C 1.519 -0.241 0 CA-C-O 120.897 0.38 . . . . 0.78000000000000003 110.655 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.09 126.45 70.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.42999999999999999 110.452 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.41 118.59 67.48 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.58999999999999997 108.997 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.14 -19.76 69.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.737 2.291 . . . . 0.60999999999999999 112.438 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.47 -42.62 10.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.056 -0.52 . . . . 1.24 111.728 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.0 m -98.7 -19.91 17.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.78000000000000003 112.195 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.36 15.52 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.29999999999999999 111.08 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -80.79 130.48 35.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.089 -0.556 . . . . 1.6100000000000001 109.985 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.44 129.13 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.321 0.581 . . . . 1.77 109.936 -178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 62.3 m-85 -117.38 149.95 39.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.278 0.561 . . . . 0.5 110.549 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -97.1 -31.58 12.41 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.243 -0.89 . . . . 2.8500000000000001 110.723 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.581 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 50.9 m95 -110.99 143.42 41.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.402 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 76.5 mtm180 -72.52 -35.13 68.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.517 -0.765 . . . . 3.3399999999999999 111.537 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.23 -49.61 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.812 0.301 . . . . 0.57999999999999996 111.812 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -74.65 -29.93 61.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.887 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 68.7 t80 -61.51 -51.14 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.59999999999999998 110.969 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 24' ' ' ARG . 50.1 mm -62.36 -33.45 59.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.044 0.449 . . . . 0.22 110.264 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -66.55 -40.55 89.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 3.6099999999999999 110.138 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.82 -39.12 90.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.42999999999999999 110.622 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? . . . . . 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.48999999999999999 110.833 177.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 72.2 m-85 . . . . . 0 N--CA 1.452 -0.344 0 N-CA-C 109.484 -0.561 . . . . 0.78000000000000003 109.484 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 20' ' ' ILE . 16.8 t -105.62 120.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.584 0.231 . . . . 0.42999999999999999 111.291 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -75.18 119.16 75.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.109 -0.7 . . . . 0.58999999999999997 109.109 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.85 -14.83 45.26 Favored 'Trans proline' 0 CA--C 1.526 0.115 0 C-N-CA 122.662 2.242 . . . . 0.60999999999999999 112.906 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -91.15 -33.81 15.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.477 -0.329 . . . . 1.24 111.693 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.9 m -113.97 -18.57 11.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.827 0.677 . . . . 0.78000000000000003 112.827 -170.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.43 15.2 79.09 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.404 -0.903 . . . . 0.29999999999999999 110.937 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -79.66 126.32 30.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.544 . . . . 1.6100000000000001 109.764 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 39.5 pt -106.69 128.69 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.598 . . . . 1.77 111.645 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HD1' ' A' ' 12' ' ' TYR . 83.1 m-85 -117.32 150.61 38.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.5 109.242 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -98.88 -21.92 16.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.948 0.404 . . . . 2.8500000000000001 110.802 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -110.34 145.21 37.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.58999999999999997 110.413 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -72.61 -36.78 68.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 3.3399999999999999 111.536 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.67 -49.25 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.812 0.339 . . . . 0.57999999999999996 111.867 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.628 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -71.16 -25.4 62.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.972 0.415 . . . . 0.72999999999999998 110.709 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.628 ' N ' HD22 ' A' ' 26' ' ' ASN . 74.6 t80 -67.01 -50.04 63.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.59999999999999998 110.362 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.26 -32.95 56.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.22 110.317 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -60.17 -48.37 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 3.6099999999999999 110.578 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -64.76 -37.51 87.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.603 -0.726 . . . . 0.42999999999999999 110.847 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.997 -0.547 . . . . 0.48999999999999999 111.568 -179.741 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 109.687 -0.486 . . . . 0.78000000000000003 109.687 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 41.9 t -108.3 117.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.926 -0.31 . . . . 0.42999999999999999 110.844 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -70.98 118.52 66.28 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.413 -0.588 . . . . 0.58999999999999997 109.413 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.33 -15.98 47.0 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.508 2.138 . . . . 0.60999999999999999 112.472 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.88 -25.76 23.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.998 -0.546 . . . . 1.24 111.181 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -121.16 -19.96 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.469 0.544 . . . . 0.78000000000000003 112.469 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.36 15.75 80.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.29999999999999999 111.227 -173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.7 tptm -83.49 135.77 34.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.518 0.327 . . . . 1.6100000000000001 110.191 -176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.26 125.6 61.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 1.77 110.371 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 87.5 m-85 -116.71 147.74 41.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.5 109.997 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -98.52 -28.39 13.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.805 -0.634 . . . . 2.8500000000000001 110.135 178.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -105.51 143.44 33.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.515 -0.766 . . . . 0.58999999999999997 110.911 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 28' ' ' ILE . 45.4 ttp180 -72.59 -36.19 68.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.063 -0.971 . . . . 3.3399999999999999 111.419 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.14 -48.61 80.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.86 0.319 . . . . 0.57999999999999996 111.86 -173.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.98 -27.0 61.55 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.994 -0.282 . . . . 0.72999999999999998 110.861 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.672 ' N ' HD22 ' A' ' 26' ' ' ASN . 74.1 t80 -66.61 -50.1 64.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.787 0.327 . . . . 0.59999999999999998 110.34 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.0 mm -64.19 -36.46 77.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.22 110.425 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -61.62 -44.77 96.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.285 0.564 . . . . 3.6099999999999999 110.253 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -66.9 -35.31 79.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.067 -0.97 . . . . 0.42999999999999999 111.038 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 C--N 1.326 -0.428 0 N-CA-C 111.91 0.337 . . . . 0.48999999999999999 111.91 179.127 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 . . . . . 0 N--CA 1.45 -0.46 0 N-CA-C 110.145 -0.317 . . . . 0.78000000000000003 110.145 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 20' ' ' ILE . 10.2 t -108.14 116.82 52.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.42999999999999999 110.51 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 17.4 t -72.25 121.2 84.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.58999999999999997 109.274 173.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.81 -13.39 24.29 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.327 2.018 . . . . 0.60999999999999999 110.328 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -90.17 -28.54 18.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.744 -1.571 . . . . 1.24 111.444 -173.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.6 m -123.53 -20.49 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.638 0.607 . . . . 0.78000000000000003 112.638 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 16.19 76.64 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.06 -0.816 . . . . 0.29999999999999999 111.06 -169.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -82.29 143.97 30.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.661 0.384 . . . . 1.6100000000000001 110.91 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 13' ' ' VAL . 11.5 mm -105.44 128.39 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.393 0.616 . . . . 1.77 111.124 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.0 m-85 -118.23 148.41 42.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.975 -1.011 . . . . 0.5 110.263 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -104.04 -23.31 13.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.823 -0.626 . . . . 2.8500000000000001 110.673 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -113.61 152.0 30.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.471 -0.331 . . . . 0.58999999999999997 110.399 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 28' ' ' ILE . 10.9 tpp180 -71.66 -47.63 53.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 3.3399999999999999 111.659 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -48.07 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.444 0.535 . . . . 0.57999999999999996 112.444 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -68.36 -26.47 65.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.296 . . . . 0.72999999999999998 110.975 -178.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.677 ' N ' HD22 ' A' ' 26' ' ' ASN . 81.0 t80 -69.7 -50.18 46.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.59999999999999998 109.799 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.502 HG12 ' O ' ' A' ' 24' ' ' ARG . 37.8 mm -59.16 -41.96 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.22 109.845 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -59.55 -42.66 92.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.557 -0.747 . . . . 3.6099999999999999 110.69 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -61.75 -42.87 99.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.546 -0.752 . . . . 0.42999999999999999 111.254 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.443 -0.344 . . . . 0.48999999999999999 110.79 179.257 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 52.5 m-85 . . . . . 0 N--CA 1.454 -0.264 0 N-CA-C 110.371 -0.233 . . . . 0.78000000000000003 110.371 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 20' ' ' ILE . 11.3 t -108.66 115.67 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.758 -0.201 . . . . 0.42999999999999999 111.176 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 t -70.67 120.93 81.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 173.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 -16.29 48.58 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.60999999999999999 112.846 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.32 -32.82 16.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.695 0.284 . . . . 1.24 111.354 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 m -113.3 -20.16 11.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.654 0.613 . . . . 0.78000000000000003 112.654 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.23 80.88 Favored Glycine 0 N--CA 1.453 -0.187 0 N-CA-C 110.586 -1.005 . . . . 0.29999999999999999 110.586 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -77.27 124.37 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.773 -0.714 . . . . 1.6100000000000001 109.699 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 36.2 mt -106.03 130.46 57.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.99 0.424 . . . . 1.77 110.745 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -115.28 149.11 38.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.722 -0.672 . . . . 0.5 110.105 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 -96.99 -16.01 20.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.455 -0.793 . . . . 2.8500000000000001 110.44 -178.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -121.62 148.61 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.51 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 28' ' ' ILE . 56.7 ttt180 -71.54 -38.97 70.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 3.3399999999999999 111.231 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 m -65.39 -48.59 82.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.158 0.429 . . . . 0.57999999999999996 112.158 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.74 -26.22 61.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.567 0.223 . . . . 0.72999999999999998 111.083 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.66 ' N ' HD22 ' A' ' 26' ' ' ASN . 63.5 t80 -65.97 -49.88 66.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.59999999999999998 110.279 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 24' ' ' ARG . 43.8 mm -60.82 -33.19 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.583 . . . . 0.22 110.052 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -62.4 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 3.6099999999999999 110.682 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -67.18 -37.29 83.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.42999999999999999 110.883 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 116.339 -0.391 . . . . 0.48999999999999999 110.873 178.173 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 38.3 m-85 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.208 -0.664 . . . . 0.78000000000000003 109.208 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 20' ' ' ILE . 15.6 t -108.58 120.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.642 0.258 . . . . 0.42999999999999999 111.619 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -73.03 120.24 79.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.666 -0.865 . . . . 0.58999999999999997 108.666 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.83 -17.11 41.99 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.576 2.184 . . . . 0.60999999999999999 112.218 -173.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -90.18 -42.69 10.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.834 -0.621 . . . . 1.24 111.389 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.31 -20.12 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.923 0.342 . . . . 0.78000000000000003 111.923 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.42 15.87 78.96 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 110.995 -0.842 . . . . 0.29999999999999999 110.995 -173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -81.53 135.02 35.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.034 -0.583 . . . . 1.6100000000000001 109.973 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 13' ' ' VAL . 49.2 pt -106.54 130.49 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.174 0.512 . . . . 1.77 111.031 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -117.4 149.33 40.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.733 -0.667 . . . . 0.5 109.977 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -96.53 -33.24 11.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.113 -0.494 . . . . 2.8500000000000001 110.651 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 62.6 m95 -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.58999999999999997 110.666 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 28' ' ' ILE . 8.8 mmm180 -71.24 -36.35 71.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 3.3399999999999999 111.818 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 m -63.03 -48.66 86.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 0.57999999999999996 111.857 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.626 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.98 -31.9 64.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.186 -0.206 . . . . 0.72999999999999998 110.984 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 31' ' ' LEU . 59.3 t80 -61.04 -50.83 71.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.732 0.301 . . . . 0.59999999999999998 110.565 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 24' ' ' ARG . 52.0 mm -65.28 -34.18 68.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.22 110.043 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -60.08 -44.9 94.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.969 -0.56 . . . . 3.6099999999999999 110.201 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.94 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.687 -0.688 . . . . 0.42999999999999999 111.158 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 120.847 0.356 . . . . 0.48999999999999999 111.396 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.709 0 N-CA-C 111.721 -0.552 . . . . 16.57 111.721 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -70.27 -41.43 73.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.946 0.403 . . . . 15.0 111.216 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 66.9 mtt -89.79 29.86 1.12 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.179 -0.464 . . . . 14.85 111.596 -176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -87.75 58.5 4.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.81 0.814 . . . . 12.380000000000001 110.672 177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.53 149.71 17.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.775 -1.195 . . . . 10.720000000000001 107.775 174.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.515 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.0 tp60 -71.78 86.42 0.95 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.344 0.593 . . . . 9.1199999999999992 110.214 -179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -149.0 135.85 19.75 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.519 -0.764 . . . . 7.5300000000000002 110.026 -178.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.8 t -95.06 14.84 20.57 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.228 0.537 . . . . 5.79 109.999 -178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -75.54 -23.6 56.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.961 -0.563 . . . . 6.1799999999999997 110.808 178.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 53.0 pttt -89.09 99.29 12.31 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.362 0.601 . . . . 5.7800000000000002 110.367 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.3 m -145.27 21.84 1.54 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.125 -0.489 . . . . 1.8899999999999999 110.795 -179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.427 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 7.2 m-85 -111.6 110.82 21.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.309 -0.405 . . . . 0.78000000000000003 109.933 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 58.4 t -110.51 128.88 66.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.27 -0.423 . . . . 0.42999999999999999 111.27 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.9 t -80.48 119.04 75.16 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 108.629 -0.878 . . . . 0.58999999999999997 108.629 168.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -61.19 -26.48 82.38 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.823 2.349 . . . . 0.60999999999999999 113.357 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -89.99 -37.39 14.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.508 -0.314 . . . . 1.24 111.689 -174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.3 m -96.87 -19.91 18.53 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.821 -0.351 . . . . 0.78000000000000003 111.757 -176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.43 16.27 77.38 Favored Glycine 0 C--N 1.331 0.274 0 N-CA-C 111.343 -0.703 . . . . 0.29999999999999999 111.343 -175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.57 134.59 37.22 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.445 . . . . 1.6100000000000001 111.354 -172.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mm -96.63 129.12 47.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.535 . . . . 1.77 110.852 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 51.7 m-85 -118.57 150.42 39.68 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.274 -0.876 . . . . 0.5 110.505 177.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 68.4 ttt180 -105.04 -19.32 13.87 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.777 -0.647 . . . . 2.8500000000000001 110.801 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 55.8 m95 -122.82 149.12 44.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.108 -0.496 . . . . 0.58999999999999997 110.373 -177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 86.7 mtm180 -73.19 -41.51 63.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 3.3399999999999999 111.896 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.0 m -63.61 -45.24 98.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 112.152 0.427 . . . . 0.57999999999999996 112.152 -170.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.671 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -74.86 -25.79 59.22 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.888 0.375 . . . . 0.72999999999999998 110.626 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.671 ' N ' HD22 ' A' ' 26' ' ' ASN . 76.3 t80 -66.33 -50.24 64.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.934 -0.575 . . . . 0.59999999999999998 110.148 178.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.1 mm -62.95 -34.41 66.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.063 -0.517 . . . . 0.22 110.267 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -61.91 -45.82 92.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.92 -0.582 . . . . 3.6099999999999999 110.152 175.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.95 -35.96 82.83 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.5 -0.773 . . . . 0.42999999999999999 110.732 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? -72.64 -25.72 61.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.32 -0.4 . . . . 0.48999999999999999 110.89 177.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -80.04 -18.23 50.67 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.674 0.749 . . . . 4.0 109.657 175.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 32.6 t -78.7 -0.41 30.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.281 -0.872 . . . . 1.6699999999999999 110.583 178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 83.5 mtm180 -66.21 -25.01 66.72 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.211 0.529 . . . . 4.29 110.049 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -68.25 -16.58 64.02 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.406 -0.816 . . . . 7.8200000000000003 110.166 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -93.54 0.24 56.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.068 -0.515 . . . . 6.2300000000000004 110.633 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -93.72 175.76 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.995 0.426 . . . . 8.0999999999999996 110.855 -177.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.418 ' HE2' ' HB3' ' A' ' 41' ' ' LYS . 11.3 ptmm? -127.19 112.03 21.53 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.728 -0.669 . . . . 10.19 109.992 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.3 -40.76 35.7 Favored 'Trans proline' 0 C--N 1.353 0.799 0 C-N-CA 123.919 3.079 . . . . 10.4 113.148 -178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.6 t60 -153.24 -79.3 0.1 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.471 -0.566 . . . . 12.77 109.471 174.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' A' ' 38' ' ' LYS . 62.3 tttm . . . . . 0 C--O 1.248 0.999 0 O-C-N 124.15 0.907 . . . . 14.94 111.661 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 112.013 -0.435 . . . . 16.57 112.013 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.04 -7.95 57.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.845 0.355 . . . . 15.0 111.422 -177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.2 mtm -124.3 42.76 3.17 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.616 0.722 . . . . 14.85 110.102 177.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -117.7 52.95 0.96 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.336 -0.847 . . . . 12.380000000000001 109.52 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.3 m -77.66 -24.16 14.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.687 -0.688 . . . . 10.720000000000001 110.335 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -74.78 99.46 3.74 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.849 -0.797 . . . . 9.1199999999999992 108.849 173.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.503 HG23 ' NH2' ' A' ' 22' ' ' ARG . 8.8 t -151.59 27.17 0.65 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 122.105 0.955 . . . . 7.5300000000000002 110.104 -175.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.2 m -96.77 160.95 14.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.678 -0.692 . . . . 5.79 110.086 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 63.74 41.14 7.19 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.147 0.499 . . . . 6.1799999999999997 111.132 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.0 mtpt -103.3 53.09 0.77 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.822 -0.626 . . . . 5.7800000000000002 109.615 176.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 m -78.06 98.72 5.85 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.575 -0.739 . . . . 1.8899999999999999 111.669 -174.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.43 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 49.6 m-85 -89.99 115.59 27.39 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.903 -0.777 . . . . 0.78000000000000003 108.903 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 t -108.39 120.88 60.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.63 0 CA-C-O 120.77 0.319 . . . . 0.42999999999999999 111.348 -174.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 t -76.79 118.68 73.37 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.177 -0.675 . . . . 0.58999999999999997 109.177 171.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -68.44 -14.27 39.52 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.392 2.062 . . . . 0.60999999999999999 112.135 -176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -89.71 -27.94 19.74 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.883 -0.599 . . . . 1.24 111.428 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.3 m -121.69 -20.29 6.53 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.673 0.619 . . . . 0.78000000000000003 112.673 -176.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 79.52 6.77 88.88 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.695 -0.764 . . . . 0.29999999999999999 111.576 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.8 tptp -73.66 131.63 41.85 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.736 0.414 . . . . 1.6100000000000001 110.406 -176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 57.4 mt -107.05 125.94 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.392 -0.367 . . . . 1.77 111.092 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -116.46 150.78 37.3 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.844 -0.616 . . . . 0.5 109.541 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.503 ' NH2' HG23 ' A' ' 7' ' ' THR . 68.0 ttt180 -104.67 -19.45 13.95 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.057 0.456 . . . . 2.8500000000000001 110.615 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -107.77 134.29 50.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.94 -0.573 . . . . 0.58999999999999997 109.495 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' O ' HG12 ' A' ' 28' ' ' ILE . 38.2 ttm180 -71.99 -30.49 65.3 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.186 -0.461 . . . . 3.3399999999999999 111.157 -178.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.4 m -66.1 -46.5 87.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.651 0.262 . . . . 0.57999999999999996 111.627 -175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.613 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.18 -25.86 58.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.05 0.452 . . . . 0.72999999999999998 110.278 177.784 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.613 ' N ' HD22 ' A' ' 26' ' ' ASN . 74.1 t80 -64.66 -50.0 68.79 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.774 -0.648 . . . . 0.59999999999999998 110.068 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 24' ' ' ARG . 46.2 mm -62.05 -33.18 57.07 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 CA-C-N 116.197 -0.456 . . . . 0.22 110.031 178.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 31.3 tpt180 -60.46 -47.12 87.5 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.167 0.508 . . . . 3.6099999999999999 110.608 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 72.0 t60 -70.29 -35.09 73.5 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.537 -0.756 . . . . 0.42999999999999999 111.241 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' O ' ' HD2' ' A' ' 34' ' ' ARG . 3.9 mm? -77.03 -29.55 55.31 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.782 0.325 . . . . 0.48999999999999999 111.223 177.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 64.8 ttt180 -62.7 -40.98 98.85 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.286 0.565 . . . . 4.0 109.836 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.4 m -103.34 42.33 1.18 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.468 -0.787 . . . . 1.6699999999999999 110.248 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.404 ' HD2' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -69.77 153.62 43.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.041 -0.527 . . . . 4.29 110.907 -177.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 71.4 mtt180 59.16 36.73 24.05 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.424 0.63 . . . . 7.8200000000000003 110.473 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -150.68 131.45 14.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.221 -0.9 . . . . 6.2300000000000004 109.748 -178.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -92.03 -28.75 16.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.864 -0.607 . . . . 8.0999999999999996 110.497 -178.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 64.1 mttp -121.86 99.48 44.28 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.145 -0.48 . . . . 10.19 110.383 -179.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.47 116.02 2.89 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.839 2.359 . . . . 10.4 111.993 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -81.31 -29.31 34.27 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.004 -0.543 . . . . 12.77 110.304 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.7 pttp . . . . . 0 C--O 1.246 0.907 0 CA-C-N 115.853 -0.612 . . . . 14.94 110.27 179.42 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.52 -0.632 . . . . 16.57 111.52 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.98 -62.63 1.55 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.903 0.383 . . . . 15.0 111.054 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.6 mtt -114.26 -8.75 12.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.155 -0.475 . . . . 14.85 111.039 -176.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.29 70.08 6.86 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.262 0.553 . . . . 12.380000000000001 111.372 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -89.49 146.55 6.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.475 -0.784 . . . . 10.720000000000001 109.14 174.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.422 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 7.1 tp60 -68.27 100.07 1.0 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.927 0.394 . . . . 9.1199999999999992 110.748 -178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.9 t -166.7 158.62 13.24 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.838 -0.619 . . . . 7.5300000000000002 109.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.1 t -100.84 1.52 40.14 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.151 0.5 . . . . 5.79 109.787 178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -99.29 47.5 0.96 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 6.1799999999999997 110.124 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.0 pttt -144.5 25.0 1.53 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.453 0.644 . . . . 5.7800000000000002 110.39 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.3 m -96.96 34.08 1.78 Allowed 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.667 -0.697 . . . . 1.8899999999999999 111.181 -176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 21' ' ' PHE . 26.6 m-85 -103.86 110.17 22.19 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.497 -0.557 . . . . 0.78000000000000003 109.497 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 t -110.1 126.36 67.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.829 -0.623 . . . . 0.42999999999999999 110.913 -176.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 11.0 t -76.84 118.43 71.7 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 108.837 -0.801 . . . . 0.58999999999999997 108.837 169.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_exo -62.36 -17.74 59.12 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.51 2.14 . . . . 0.60999999999999999 112.145 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.445 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 25.3 t-20 -89.83 -28.36 19.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.85 -0.614 . . . . 1.24 111.561 -176.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.2 m -121.66 -20.93 6.33 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 113.084 0.772 . . . . 0.78000000000000003 113.084 -175.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.61 7.56 83.29 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.664 -0.779 . . . . 0.29999999999999999 111.239 -172.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 22.2 tptp -67.31 137.25 55.92 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.264 0.626 . . . . 1.6100000000000001 110.851 -177.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 10.6 mm -102.47 130.86 51.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.47 0.653 . . . . 1.77 111.063 177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.539 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.1 m-85 -119.19 150.04 40.73 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.691 -1.141 . . . . 0.5 110.634 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 67.1 ttt180 -106.02 -13.07 15.58 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.393 0.616 . . . . 2.8500000000000001 110.447 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.556 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 17.4 m95 -127.57 133.32 49.76 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.384 -0.599 . . . . 0.58999999999999997 109.384 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' O ' HG12 ' A' ' 28' ' ' ILE . 62.1 mtm180 -72.46 -28.96 63.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.352 -0.385 . . . . 3.3399999999999999 111.529 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.15 -49.31 84.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.835 0.35 . . . . 0.57999999999999996 111.644 -176.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -75.98 -30.2 58.49 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.512 -0.313 . . . . 0.72999999999999998 110.956 176.404 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 76.0 t80 -59.15 -51.28 70.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.331 -0.395 . . . . 0.59999999999999998 110.835 177.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' O ' ' A' ' 24' ' ' ARG . 51.2 mm -62.32 -34.59 64.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.06 0.457 . . . . 0.22 110.217 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -65.33 -41.14 94.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.896 -0.593 . . . . 3.6099999999999999 110.279 178.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -66.59 -37.34 84.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.592 -0.731 . . . . 0.42999999999999999 110.84 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.436 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? -73.42 -27.8 61.64 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.14 0.495 . . . . 0.48999999999999999 110.365 176.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 32' ' ' ARG . 39.5 ttm180 -74.77 -16.39 60.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.674 -0.694 . . . . 4.0 109.955 176.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.6 t -94.82 22.61 6.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.415 -0.811 . . . . 1.6699999999999999 110.614 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 80.9 mtm180 -83.51 -25.44 31.07 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.045 0.45 . . . . 4.29 110.395 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -70.91 -22.77 62.21 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.852 -0.613 . . . . 7.8200000000000003 110.071 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -88.44 36.02 0.78 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.667 -0.697 . . . . 6.2300000000000004 110.42 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -126.21 166.59 16.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.004 -0.544 . . . . 8.0999999999999996 110.298 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -105.73 121.39 46.08 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.061 -0.518 . . . . 10.19 110.462 176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -46.91 -60.28 0.94 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.836 2.357 . . . . 10.4 112.537 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 40.7 t60 -154.17 -49.28 0.09 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.481 -0.327 . . . . 12.77 110.458 176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.2 tttm . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.107 -0.949 . . . . 14.94 110.253 -177.082 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 112.109 -0.397 . . . . 16.57 112.109 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.35 -66.78 0.2 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 15.0 110.435 -179.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 60.0 ttp -99.29 -81.71 0.45 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.356 -0.384 . . . . 14.85 110.097 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 64.59 -64.53 0.15 Allowed 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.947 0.779 . . . . 12.380000000000001 111.481 -177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.1 t -93.46 137.32 22.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.769 -0.456 . . . . 10.720000000000001 109.769 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.2 mm100 -69.55 107.88 3.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.167 0.508 . . . . 9.1199999999999992 110.396 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.5 p -113.5 111.63 22.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.916 -0.583 . . . . 7.5300000000000002 111.357 -176.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.6 t 55.35 44.21 27.66 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.744 -0.662 . . . . 5.79 110.255 -177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 46.6 mt-30 -121.25 156.18 33.04 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.751 -0.659 . . . . 6.1799999999999997 109.595 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -102.35 74.14 1.38 Allowed 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.475 0.655 . . . . 5.7800000000000002 110.487 -177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 3.8 m -110.19 92.49 4.07 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.31 -0.859 . . . . 1.8899999999999999 109.34 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.408 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 39.1 m-85 -86.19 110.68 19.76 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.155 -0.475 . . . . 0.78000000000000003 109.801 -177.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.1 t -108.67 115.12 48.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 110.501 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 39.6 t -67.09 122.53 83.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.123 -0.695 . . . . 0.58999999999999997 109.123 175.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.44 -28.6 71.11 Favored 'Trans proline' 0 N--CA 1.475 0.398 0 C-N-CA 123.327 2.684 . . . . 0.60999999999999999 112.715 -170.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -89.08 -28.03 20.38 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.186 -0.916 . . . . 1.24 111.925 -172.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.4 m -113.5 -19.16 11.77 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.191 0.441 . . . . 0.78000000000000003 112.191 -175.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.91 15.42 81.36 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.764 -0.732 . . . . 0.29999999999999999 112.024 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -83.46 124.69 30.95 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 110.046 -0.353 . . . . 1.6100000000000001 110.046 -176.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 0.0 OUTLIER -102.86 128.9 55.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.188 0.518 . . . . 1.77 110.498 -178.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.442 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 95.1 m-85 -118.15 149.37 41.17 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-N 115.949 -0.569 . . . . 0.5 110.009 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.9 ttt180 -99.18 -9.28 23.94 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.139 0.495 . . . . 2.8500000000000001 110.332 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.496 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 29.9 m95 -130.16 149.47 51.85 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.949 -0.569 . . . . 0.58999999999999997 109.83 -176.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' O ' HG12 ' A' ' 28' ' ' ILE . 50.4 mtm180 -71.91 -38.82 69.85 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.161 -0.472 . . . . 3.3399999999999999 111.582 -178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -62.2 -49.82 82.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.37 0.507 . . . . 0.57999999999999996 112.37 -172.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.496 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.3 OUTLIER -70.83 -29.38 65.51 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.691 0.282 . . . . 0.72999999999999998 110.812 178.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.442 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 55.2 t80 -62.98 -50.28 71.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.096 -0.502 . . . . 0.59999999999999998 110.332 175.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.485 HG12 ' O ' ' A' ' 24' ' ' ARG . 42.6 mm -63.37 -35.3 71.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.059 -0.519 . . . . 0.22 110.285 178.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -59.84 -44.68 93.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.113 -0.494 . . . . 3.6099999999999999 110.048 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -65.79 -39.8 91.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.612 -0.722 . . . . 0.42999999999999999 110.991 178.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -68.58 -35.14 76.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.469 -0.332 . . . . 0.48999999999999999 110.741 178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 81.7 mtp180 -73.51 -13.42 61.04 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.046 0.451 . . . . 4.0 110.429 175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 m -98.04 30.22 3.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.945 -0.571 . . . . 1.6699999999999999 110.284 176.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -68.44 94.35 0.55 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.073 0.464 . . . . 4.29 110.365 176.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.517 ' HA ' ' HE ' ' A' ' 35' ' ' ARG . 1.7 mmp_? -101.3 60.74 0.92 Allowed 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.988 -0.551 . . . . 7.8200000000000003 109.804 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -82.58 65.78 7.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.253 0.549 . . . . 6.2300000000000004 110.803 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -69.33 -62.46 1.37 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 8.0999999999999996 110.159 178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -92.81 147.31 33.8 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.624 -0.717 . . . . 10.19 109.909 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -79.27 40.07 0.9 Allowed 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 122.949 2.433 . . . . 10.4 112.905 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 35.1 t60 69.95 -61.32 0.46 Allowed 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.475 0.71 . . . . 12.77 111.778 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.4 tptp . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.674 -0.679 . . . . 14.94 110.043 -178.101 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 111.719 -0.553 . . . . 16.57 111.719 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.5 -15.29 17.18 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.085 0.469 . . . . 15.0 110.7 178.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.2 mtt -101.55 63.48 0.96 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.392 0.615 . . . . 14.85 109.882 179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -83.64 35.44 0.51 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.542 -0.754 . . . . 12.380000000000001 111.686 -173.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.2 t -74.21 136.08 26.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.861 -0.609 . . . . 10.720000000000001 109.509 176.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.431 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.8 tp60 -72.76 106.26 4.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.151 0.5 . . . . 9.1199999999999992 110.461 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.0 t -162.25 136.24 6.5 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.677 -0.692 . . . . 7.5300000000000002 109.756 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 t -83.4 -5.5 59.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.259 -0.428 . . . . 5.79 110.51 -177.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.4 tt0 -67.55 -33.6 75.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.193 -0.458 . . . . 6.1799999999999997 110.957 -178.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' LYS . 60.2 pttt -76.11 77.84 2.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.77 0.795 . . . . 5.7800000000000002 110.928 -177.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.5 t -130.26 24.14 5.2 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.75 -0.659 . . . . 1.8899999999999999 110.668 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -104.81 108.34 19.77 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.73 -0.47 . . . . 0.78000000000000003 109.73 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.7 t -112.9 123.97 69.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.968 -0.56 . . . . 0.42999999999999999 110.597 177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.2 t -67.79 116.86 42.41 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.58999999999999997 108.683 173.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.47 -18.28 62.44 Favored 'Trans proline' 0 C--N 1.34 0.119 0 C-N-CA 122.466 2.111 . . . . 0.60999999999999999 112.398 -175.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -90.62 -27.53 19.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.171 -0.468 . . . . 1.24 112.027 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.4 m -114.74 -20.36 10.67 Favored 'General case' 0 N--CA 1.466 0.348 0 C-N-CA 120.364 -0.534 . . . . 0.78000000000000003 112.311 -177.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 9.58 86.73 Favored Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.778 -0.725 . . . . 0.29999999999999999 111.595 -173.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.0 tptp -78.7 129.14 34.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.993 -0.373 . . . . 1.6100000000000001 109.993 -176.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -105.61 131.42 55.07 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.007 0.432 . . . . 1.77 110.197 -178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.463 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 72.1 m-85 -117.48 149.82 39.95 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.045 0.45 . . . . 0.5 110.645 -174.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 70.7 ttt180 -96.55 -25.15 15.73 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.472 -0.786 . . . . 2.8500000000000001 110.588 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 56.5 m95 -117.5 141.49 48.29 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.769 -0.651 . . . . 0.58999999999999997 110.072 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -73.1 -35.13 66.53 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 112.361 0.504 . . . . 3.3399999999999999 112.361 -177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.0 m -65.43 -44.31 94.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.854 -0.338 . . . . 0.57999999999999996 111.282 -173.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.648 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -75.57 -26.2 57.74 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.751 0.31 . . . . 0.72999999999999998 110.606 178.084 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.648 ' N ' HD22 ' A' ' 26' ' ' ASN . 72.4 t80 -64.44 -50.84 65.97 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.313 -0.403 . . . . 0.59999999999999998 110.426 176.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 51.2 mm -63.81 -34.37 67.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.171 0.51 . . . . 0.22 109.96 178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 61.4 ttp180 -61.06 -40.99 95.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.706 -0.679 . . . . 3.6099999999999999 110.455 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.8 t60 -71.48 -41.12 69.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.784 -0.643 . . . . 0.42999999999999999 111.115 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.51 -37.52 85.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.805 0.336 . . . . 0.48999999999999999 110.916 178.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.0 ttm105 -68.47 -23.49 64.59 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.168 0.509 . . . . 4.0 110.436 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -80.14 10.85 3.92 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 115.947 -0.569 . . . . 1.6699999999999999 111.023 -178.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -74.97 -9.18 58.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.463 0.649 . . . . 4.29 109.785 173.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 69.0 ttt180 -66.18 -22.99 66.38 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.996 -1.002 . . . . 7.8200000000000003 111.252 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -112.89 27.71 9.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.376 -0.374 . . . . 6.2300000000000004 111.526 -174.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -98.57 170.28 8.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.916 0.389 . . . . 8.0999999999999996 111.089 -178.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -137.09 102.34 9.12 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 115.95 -0.568 . . . . 10.19 109.83 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -47.2 -43.89 24.93 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.569 2.846 . . . . 10.4 113.06 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -157.39 -65.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.579 -0.282 . . . . 12.77 110.32 176.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.6 tttm . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.222 -0.894 . . . . 14.94 110.712 -179.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.81 0 N-CA-C 111.819 -0.512 . . . . 16.57 111.819 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.33 123.53 11.52 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.773 0.287 . . . . 15.0 110.601 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.2 ptt? -163.35 177.07 9.25 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.47 -0.332 . . . . 14.85 110.586 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 53.4 mm-40 -73.3 -177.45 2.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.486 -0.325 . . . . 12.380000000000001 111.139 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.5 t 73.94 -61.03 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 115.755 -0.657 . . . . 10.720000000000001 111.19 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -90.04 7.25 38.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.6 -0.273 . . . . 9.1199999999999992 111.104 -177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 4' ' ' GLU . 3.7 m -60.09 -23.92 64.19 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.972 0.415 . . . . 7.5300000000000002 111.651 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.0 m 65.27 26.74 12.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 115.527 -0.761 . . . . 5.79 110.782 178.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -75.84 -59.47 2.74 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.743 -0.662 . . . . 6.1799999999999997 109.951 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.3 ptpt -162.35 64.97 0.22 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.8 0.81 . . . . 5.7800000000000002 110.872 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.0 m -95.0 100.35 12.2 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.161 -0.927 . . . . 1.8899999999999999 109.612 176.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -96.31 110.97 23.2 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.559 -0.291 . . . . 0.78000000000000003 110.346 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 45.0 t -109.44 120.1 60.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.873 -0.418 . . . . 0.42999999999999999 109.873 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.1 t -73.86 119.22 75.06 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.968 -0.753 . . . . 0.58999999999999997 108.968 173.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.23 -27.24 78.12 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 123.178 2.586 . . . . 0.60999999999999999 112.91 -171.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.445 ' ND2' HH21 ' A' ' 35' ' ' ARG . 26.6 t-20 -90.02 -41.47 11.7 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.229 -0.441 . . . . 1.24 111.911 -175.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.0 m -98.05 -14.84 20.29 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.175 0.435 . . . . 0.78000000000000003 112.175 -172.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.39 16.64 78.8 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.681 -0.771 . . . . 0.29999999999999999 111.916 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.9 tptm -84.09 126.74 33.36 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.178 -0.304 . . . . 1.6100000000000001 110.178 -175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 tp -106.04 120.93 57.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.064 0.459 . . . . 1.77 110.765 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 94.9 m-85 -115.88 149.45 38.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.026 -0.533 . . . . 0.5 109.601 -179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.2 ttp180 -104.13 -12.25 16.84 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.892 -0.595 . . . . 2.8500000000000001 110.428 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.57 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 37.1 m95 -126.47 142.69 51.45 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.849 -0.614 . . . . 0.58999999999999997 109.979 -178.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.51 ' O ' HG12 ' A' ' 28' ' ' ILE . 20.3 ttt180 -72.89 -34.83 66.93 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.605 -0.725 . . . . 3.3399999999999999 112.061 -175.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.6 m -61.49 -49.17 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.806 0.336 . . . . 0.57999999999999996 111.878 -175.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.57 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -74.94 -29.06 60.83 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.474 -0.33 . . . . 0.72999999999999998 110.864 179.131 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.49 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 59.9 t80 -59.95 -50.22 74.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.386 -0.37 . . . . 0.59999999999999998 110.614 173.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 35.6 mm -63.43 -33.63 62.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.22 110.339 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -59.33 -44.8 92.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.853 -0.612 . . . . 3.6099999999999999 109.923 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.6 t60 -63.68 -46.31 86.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 110.231 176.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -65.5 -24.02 67.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.912 -0.585 . . . . 0.48999999999999999 112.196 -178.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.645 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 5.1 mmp_? -58.37 -38.58 77.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.876 0.37 . . . . 4.0 110.463 174.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 29.9 t -96.86 -22.62 16.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.042 0.448 . . . . 1.6699999999999999 109.991 177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' SER . 81.1 mtm180 70.86 -81.69 0.03 OUTLIER 'General case' 0 C--O 1.243 0.729 0 CA-C-N 115.171 -0.922 . . . . 4.29 111.325 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.445 HH21 ' ND2' ' A' ' 16' ' ' ASN . 40.6 ttm180 -101.61 130.21 47.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.647 -0.706 . . . . 7.8200000000000003 110.636 -171.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 -86.01 -42.09 14.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.538 . . . . 6.2300000000000004 110.874 -176.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -117.82 139.7 50.73 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.338 0.59 . . . . 8.0999999999999996 110.511 -177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 25.3 ttmm -96.85 -43.29 0.25 Allowed Pre-proline 0 C--N 1.311 -1.088 0 CA-C-N 115.31 -0.859 . . . . 10.19 110.84 178.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 15.7 Cg_exo -70.26 147.73 60.31 Favored 'Trans proline' 0 C--N 1.356 0.941 0 C-N-CA 121.683 1.589 . . . . 10.4 111.492 172.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -80.46 59.94 3.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.177 0.513 . . . . 12.77 110.668 178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.545 -0.741 . . . . 14.94 110.11 -178.26 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.874 0 N-CA-C 112.222 -0.351 . . . . 16.57 112.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.69 66.48 0.84 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.072 0.463 . . . . 15.0 111.443 177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.1 ttm -82.51 98.11 8.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.893 -0.594 . . . . 14.85 109.922 177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -80.28 155.69 27.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.932 -0.576 . . . . 12.380000000000001 110.923 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.7 m -67.72 150.14 11.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 115.68 -0.691 . . . . 10.720000000000001 111.201 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -87.97 112.72 22.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.83 -0.623 . . . . 9.1199999999999992 110.258 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.0 p -119.47 4.57 11.16 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.025 -0.534 . . . . 7.5300000000000002 110.965 178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 50.2 m -96.5 134.68 39.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.685 -0.689 . . . . 5.79 109.609 176.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.402 ' HG2' ' HG3' ' A' ' 10' ' ' LYS . 34.9 tt0 -74.86 -55.96 5.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.616 -0.72 . . . . 6.1799999999999997 112.032 -170.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.402 ' HG3' ' HG2' ' A' ' 9' ' ' GLN . 65.1 mttm -135.94 33.53 2.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.316 0.579 . . . . 5.7800000000000002 110.914 -177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 2.5 p -131.68 86.09 2.31 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.454 -0.794 . . . . 1.8899999999999999 109.618 175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.418 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 45.1 m-85 -96.56 122.34 39.37 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.522 -0.763 . . . . 0.78000000000000003 109.668 -176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.485 HG22 HG22 ' A' ' 20' ' ' ILE . 20.3 t -108.25 124.27 64.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.511 0.196 . . . . 0.42999999999999999 110.958 -176.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.0 t -72.89 118.58 69.49 Favored Pre-proline 0 C--N 1.327 -0.389 0 N-CA-C 109.339 -0.615 . . . . 0.58999999999999997 109.339 173.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -61.29 -19.38 63.69 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.767 2.312 . . . . 0.60999999999999999 112.305 -178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.3 -28.15 18.96 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.942 -0.572 . . . . 1.24 111.854 -176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.1 m -121.67 -19.69 6.74 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.965 0.728 . . . . 0.78000000000000003 112.965 -173.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 77.27 14.22 82.78 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.618 -0.801 . . . . 0.29999999999999999 111.325 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.5 tptp -77.44 135.64 38.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.232 -0.484 . . . . 1.6100000000000001 110.246 -176.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.485 HG22 HG22 ' A' ' 13' ' ' VAL . 41.8 pt -106.68 128.72 61.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 121.195 0.522 . . . . 1.77 111.372 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.418 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 86.4 m-85 -118.08 150.11 39.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.595 -0.729 . . . . 0.5 110.029 178.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -95.73 -22.28 17.63 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.225 -0.443 . . . . 2.8500000000000001 110.494 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.518 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 40.3 m95 -119.11 143.59 47.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.993 -0.549 . . . . 0.58999999999999997 110.035 -178.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.428 ' O ' HG12 ' A' ' 28' ' ' ILE . 27.9 ttm180 -72.29 -34.62 68.28 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.785 -0.643 . . . . 3.3399999999999999 111.593 -176.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 14.2 m -62.55 -49.52 83.51 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 N-CA-C 112.033 0.382 . . . . 0.57999999999999996 112.033 -174.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.518 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.3 -30.02 64.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.673 0.273 . . . . 0.72999999999999998 110.504 177.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.438 ' O ' HD23 ' A' ' 31' ' ' LEU . 63.2 t80 -59.36 -50.85 72.39 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.294 -0.412 . . . . 0.59999999999999998 110.697 174.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.428 HG12 ' O ' ' A' ' 24' ' ' ARG . 48.2 mm -65.12 -35.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.861 0.362 . . . . 0.22 110.234 179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -61.1 -42.89 99.34 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.941 -0.572 . . . . 3.6099999999999999 110.208 177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 61.0 t60 -69.71 -33.57 72.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.655 -0.702 . . . . 0.42999999999999999 110.895 177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 27' ' ' PHE . 3.9 mm? -71.42 -31.14 66.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.75 0.309 . . . . 0.48999999999999999 110.769 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 68.5 mtp180 -72.27 -12.65 61.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 4.0 111.352 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.7 m -62.21 -33.51 74.7 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.931 0.396 . . . . 1.6699999999999999 110.112 177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.423 ' C ' ' H ' ' A' ' 36' ' ' GLU . 9.7 ptm180 -104.75 87.48 2.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.45 0.643 . . . . 4.29 110.863 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 21.4 tpp180 -82.78 38.96 0.6 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 122.139 0.971 . . . . 7.8200000000000003 109.113 175.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 34' ' ' ARG . 19.1 mm-40 -77.09 -17.74 58.48 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.984 -1.007 . . . . 6.2300000000000004 109.487 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.5 mm100 -65.62 153.76 40.69 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.132 -0.94 . . . . 8.0999999999999996 110.145 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -81.62 134.97 49.95 Favored Pre-proline 0 C--N 1.319 -0.739 0 N-CA-C 109.209 -0.663 . . . . 10.19 109.209 177.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.29 61.09 5.82 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.643 2.229 . . . . 10.4 112.951 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.7 t-80 -73.43 -16.7 61.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.359 0.6 . . . . 12.77 109.398 177.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? . . . . . 0 C--O 1.246 0.903 0 CA-C-O 118.285 -0.864 . . . . 14.94 109.42 175.77 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.972 -0.451 . . . . 16.57 111.972 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.09 26.81 3.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.175 0.512 . . . . 15.0 110.703 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.1 mtt -92.67 64.14 4.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.826 -0.625 . . . . 14.85 109.783 178.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -92.18 20.45 5.95 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.782 -0.645 . . . . 12.380000000000001 111.289 -173.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.36 128.93 36.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.071 -0.513 . . . . 10.720000000000001 109.678 176.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.7 tp60 -72.34 101.96 3.02 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.072 0.463 . . . . 9.1199999999999992 110.616 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -165.64 146.31 6.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.867 -0.606 . . . . 7.5300000000000002 110.054 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 11.9 t -100.72 6.77 44.04 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.017 0.437 . . . . 5.79 110.186 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -80.17 -28.34 38.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.066 -0.515 . . . . 6.1799999999999997 110.428 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -76.13 61.59 1.6 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.844 0.831 . . . . 5.7800000000000002 111.078 -177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 8.3 t -118.15 27.29 9.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.654 -0.703 . . . . 1.8899999999999999 110.821 -175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -109.09 107.6 17.98 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.453 -0.499 . . . . 0.78000000000000003 110.098 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.1 t -113.11 126.82 70.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.041 -0.527 . . . . 0.42999999999999999 111.048 177.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 33.2 t -77.37 118.63 73.23 Favored Pre-proline 0 C--N 1.325 -0.48 0 N-CA-C 108.724 -0.843 . . . . 0.58999999999999997 108.724 171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -67.61 -19.08 48.52 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.623 2.216 . . . . 0.60999999999999999 112.565 -174.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -90.17 -39.15 13.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.967 -0.561 . . . . 1.24 111.757 -176.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -99.81 -19.79 16.52 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.715 -0.394 . . . . 0.78000000000000003 111.869 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.78 16.01 80.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.731 -0.747 . . . . 0.29999999999999999 111.316 -173.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.1 tptp -86.48 130.09 34.62 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.552 -0.324 . . . . 1.6100000000000001 110.588 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.401 HD13 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -103.17 134.04 45.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 109.554 -0.535 . . . . 1.77 109.554 176.345 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.401 ' N ' HD13 ' A' ' 20' ' ' ILE . 58.4 m-85 -118.37 149.9 40.43 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 116.058 -0.519 . . . . 0.5 110.302 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -96.13 -25.67 15.78 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.808 -0.633 . . . . 2.8500000000000001 111.021 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.544 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 41.0 m95 -116.38 146.55 42.39 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.257 -0.429 . . . . 0.58999999999999997 110.202 -179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.438 ' O ' HG12 ' A' ' 28' ' ' ILE . 77.2 mtm180 -72.36 -36.84 68.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.97 -0.559 . . . . 3.3399999999999999 112.114 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.7 m -60.97 -49.5 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.854 0.316 . . . . 0.57999999999999996 111.854 -173.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.544 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.22 -31.93 66.29 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.664 0.268 . . . . 0.72999999999999998 110.477 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.52 -50.7 72.49 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.278 -0.419 . . . . 0.59999999999999998 110.745 176.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.7 mm -64.83 -32.27 57.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.219 0.533 . . . . 0.22 110.477 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.97 -48.42 76.53 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.012 -0.54 . . . . 3.6099999999999999 110.178 176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -65.98 -34.76 78.83 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.627 -0.715 . . . . 0.42999999999999999 110.805 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.83 -24.54 61.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.312 -0.404 . . . . 0.48999999999999999 112.025 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.7 ttm180 -70.23 -17.19 63.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.218 0.532 . . . . 4.0 110.163 177.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.3 t -79.34 13.96 1.73 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.907 -0.588 . . . . 1.6699999999999999 110.839 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -70.73 -13.52 62.09 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 120.86 0.362 . . . . 4.29 111.335 179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -76.6 -14.24 60.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.33 0.586 . . . . 7.8200000000000003 110.018 177.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -104.26 22.95 13.89 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.733 -0.667 . . . . 6.2300000000000004 110.906 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -91.53 167.62 12.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.139 -0.482 . . . . 8.0999999999999996 110.279 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 39' ' ' PRO . 13.8 ptmm? -139.71 108.56 7.14 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-O 120.953 0.406 . . . . 10.19 110.557 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 38' ' ' LYS . 10.5 Cg_endo -55.39 -39.9 88.5 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.96 2.44 . . . . 10.4 112.411 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -159.51 -57.96 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.154 -0.475 . . . . 12.77 110.145 177.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 65.0 tttm . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.123 -0.942 . . . . 14.94 110.643 -178.935 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 111.979 -0.448 . . . . 16.57 111.979 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.08 86.69 3.09 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.009 0.433 . . . . 15.0 110.888 -178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -124.99 105.58 9.31 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.109 -0.496 . . . . 14.85 110.039 -179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -160.78 97.1 1.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.827 -0.624 . . . . 12.380000000000001 109.505 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.0 t -73.73 107.53 4.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.055 0.455 . . . . 10.720000000000001 110.156 -178.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.51 ' CD ' ' H ' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -80.33 85.63 5.8 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.502 -0.772 . . . . 9.1199999999999992 111.525 -174.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' OG1' ' HB2' ' A' ' 10' ' ' LYS . 14.5 t -168.48 159.1 10.07 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.695 -0.684 . . . . 7.5300000000000002 110.112 176.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 m -114.34 -27.23 7.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.115 -0.493 . . . . 5.79 111.277 -178.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -130.95 -16.44 3.25 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 112.217 0.451 . . . . 6.1799999999999997 112.217 -176.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.465 ' HB2' ' OG1' ' A' ' 7' ' ' THR . 4.1 mptp? -84.49 68.78 10.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.396 0.617 . . . . 5.7800000000000002 110.695 -177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 58.6 m -129.0 78.69 1.87 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.467 -0.788 . . . . 1.8899999999999999 109.64 176.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -82.49 114.03 20.64 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.573 -0.739 . . . . 0.78000000000000003 109.927 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 43.7 t -108.41 125.27 65.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 120.813 0.339 . . . . 0.42999999999999999 111.475 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.9 t -74.71 118.12 67.71 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 108.354 -0.98 . . . . 0.58999999999999997 108.354 171.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -66.17 -22.07 54.56 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.666 2.244 . . . . 0.60999999999999999 113.223 -169.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -85.3 -36.98 20.5 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.438 -0.346 . . . . 1.24 111.428 -177.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 m -105.77 -19.64 13.69 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.035 0.383 . . . . 0.78000000000000003 112.035 -172.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 78.39 16.43 79.49 Favored Glycine 0 C--N 1.329 0.181 0 C-N-CA 120.692 -0.766 . . . . 0.29999999999999999 111.836 -177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 41.7 tptt -83.06 130.19 35.1 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.682 -0.259 . . . . 1.6100000000000001 110.317 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 7.7 tt -106.93 128.35 61.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 120.982 0.42 . . . . 1.77 111.212 -178.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.513 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 85.9 m-85 -118.01 150.44 39.28 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.149 -0.478 . . . . 0.5 109.819 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 59.6 ttt180 -100.57 -16.83 17.34 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.878 -0.601 . . . . 2.8500000000000001 110.439 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 22.8 m95 -122.6 146.27 47.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.96 -0.564 . . . . 0.58999999999999997 109.833 -177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' O ' HG12 ' A' ' 28' ' ' ILE . 25.7 ttt180 -72.28 -39.29 68.46 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.889 -0.596 . . . . 3.3399999999999999 112.441 -175.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.2 m -60.05 -49.8 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 112.062 0.393 . . . . 0.57999999999999996 112.062 -173.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.438 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -72.53 -29.7 63.81 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.779 0.323 . . . . 0.72999999999999998 110.663 178.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.513 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 48.4 t80 -61.18 -50.92 71.2 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.976 -0.556 . . . . 0.59999999999999998 110.956 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.471 HG12 ' O ' ' A' ' 24' ' ' ARG . 49.9 mm -63.87 -34.25 67.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.095 0.474 . . . . 0.22 110.321 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -62.25 -46.21 89.86 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.599 -0.728 . . . . 3.6099999999999999 110.223 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -72.51 -27.28 62.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.08 -0.509 . . . . 0.42999999999999999 111.522 178.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -62.7 -23.22 67.03 Favored 'General case' 0 C--N 1.322 -0.63 0 O-C-N 122.154 -0.341 . . . . 0.48999999999999999 111.299 178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.9 mmm180 -60.42 -25.77 66.2 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 4.0 109.43 169.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.402 ' HA ' ' OE2' ' A' ' 36' ' ' GLU . 58.7 m -97.31 74.73 2.51 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 122.265 1.031 . . . . 1.6699999999999999 110.432 172.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -118.57 -53.56 2.31 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 113.845 -1.525 . . . . 4.29 107.733 170.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -159.6 60.26 0.38 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.749 -1.114 . . . . 7.8200000000000003 109.757 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.475 ' HG2' ' N ' ' A' ' 37' ' ' GLN . 1.4 pm0 -85.48 -46.46 10.85 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.772 -0.371 . . . . 6.2300000000000004 110.114 -178.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.475 ' N ' ' HG2' ' A' ' 36' ' ' GLU . 14.5 mm100 -146.11 -70.36 0.26 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.912 -0.585 . . . . 8.0999999999999996 109.765 179.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -121.16 125.46 26.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.7 -0.682 . . . . 10.19 109.876 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_exo -51.99 116.25 2.66 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.141 2.561 . . . . 10.4 112.771 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -93.55 64.76 3.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 12.77 110.658 -179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 61.6 tttm . . . . . 0 C--O 1.25 1.094 0 CA-C-O 118.462 -0.78 . . . . 14.94 109.689 177.865 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.801 0 N-CA-C 111.818 -0.513 . . . . 16.57 111.818 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.61 -1.65 22.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.837 0.351 . . . . 15.0 111.315 -177.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.5 mtt -88.32 -12.67 42.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.389 -0.369 . . . . 14.85 111.164 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.7 mm-40 -78.83 57.34 2.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.113 0.483 . . . . 12.380000000000001 111.231 178.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.6 t -87.38 126.6 41.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 115.782 -0.645 . . . . 10.720000000000001 109.499 176.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 6' ' ' GLN . 6.8 tp60 -72.06 89.17 1.12 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.115 0.484 . . . . 9.1199999999999992 110.756 -177.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.9 t -166.91 148.85 6.15 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.961 -0.563 . . . . 7.5300000000000002 110.075 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.2 t -91.28 76.65 5.98 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.952 -0.759 . . . . 5.79 108.952 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -146.51 -41.39 0.2 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.869 -0.605 . . . . 6.1799999999999997 111.483 -175.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.42 ' HB2' HD11 ' A' ' 20' ' ' ILE . 47.7 pttt -75.32 70.73 2.25 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.771 0.796 . . . . 5.7800000000000002 111.172 -175.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 10.2 t -115.53 12.78 16.26 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.596 -0.729 . . . . 1.8899999999999999 110.795 -176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -97.39 108.42 21.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.897 0.38 . . . . 0.78000000000000003 110.655 -175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.3 t -113.09 126.45 70.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.864 -0.607 . . . . 0.42999999999999999 110.452 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.1 t -71.41 118.59 67.48 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 108.997 -0.742 . . . . 0.58999999999999997 108.997 171.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.14 -19.76 69.51 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.737 2.291 . . . . 0.60999999999999999 112.438 -175.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -90.47 -42.62 10.76 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.056 -0.52 . . . . 1.24 111.728 -177.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 39.0 m -98.7 -19.91 17.23 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.195 0.443 . . . . 0.78000000000000003 112.195 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.36 15.52 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.29999999999999999 111.08 -172.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.6 tptp -80.79 130.48 35.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.089 -0.556 . . . . 1.6100000000000001 109.985 -175.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -106.44 129.13 60.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.321 0.581 . . . . 1.77 109.936 -178.411 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 62.3 m-85 -117.38 149.95 39.67 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.278 0.561 . . . . 0.5 110.549 -174.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -97.1 -31.58 12.41 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.243 -0.89 . . . . 2.8500000000000001 110.723 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.581 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 50.9 m95 -110.99 143.42 41.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.078 0.466 . . . . 0.58999999999999997 110.402 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' O ' HG12 ' A' ' 28' ' ' ILE . 76.5 mtm180 -72.52 -35.13 68.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.517 -0.765 . . . . 3.3399999999999999 111.537 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.8 m -61.23 -49.61 83.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 111.812 0.301 . . . . 0.57999999999999996 111.812 -174.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.581 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.5 OUTLIER -74.65 -29.93 61.44 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.887 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.546 ' HD1' ' CD1' ' A' ' 21' ' ' PHE . 68.7 t80 -61.51 -51.14 69.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.215 -0.448 . . . . 0.59999999999999998 110.969 178.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.536 HG12 ' O ' ' A' ' 24' ' ' ARG . 50.1 mm -62.36 -33.45 59.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.044 0.449 . . . . 0.22 110.264 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -66.55 -40.55 89.11 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 3.6099999999999999 110.138 177.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -65.82 -39.12 90.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.763 -0.653 . . . . 0.42999999999999999 110.622 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.1 mm? -69.01 -25.16 64.36 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.23 -0.441 . . . . 0.48999999999999999 110.833 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.1 ttm180 -68.17 -26.16 65.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.336 0.588 . . . . 4.0 110.028 174.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.7 t -76.1 2.34 13.18 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.649 -0.705 . . . . 1.6699999999999999 111.2 -176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -69.72 -21.07 63.5 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.338 0.59 . . . . 4.29 109.892 174.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -83.05 -7.37 59.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.438 -0.801 . . . . 7.8200000000000003 109.953 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -102.28 16.27 26.7 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.837 -0.62 . . . . 6.2300000000000004 109.961 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -109.94 164.77 12.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.637 -0.711 . . . . 8.0999999999999996 110.622 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -99.16 130.9 26.27 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.795 -0.639 . . . . 10.19 110.213 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -46.81 -63.38 0.33 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.365 2.71 . . . . 10.4 113.205 -173.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.3 t60 -159.62 -58.36 0.06 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.311 -0.404 . . . . 12.77 110.342 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 55.2 tttm . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.972 -1.013 . . . . 14.94 109.975 -174.396 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.774 0 N-CA-C 112.179 -0.369 . . . . 16.57 112.179 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.73 118.05 25.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 110.427 -0.212 . . . . 15.0 110.427 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 67.0 mtm 72.69 -44.42 0.59 Allowed 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.512 0.725 . . . . 14.85 111.406 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -127.33 141.05 51.8 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.705 -0.48 . . . . 12.380000000000001 109.705 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.65 159.95 15.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.255 -0.429 . . . . 10.720000000000001 110.611 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -89.38 43.07 1.12 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.33 0.586 . . . . 9.1199999999999992 110.755 -177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 t -161.57 145.9 13.02 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.415 -0.811 . . . . 7.5300000000000002 109.67 178.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 p -74.5 -60.5 2.24 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.142 -0.481 . . . . 5.79 111.01 178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.454 ' HG3' ' HG2' ' A' ' 10' ' ' LYS . 3.0 pt20 -170.62 -45.49 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.191 -0.459 . . . . 6.1799999999999997 110.921 177.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.454 ' HG2' ' HG3' ' A' ' 9' ' ' GLN . 51.8 pttt -153.71 128.96 9.75 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.957 0.408 . . . . 5.7800000000000002 110.85 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.5 m -101.53 141.31 34.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.002 -0.545 . . . . 1.8899999999999999 109.716 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 72.2 m-85 -100.06 117.36 34.16 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.906 -0.588 . . . . 0.78000000000000003 109.484 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 20' ' ' ILE . 16.8 t -105.62 120.84 57.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.584 0.231 . . . . 0.42999999999999999 111.291 -175.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 36.1 t -75.18 119.16 75.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.109 -0.7 . . . . 0.58999999999999997 109.109 170.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -66.85 -14.83 45.26 Favored 'Trans proline' 0 CA--C 1.526 0.115 0 C-N-CA 122.662 2.242 . . . . 0.60999999999999999 112.906 -175.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -91.15 -33.81 15.28 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.477 -0.329 . . . . 1.24 111.693 -178.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.9 m -113.97 -18.57 11.71 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.827 0.677 . . . . 0.78000000000000003 112.827 -170.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.43 15.2 79.09 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.404 -0.903 . . . . 0.29999999999999999 110.937 -172.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 tptt -79.66 126.32 30.77 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.113 -0.544 . . . . 1.6100000000000001 109.764 -176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.51 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 39.5 pt -106.69 128.69 61.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.357 0.598 . . . . 1.77 111.645 -178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HD1' ' A' ' 12' ' ' TYR . 83.1 m-85 -117.32 150.61 38.54 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.541 -0.754 . . . . 0.5 109.242 -178.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 20.8 ttm180 -98.88 -21.92 16.06 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 120.948 0.404 . . . . 2.8500000000000001 110.802 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.7 m95 -110.34 145.21 37.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.216 -0.447 . . . . 0.58999999999999997 110.413 -179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 21.3 tpt180 -72.61 -36.78 68.15 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.896 -0.593 . . . . 3.3399999999999999 111.536 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.6 m -64.67 -49.25 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.213 0 CA-C-O 120.812 0.339 . . . . 0.57999999999999996 111.867 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.628 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -71.16 -25.4 62.53 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.972 0.415 . . . . 0.72999999999999998 110.709 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.628 ' N ' HD22 ' A' ' 26' ' ' ASN . 74.6 t80 -67.01 -50.04 63.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.867 -0.606 . . . . 0.59999999999999998 110.362 178.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.8 mm -62.26 -32.95 56.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.077 -0.51 . . . . 0.22 110.317 179.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -60.17 -48.37 82.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.757 -0.656 . . . . 3.6099999999999999 110.578 175.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 60.4 t60 -64.76 -37.51 87.84 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.603 -0.726 . . . . 0.42999999999999999 110.847 -179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -77.35 -24.62 50.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.997 -0.547 . . . . 0.48999999999999999 111.568 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -64.03 -35.86 82.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.021 0.439 . . . . 4.0 110.137 178.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.513 ' O ' ' HG3' ' A' ' 36' ' ' GLU . 21.3 m -86.21 42.34 0.98 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.942 -0.572 . . . . 1.6699999999999999 110.053 175.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 16.1 ttm180 -56.98 146.88 25.55 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 115.574 -0.739 . . . . 4.29 111.01 -175.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 70.54 48.67 0.44 Allowed 'General case' 0 C--O 1.235 0.324 0 CA-C-O 122.34 1.067 . . . . 7.8200000000000003 108.257 -172.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 33' ' ' SER . 3.2 mp0 -60.78 -48.13 83.2 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 113.839 -1.528 . . . . 6.2300000000000004 110.152 178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 67.84 165.3 0.23 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.404 -0.816 . . . . 8.0999999999999996 111.192 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.552 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . 23.7 tptm -94.89 -53.33 0.23 Allowed Pre-proline 0 C--N 1.32 -0.674 0 CA-C-N 115.584 -0.734 . . . . 10.19 110.758 178.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 38' ' ' LYS . 93.4 Cg_endo -78.38 92.34 1.14 Allowed 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 121.941 1.761 . . . . 10.4 112.161 176.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 10.3 p-80 -105.47 25.47 10.67 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.254 -0.43 . . . . 12.77 111.341 -177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.716 -0.659 . . . . 14.94 109.804 177.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.685 0 N-CA-C 112.023 -0.431 . . . . 16.57 112.023 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.73 101.39 9.49 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.765 0.317 . . . . 15.0 110.522 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.4 ttt -59.44 -51.08 71.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.76 -0.655 . . . . 14.85 110.802 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -110.85 113.0 25.24 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.864 -0.607 . . . . 12.380000000000001 109.691 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 90.8 t -61.75 119.33 5.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.78 -0.645 . . . . 10.720000000000001 111.14 -177.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 56.65 63.98 1.8 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.109 -0.95 . . . . 9.1199999999999992 110.898 179.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.9 t -83.03 60.23 5.36 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.813 0.816 . . . . 7.5300000000000002 109.467 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.601 ' OG ' ' HD3' ' A' ' 22' ' ' ARG . 66.1 m 65.06 -80.67 0.03 OUTLIER 'General case' 0 C--O 1.235 0.301 0 CA-C-N 114.583 -1.19 . . . . 5.79 111.175 -174.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -175.11 -48.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.214 0.531 . . . . 6.1799999999999997 109.929 -177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.8 pttp -93.63 150.69 20.22 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.597 -0.729 . . . . 5.7800000000000002 109.985 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.0 p -150.04 125.13 10.0 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.143 0.497 . . . . 1.8899999999999999 110.841 -177.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -100.99 120.65 40.5 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.734 -0.667 . . . . 0.78000000000000003 109.687 -178.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 19' ' ' LYS . 41.9 t -108.3 117.43 53.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 120.926 -0.31 . . . . 0.42999999999999999 110.844 179.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.3 t -70.98 118.52 66.28 Favored Pre-proline 0 C--N 1.325 -0.471 0 N-CA-C 109.413 -0.588 . . . . 0.58999999999999997 109.413 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -67.33 -15.98 47.0 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.508 2.138 . . . . 0.60999999999999999 112.472 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -87.88 -25.76 23.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.998 -0.546 . . . . 1.24 111.181 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.4 m -121.16 -19.96 6.94 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.469 0.544 . . . . 0.78000000000000003 112.469 -174.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 74.36 15.75 80.14 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.577 -0.82 . . . . 0.29999999999999999 111.227 -173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 17.7 tptm -83.49 135.77 34.54 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.518 0.327 . . . . 1.6100000000000001 110.191 -176.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -106.26 125.6 61.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.175 0.512 . . . . 1.77 110.371 -179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.4 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 87.5 m-85 -116.71 147.74 41.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.992 -0.549 . . . . 0.5 109.997 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.601 ' HD3' ' OG ' ' A' ' 8' ' ' SER . 13.1 ttm180 -98.52 -28.39 13.61 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.805 -0.634 . . . . 2.8500000000000001 110.135 178.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 58.6 m95 -105.51 143.44 33.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.515 -0.766 . . . . 0.58999999999999997 110.911 -175.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' O ' HG12 ' A' ' 28' ' ' ILE . 45.4 ttp180 -72.59 -36.19 68.09 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.063 -0.971 . . . . 3.3399999999999999 111.419 -178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.14 -48.61 80.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 111.86 0.319 . . . . 0.57999999999999996 111.86 -173.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.98 -27.0 61.55 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.994 -0.282 . . . . 0.72999999999999998 110.861 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' N ' HD22 ' A' ' 26' ' ' ASN . 74.1 t80 -66.61 -50.1 64.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.787 0.327 . . . . 0.59999999999999998 110.34 177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 24' ' ' ARG . 47.0 mm -64.19 -36.46 77.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.141 -0.481 . . . . 0.22 110.425 179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 36.0 ttm180 -61.62 -44.77 96.38 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.285 0.564 . . . . 3.6099999999999999 110.253 176.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 71.7 t60 -66.9 -35.31 79.72 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.067 -0.97 . . . . 0.42999999999999999 111.038 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.449 ' O ' ' HG3' ' A' ' 34' ' ' ARG . 3.9 mm? -78.08 -34.47 50.22 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 111.91 0.337 . . . . 0.48999999999999999 111.91 179.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.34 -42.31 99.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.83 0.347 . . . . 4.0 110.935 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.1 m -75.76 -33.85 60.24 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.301 -0.409 . . . . 1.6699999999999999 110.644 178.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 11.2 mtp180 67.49 -63.46 0.3 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.402 0.681 . . . . 4.29 112.521 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' NH2' ' HA ' ' A' ' 39' ' ' PRO . 23.3 tpt180 -156.21 -70.17 0.11 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 110.169 -0.308 . . . . 7.8200000000000003 110.169 -176.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.5 mm-40 55.77 42.32 29.27 Favored 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.432 0.457 . . . . 6.2300000000000004 111.779 179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -174.81 138.34 0.48 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.741 -0.837 . . . . 8.0999999999999996 108.741 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -54.22 113.22 4.78 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.749 0.309 . . . . 10.19 111.633 -174.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.469 ' HA ' ' NH2' ' A' ' 35' ' ' ARG . 64.4 Cg_endo -76.95 -24.88 9.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.789 2.326 . . . . 10.4 111.993 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 9.2 p80 -179.86 -29.73 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.123 -0.944 . . . . 12.77 108.895 178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 41' ' ' LYS . 39.2 ttmt . . . . . 0 C--O 1.248 1.012 0 CA-C-N 115.323 -0.853 . . . . 14.94 109.339 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.611 0 N-CA-C 112.08 -0.408 . . . . 16.57 112.08 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.2 -48.95 1.32 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.84 0.352 . . . . 15.0 110.916 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.7 tmm? -86.67 109.55 19.27 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.255 -0.43 . . . . 14.85 110.155 -177.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -171.22 101.43 0.21 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.881 -0.6 . . . . 12.380000000000001 109.793 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.0 t 56.35 66.76 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.632 0.729 . . . . 10.720000000000001 110.473 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.463 ' HA ' ' HB3' ' A' ' 10' ' ' LYS . 3.4 pt20 -108.72 32.48 4.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.533 -0.758 . . . . 9.1199999999999992 110.36 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.5 p -59.46 -74.87 0.06 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.335 -0.848 . . . . 7.5300000000000002 111.268 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.1 t -142.26 9.92 1.88 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.77 0.319 . . . . 5.79 110.637 178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.453 ' HA ' ' NH2' ' A' ' 24' ' ' ARG . 17.8 pt20 -115.17 1.09 13.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.713 0.292 . . . . 6.1799999999999997 111.498 -178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.463 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . 64.9 tttm -154.14 148.47 26.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.505 -0.554 . . . . 5.7800000000000002 109.505 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 6' ' ' GLN . 21.4 p 47.24 72.63 0.24 Allowed 'General case' 0 N--CA 1.467 0.409 0 O-C-N 123.891 0.744 . . . . 1.8899999999999999 110.362 -174.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -77.42 124.78 28.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.227 -0.897 . . . . 0.78000000000000003 110.145 -174.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.446 HG22 ' CD1' ' A' ' 20' ' ' ILE . 10.2 t -108.14 116.82 52.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.265 -0.425 . . . . 0.42999999999999999 110.51 -178.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.512 ' SG ' ' HB3' ' A' ' 16' ' ' ASN . 17.4 t -72.25 121.2 84.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.274 -0.639 . . . . 0.58999999999999997 109.274 173.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -73.81 -13.39 24.29 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 C-N-CA 122.327 2.018 . . . . 0.60999999999999999 110.328 178.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.512 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -90.17 -28.54 18.84 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.744 -1.571 . . . . 1.24 111.444 -173.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.6 m -123.53 -20.49 5.54 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 112.638 0.607 . . . . 0.78000000000000003 112.638 177.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.38 16.19 76.64 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.06 -0.816 . . . . 0.29999999999999999 111.06 -169.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.9 tptm -82.29 143.97 30.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 122.661 0.384 . . . . 1.6100000000000001 110.91 -173.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' CD1' HG22 ' A' ' 13' ' ' VAL . 11.5 mm -105.44 128.39 59.49 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.252 0 CA-C-O 121.393 0.616 . . . . 1.77 111.124 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' CD1' ' HD1' ' A' ' 27' ' ' PHE . 63.0 m-85 -118.23 148.41 42.43 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.975 -1.011 . . . . 0.5 110.263 178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -104.04 -23.31 13.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.823 -0.626 . . . . 2.8500000000000001 110.673 -178.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 63.5 m95 -113.61 152.0 30.93 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.471 -0.331 . . . . 0.58999999999999997 110.399 -179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.502 ' O ' HG12 ' A' ' 28' ' ' ILE . 10.9 tpp180 -71.66 -47.63 53.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.027 -0.533 . . . . 3.3399999999999999 111.659 -177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 16.9 m -63.0 -48.07 89.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 112.444 0.535 . . . . 0.57999999999999996 112.444 -169.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.677 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -68.36 -26.47 65.6 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.723 0.296 . . . . 0.72999999999999998 110.975 -178.557 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.677 ' N ' HD22 ' A' ' 26' ' ' ASN . 81.0 t80 -69.7 -50.18 46.22 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.063 -0.517 . . . . 0.59999999999999998 109.799 177.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.568 ' O ' ' HG2' ' A' ' 32' ' ' ARG . 37.8 mm -59.16 -41.96 85.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.828 -0.624 . . . . 0.22 109.845 178.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -59.55 -42.66 92.88 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.557 -0.747 . . . . 3.6099999999999999 110.69 178.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 50.5 t60 -61.75 -42.87 99.53 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.546 -0.752 . . . . 0.42999999999999999 111.254 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -74.1 -36.69 64.27 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.443 -0.344 . . . . 0.48999999999999999 110.79 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 28' ' ' ILE . 26.2 mmm180 -66.27 -40.57 90.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.589 -0.278 . . . . 4.0 110.729 177.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.2 t -60.36 -41.48 93.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.053 -0.522 . . . . 1.6699999999999999 110.577 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -65.59 -45.6 82.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.051 -0.522 . . . . 4.29 110.678 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 27.9 ttm180 55.32 78.8 0.17 Allowed 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.344 0.593 . . . . 7.8200000000000003 110.106 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -78.68 63.8 3.54 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.492 -0.777 . . . . 6.2300000000000004 111.565 -175.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -122.33 168.61 11.85 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.685 -0.689 . . . . 8.0999999999999996 109.801 177.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -113.12 101.14 53.03 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.173 -0.467 . . . . 10.19 110.119 178.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -56.64 -34.98 96.97 Favored 'Trans proline' 0 C--N 1.342 0.237 0 C-N-CA 123.088 2.525 . . . . 10.4 112.727 -178.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -151.5 -46.03 0.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.557 -0.292 . . . . 12.77 111.342 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.8 ptmm? . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.219 -0.896 . . . . 14.94 111.634 -176.148 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.702 0 N-CA-C 112.148 -0.381 . . . . 16.57 112.148 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 59.19 -165.93 0.18 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 122.81 0.444 . . . . 15.0 111.191 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.4 mtp 67.6 28.53 7.43 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.061 0.458 . . . . 14.85 110.928 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 63.2 mm-40 -86.86 70.09 10.32 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.975 -0.557 . . . . 12.380000000000001 110.362 178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.8 t 58.43 55.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.742 0.782 . . . . 10.720000000000001 109.839 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.42 76.42 1.36 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.381 -0.827 . . . . 9.1199999999999992 108.913 178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -87.36 54.3 3.1 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.72 -0.673 . . . . 7.5300000000000002 109.896 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t 57.33 80.94 0.15 Allowed 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.31 -0.859 . . . . 5.79 109.594 -173.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -68.28 94.75 0.55 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.661 -0.7 . . . . 6.1799999999999997 111.182 -175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 22' ' ' ARG . 47.7 mmtm 55.76 48.93 17.25 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.812 -0.631 . . . . 5.7800000000000002 111.219 176.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.8 m -132.78 77.08 1.72 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.555 -0.748 . . . . 1.8899999999999999 109.781 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.53 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 52.5 m-85 -91.57 117.19 29.5 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.711 -0.677 . . . . 0.78000000000000003 110.371 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 20' ' ' ILE . 11.3 t -108.66 115.67 49.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.758 -0.201 . . . . 0.42999999999999999 111.176 -176.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.2 t -70.67 120.93 81.98 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 109.528 -0.545 . . . . 0.58999999999999997 109.528 173.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -67.13 -16.29 48.58 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.702 2.268 . . . . 0.60999999999999999 112.846 -175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -90.32 -32.82 16.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.695 0.284 . . . . 1.24 111.354 -177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.2 m -113.3 -20.16 11.49 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.654 0.613 . . . . 0.78000000000000003 112.654 -172.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.8 12.23 80.88 Favored Glycine 0 N--CA 1.453 -0.187 0 N-CA-C 110.586 -1.005 . . . . 0.29999999999999999 110.586 -171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -77.27 124.37 27.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.773 -0.714 . . . . 1.6100000000000001 109.699 -177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 12' ' ' TYR . 36.2 mt -106.03 130.46 57.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.99 0.424 . . . . 1.77 110.745 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -115.28 149.11 38.32 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.722 -0.672 . . . . 0.5 110.105 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 10' ' ' LYS . 12.3 ttm180 -96.99 -16.01 20.81 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.455 -0.793 . . . . 2.8500000000000001 110.44 -178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 73.4 m95 -121.62 148.61 44.32 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.008 -0.542 . . . . 0.58999999999999997 110.51 -177.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' O ' HG12 ' A' ' 28' ' ' ILE . 56.7 ttt180 -71.54 -38.97 70.99 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.621 -0.718 . . . . 3.3399999999999999 111.231 -178.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 12.7 m -65.39 -48.59 82.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 112.158 0.429 . . . . 0.57999999999999996 112.158 -172.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.66 HD22 ' N ' ' A' ' 27' ' ' PHE . 0.4 OUTLIER -72.74 -26.22 61.49 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.567 0.223 . . . . 0.72999999999999998 111.083 -179.756 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.66 ' N ' HD22 ' A' ' 26' ' ' ASN . 63.5 t80 -65.97 -49.88 66.29 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.994 0.426 . . . . 0.59999999999999998 110.279 177.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 24' ' ' ARG . 43.8 mm -60.82 -33.19 54.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.916 -0.583 . . . . 0.22 110.052 178.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.5 ttt180 -62.4 -43.86 97.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.876 -0.602 . . . . 3.6099999999999999 110.682 176.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 73.1 t60 -67.18 -37.29 83.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.659 -0.7 . . . . 0.42999999999999999 110.883 -179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -78.09 -29.64 49.19 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.339 -0.391 . . . . 0.48999999999999999 110.873 178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 56.1 ttp180 -66.66 -37.93 85.79 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.569 -0.53 . . . . 4.0 109.569 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.1 m -79.27 55.59 1.9 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.563 -0.744 . . . . 1.6699999999999999 109.604 174.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 -80.61 60.05 3.8 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.887 0.851 . . . . 4.29 110.27 -177.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 36.1 ptt180 -112.43 25.16 11.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.583 -1.189 . . . . 7.8200000000000003 109.085 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -82.63 -25.48 33.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.791 -1.095 . . . . 6.2300000000000004 109.883 -175.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -131.61 -63.33 0.84 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.367 -0.833 . . . . 8.0999999999999996 110.103 174.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.49 92.11 0.07 OUTLIER Pre-proline 0 C--O 1.235 0.329 0 O-C-N 123.812 0.695 . . . . 10.19 111.488 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.09 141.62 26.59 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.762 2.308 . . . . 10.4 111.249 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -79.86 -20.85 44.96 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.599 -0.519 . . . . 12.77 109.599 179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.246 0.911 0 CA-C-O 118.368 -0.825 . . . . 14.94 110.132 176.669 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.826 -0.11 . . . . 16.57 112.826 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.79 -51.66 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.936 0.398 . . . . 15.0 110.428 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.6 mmt -121.69 77.78 1.39 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.115 0.483 . . . . 14.85 111.031 -178.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -98.58 125.33 43.8 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.694 -0.685 . . . . 12.380000000000001 110.117 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.8 t -92.71 -40.44 12.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.878 0.371 . . . . 10.720000000000001 110.505 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -80.75 69.68 7.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.27 0.557 . . . . 9.1199999999999992 110.643 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.3 t -160.36 175.36 12.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.664 -0.698 . . . . 7.5300000000000002 109.468 177.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 16.4 m 69.7 130.19 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.248 0 O-C-N 123.936 0.773 . . . . 5.79 111.09 -179.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -68.08 -30.22 69.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.91 -0.586 . . . . 6.1799999999999997 109.851 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.1 ptpp? -147.55 123.68 10.8 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.513 -0.767 . . . . 5.7800000000000002 109.775 172.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.1 p -145.33 124.85 13.17 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.313 0.577 . . . . 1.8899999999999999 110.945 -178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' ILE . 38.3 m-85 -111.54 129.04 56.18 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.42 -0.809 . . . . 0.78000000000000003 109.208 179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG22 HG22 ' A' ' 20' ' ' ILE . 15.6 t -108.58 120.47 60.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 120.642 0.258 . . . . 0.42999999999999999 111.619 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 19.6 t -73.03 120.24 79.93 Favored Pre-proline 0 C--N 1.327 -0.381 0 N-CA-C 108.666 -0.865 . . . . 0.58999999999999997 108.666 169.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -68.83 -17.11 41.99 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.576 2.184 . . . . 0.60999999999999999 112.218 -173.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -90.18 -42.69 10.9 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.834 -0.621 . . . . 1.24 111.389 -177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 36.1 m -98.31 -20.12 17.38 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 111.923 0.342 . . . . 0.78000000000000003 111.923 -175.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 73.42 15.87 78.96 Favored Glycine 0 N--CA 1.453 -0.202 0 N-CA-C 110.995 -0.842 . . . . 0.29999999999999999 110.995 -173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -81.53 135.02 35.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.034 -0.583 . . . . 1.6100000000000001 109.973 -174.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.434 HG22 HG22 ' A' ' 13' ' ' VAL . 49.2 pt -106.54 130.49 58.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.174 0.512 . . . . 1.77 111.031 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -117.4 149.33 40.7 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.733 -0.667 . . . . 0.5 109.977 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -96.53 -33.24 11.9 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.113 -0.494 . . . . 2.8500000000000001 110.651 -178.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.626 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 62.6 m95 -106.87 149.8 27.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.58999999999999997 110.666 -179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' O ' HG12 ' A' ' 28' ' ' ILE . 8.8 mmm180 -71.24 -36.35 71.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.458 -0.792 . . . . 3.3399999999999999 111.818 -178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.7 m -63.03 -48.66 86.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 111.857 0.317 . . . . 0.57999999999999996 111.857 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.626 ' OD1' ' HB2' ' A' ' 23' ' ' TRP . 0.6 OUTLIER -72.98 -31.9 64.84 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.186 -0.206 . . . . 0.72999999999999998 110.984 179.077 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.464 ' O ' HD23 ' A' ' 31' ' ' LEU . 59.3 t80 -61.04 -50.83 71.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.732 0.301 . . . . 0.59999999999999998 110.565 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 24' ' ' ARG . 52.0 mm -65.28 -34.18 68.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 120.881 0.372 . . . . 0.22 110.043 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -60.08 -44.9 94.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.969 -0.56 . . . . 3.6099999999999999 110.201 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 78.9 t60 -64.94 -38.64 91.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.687 -0.688 . . . . 0.42999999999999999 111.158 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.464 HD23 ' O ' ' A' ' 27' ' ' PHE . 4.5 mm? -77.21 -31.9 55.56 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.847 0.356 . . . . 0.48999999999999999 111.396 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -72.57 -25.45 61.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.046 0.451 . . . . 4.0 110.703 179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.5 m -85.11 10.05 13.2 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.05 -0.523 . . . . 1.6699999999999999 111.281 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 63.5 mtp180 -74.56 -66.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.113 -0.329 . . . . 4.29 110.113 176.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 56.79 44.62 23.1 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.736 0.779 . . . . 7.8200000000000003 109.505 -175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -117.99 29.95 7.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 114.833 -1.076 . . . . 6.2300000000000004 110.048 -177.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -68.62 -24.24 64.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.773 -0.649 . . . . 8.0999999999999996 110.215 178.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' H ' ' CD ' ' A' ' 39' ' ' PRO . 28.7 ttpp -134.21 -46.47 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 115.622 -0.717 . . . . 10.19 110.782 173.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.553 ' CD ' ' H ' ' A' ' 38' ' ' LYS . 3.2 Cg_exo -82.43 86.29 1.53 Allowed 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 122.275 1.984 . . . . 10.4 111.816 175.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.8 p-80 -94.5 44.89 1.11 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.35 0.595 . . . . 12.77 110.854 -178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.4 pttt . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.647 -0.706 . . . . 14.94 111.128 -178.052 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_